• SHOP
      • COMBOS
      • TESTIMONIALS
      • CART
      • INGREDIENTS
        • 2-DEOXY-D-GLUCOSE (2DG)
        • ACACIA CYANOPHYLLA FLOWER
        • ACORI GRAMINEI RHIZOMA
        • AEGLE MARMELOS CORREA
        • AGARICUS BLAZEI
        • AGED GARLIC EXTRACT
        • AFRAMOMUM MELEGUETA
        • ALOE ARBORESCENS
        • ALBIZIA
        • ALPINIA OFFICINARUM
        • ALTERNANTHERA SESSILIS
        • AMERICAN GINSENG
        • AMYGDALIN
        • ANACYCLUS PYRETHRUM
        • ANGELICA ARCHANGELICA
        • ANGELICA SINENSIS
        • ANTRODIA
        • ARTICHOKE LEAF
        • ARTOCARPIN
        • AJUGA TURKESTANICA
        • ASHWAGANDHA
        • ASPALATHIN
        • ASTRAGALUS COMPLANATUS
        • AVENA SATIVA
        • BACOPA MONNIERI
        • BAVACHIN
        • BEE POLLEN
        • BETULINIC ACID
        • BOSWELLIC ACID
        • BREVILIN A
        • CAMPESTEROL
        • CAPSAICIN
        • CARCININE
        • CASTICIN
        • CHRYSIN
        • CIANIDANOL
        • CINNAMOMUM ZEYLANICUM
        • CITRULLUS COLOCYNTHIS
        • CITRUS RETICULATA PEEL
        • CODONOPSIS
        • CONJUGATED LINOLEIC ACID
        • COSTUNOLIDE
        • CYANIDIN
        • CUCURBITACIN D
        • DAIDZEIN
        • DECURSIN
        • DELPHINIDIN
        • DIGITALIS PURPREA (DIGOXIN)
        • DIOSMIN
        • ECKLONIA CAVA
        • ELLAGIC ACID
        • EMBELIN
        • ERIODICTYOL
        • GALLIC ACID
        • GLYCITEIN
        • GLYCYRRHIZIN
        • HYPERFORIN
        • ICARIIN
        • ISORHAMNETIN
        • ISOORIENTIN
        • ISOVITEXIN
        • JACEOSIDIN
        • KAEMPFEROL
        • KIGELIA AFRICANA
        • KURARINONE
        • LEMON BALM
        • LICORICIDIN
        • LIPOIC ACID
        • LUPEOL
        • MAGNOLOL
        • MENAQUINONE 4
        • MULBERRY LEAF
        • NARINGENIN
        • NOBILETIN
        • OLEACEIN
        • OLEANOLIC ACID
        • OLIVE OIL
        • ORIDONIN
        • PARTHENOLIDE
        • PHLOROGLUCINOL
        • PHLORIZIN
        • PICEATANNOL
        • PRISTIMERIN
        • PROANTHOCYANIDINS
        • PROCYANIDIN B3
        • PSEUDOLARIC ACID B
        • PTEROSTILBENE
        • RUTIN
        • SOLIDAGO VIRGAUREA
        • TANGERETIN
        • TARAXASTEROL
        • TRICHOSTATIN A
        • WEDELOLACTONE
        • WOGONIN
        • YERBA MATE
      • ABOUT
      • SCIENTIFIC STUDIES
        • ADAPTOGENS
        • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
        • ADDICTION & THE BRAIN
        • ADDICTION & STRESS
        • ADDICTION WITHDRAWAL
        • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
        • ADIPOCYTE DIFFERENTIATION
        • ADROPIN
        • ALLERGIES & CYTOKINES
        • ALDOSTERONE & OBESITY/HYPERTENSION
        • ALZHEIMER’S, DEMENTIA, PARKINSON’S
        • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
        • ADVANCED GLYCATION END PRODUCTS (AGES)
        • ADDICTION TREATMENT
        • ADDICTION & DOPAMINE
        • AMPK
        • ANTI AGING
        • ANTIAGING EFFECTS OF COFFEE
        • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
        • ANTI-APOPTOTIC PATHWAYS
        • ANTI ATHEROGENIC
        • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
        • ANTI CARIOGENIC (Protecting From Tooth Decay)
        • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
        • ANTI GLYCATIVE
        • ANTI GLYCATION AGENTS
        • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
        • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
        • ANTI WRINKLE AGENTS
        • ANXIOGENIC
        • ANXIOLYTIC
        • APOPTOSIS
        • APOPTOSIS IN 3T3-L1
        • AUTOPHAGY
        • BCL-2
        • BCL-W
        • BCL-XL
        • BDNF
        • BECLIN-1 & AUTOPHAGY
        • BH3 MIMETICS
        • BIM aka BCL2L11
        • BIOMIMETIC HYDROXYAPATITE
        • BMI-1
        • BPA & OBESITY
        • BRASSINOSTEROIDS
        • CALORIE RESTRICTION
        • CALORIE RESTRICTION & LIFESPAN EXTENSION
        • CARBAMYLATION
        • CARBONYL SCAVENGER
        • CARBONYL STRESS
        • CARDIOPROTECTIVE AGENTS
        • CARDIAC GLYCOSIDES
        • CATALASE
        • CELL CYCLE ARREST
        • CENTENARIANS
        • CDK5
        • CHOLESTEROL EFFLUX
        • COGNITIVE ENHANCEMENT
        • COLD SHOCK PROTEINS
        • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
        • CONDITIONED PLACE PREFERENCE
        • CORTICOTROPIN RELEASING FACTOR
        • COSMECEUTICAL
        • CRYOTHERAPY
        • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
        • CYP2E1
        • CYTOKINES IN PAIN, INFLAMMATION & AGING
        • DAF-16
        • DEPERSONALIZATION
        • DIABETES & CANCER
        • DIHYDROTESTOSTERONE (DHT)
        • DNA METHYLATION & AGING
        • DNA REPAIR
        • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
        • DRY FASTING AND FLUID RESTRICTION FASTING
        • DYNORPHIN
        • ELLAGITANNINS
        • ENDOCRINE DISRUPTING CHEMICALS
        • ENLARGED HEART AND CARDIOMEGALY
        • EPIGENETIC ALTERATIONS
        • EPIGENETIC MODIFIERS
        • EPINEPHRINE
        • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
        • EXCITOXICITY & THE BRAIN
        • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
        • EXTRACELLULAR MICROVESICLES
        • EXTENDS LIFESPAN
        • EXTINCTION TRAINING
        • FASTING & THE BRAIN
        • FASTING & CANCER
        • FASTING MIMICKING DIET
        • FEAR EXTINCTION
        • FGF21
        • FLAVONES
        • GABA (γ-AMINOBUTYRIC ACID)
        • GALLOTANNINS
        • GLUCONEOGENESIS
        • GLUCOCORTICOID RECEPTOR ACTIVATION
        • GLUTAMATE & BRAIN
        • GLYCATION
        • GUT BRAIN AXIS
        • GYPENOSIDE
        • KLOTHO
        • K OPIOD RECEPTOR & ADDICTION
        • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
        • FGF21
        • FOXO3
        • FOXO4
        • HALLMARKS OF AGING
        • HAIR GROWTH
        • HAIR REGENERATION
        • HAIR REPIGMENTATION
        • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
        • HMGB1
        • HORMESIS
        • HPA AXIS
        • HSP70, THE ANTI-AGING PROTEIN
        • HSP90 INHIBITORS
        • HYPERGLYCEMIA
        • HYPERALGESIA
        • HYPERINSULINEMIA
        • HYPOTHALAMIC PITUITARY ADRENAL HPA AXIS
        • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
        • HYPOCRETIN OREXIN
        • IKK
        • IL-6/STAT3
        • IRISIN
        • ISOFLAVONES
        • IMMUNOSENESCENCE
        • INHIBITION OF ADVANCED GLYCATION END PRODUCTS
        • INCREASE PROTEIN SYNTHESIS
        • INCREASES SPERMATOGENESIS
        • INFECTOBESITY
        • INFLAMMATION & ANXIETY
        • INFLAMMATION & CANCER
        • INFLAMMATION & DEPRESSION
        • INFLAMMATION & OBESITY
        • INFLAMMAGING
        • INHIBITION OF RENAL GLUCOSE REABSORPTION
        • INSULIN & AGING
        • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
        • INSULIN & MTOR
        • INSULIN & OBESITY
        • INSULIN OXIDATIVE STRESS
        • INTERMITTENT FASTING
        • JAK INHIBITION ALLEVIATES SASP
        • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
        • KETONE BODIES
        • KETOGENIC DIET
        • LACTOBACILLUS REUTERI
        • LACTOFERRIN
        • LEYDIG CELL STEROIDOGENESIS
        • LIFESPAN EXTENSION
        • LIVER REGENERATION
        • LIPOLYTIC AGENTS
        • LIPID DROPLETS
        • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
        • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
        • MATRIX METALLOPROTEINASES (MMPs)
        • MCL-1
        • MDM2 INHIBITION AS SASP INHIBITOR
        • MEDICINAL MUSHROOMS
        • MEDITERRANEAN DIET
        • METABOLIC REPROGRAMMING
        • METABOLIC SYNDROME
        • METHIONINE RESTRICTION
        • MITOCHONDRIAL UNCOUPLING
        • MONKEYPOX
        • MSG (MONOSOSODIUM GLUTAMATE)
        • MUSCLE FORCE PRODUCTION
        • MUSCLE ATROPHY (PREVENTING)
        • MYOGENESIS
        • MYOSTATIN INHIBITION
        • MYOSTATIN INHIBITION PRESERVES MUSCLE
        • mTORC2
        • mTOR: THE RAPID AGING PATHWAY
        • NATURAL ANTICOAGULANTS
        • NATURAL AROMATASE INHIBITORS
        • NEUROGENESIS (GROWING NEW BRAIN CELLS)
        • NEUROCHEMISTRY OF ADDICTION
        • NEUROPLASTICITY
        • NEUROINFLAMMATION
        • NEUROPROTECTIVE AGENTS
        • NEUTRALIZING OXIDATIVE STRESS WITH MEDICINAL PLANTS
        • NMDA & ANXIETY & DEPRESSION
        • NMDA RECEPTOR & FEAR
        • NON OPIOD ANALGESICS
        • NOOTROPICS
        • NORADRENERGIC
        • NOREPINEPHRINE
        • NRF2: MASTER REGULATOR OF THE AGING PROCESS
        • NF-KB
        • NUTRACEUTICAL
        • OBESOGENS
        • ONCOGENE ACTIVATION INDUCED SENESCENCE
        • ORGANOTINS
        • OVERNUTRITION
        • OXIDATIVE STRESS & AGING
        • P16INK4A
        • P38MAPK
        • P53: TUMOR SUPRESSOR
        • PERIODONTITIS
        • PHOSPHATIDYLINOSITOL 3 KINASE
        • PHYTOCHEMICALS
        • PHYTOSTEROLS
        • PHYTOSTANOLS
        • PHYTOECDYSTEROIDS
        • PROANTHOCYANIDINS
        • PROTEIN CARBONYLATION
        • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
        • POLYPHENOLS AS COVID-19 TREATMENT & PREVENTION
        • PPARY2
        • PREMATURE SENESCENCE
        • PREVENTING SKIN AGING
        • PUFAS
        • PURGATIVES
        • RADIATION EXTRACT
        • RAPAMYCIN (MTOR INHIBITION)
        • RED WINE
        • RENAL (KIDNEY) PROTECTIVE AGENTS
        • REMINERALIZATION OF TEETH
        • REMYELINATION
        • REPAIR OF DNA BREAKS “DOUBLE STRAND”
        • RESTORE INSULIN SENSITIVITY
        • REVERSAL OF OBESITY
        • SASP & ADIPOSE TISSUE
        • SEX HORMONE BINDING GLOBULIN
        • SENESCENT CELLS, SASP & SENOLYTICS
        • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
        • SGLT2 INHIBITORS
        • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
        • SHBG
        • SIRT1
        • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
        • SKIN ELASTICITY
        • SKIN PHOTOAGING (Preventing & Repairing)
        • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
        • SIRT1 & LONGEVITY
        • SMALLPOX
        • SUGAR & AGING
        • STAR PROTEIN
        • STAT3
        • STEM CELL EXHAUSTION
        • STEM CELL REGENERATION
        • STEM CELL THERAPY
        • STIMULATED LIPOLYSYS
        • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
        • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
        • STRESS & AGING
        • STRESS & THE BRAIN
        • TELOMERE SHORTENING & PREMATURE AGING
        • TIME RESTRICTED FEEDING
        • THROMBOLYTICS (PLANT BASED)
        • TRAUMATIC BRAIN INJURY (HEALING)
        • TRYPTOPHAN HYDROXYLASE 2
        • VISCERAL ADIPOSITY
        • XENOBIOTICS
        • XENOESTROGEN
      • HOME
      • CONTACT
      • TELEGRAM PORTAL
      • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
      • The Ultimate Dry Fasting Resource
      0
      blank
      INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      February 23, 2021
      blank
      DIABETES & CANCER
      February 23, 2021
      1. Female sexual dysfunction-Medical and psychological treatments, Committee 14: Erratum.
      2. I am no male or female or any other, I have no sex: a case report on asexuality.
      3. It’s complicated: the lived experience of female sexual desire: a thesis presented in partial fulfilment of the requirements for the degree of Masters of Science in …
      4. Methodological issues for studying asexuality: Reply to Hinderliter (2009).
      5. Sick, Dead, or Lying: A critical textual analysis of asexuality in popular culture
      6. The nature of the body: anatomizing heterogender in sexual medicine
      7. They Need Labels: Contemporary Institutional and Popular Frameworks for Gender Variance
      8. Women’s sexual desire and arousal disorders: Erratum.
      9. ? Maybe all these random experiences form a cohesive picture?: towards a grounded theory of asexual college students? identity development
      10. … -67: Validation of the “Decreased sexual desire Screener”(DSDS): A brief diagnostic instrument for generalized, acquired hypoactive sexual desire disorder in women
      11. … , AND THE EFFECTIVENESS OF ORGASM CONSISTENCY TRAINING IN THE TREATMENT OF WOMEN REPORTING hypoactive sexual desire.
      12. … : A Randomized, Double-Blind, Placebo-Controlled Study on Efficacy and Safety of Bupropion for the Treatment of hypoactive sexual desire Disorder in Menstruating …
      13. … : The sexual Interest and desire Inventory—Female (SIDI‐F): Item Response Analyses of Data from Women Diagnosed with hypoactive sexual desire Disorder
      14. … and evaluation of the Women’s sexual Interest Diagnostic Interview (WSID): a structured interview to diagnose hypoactive sexual desire disorder (HSDD) in …
      15. … as Measured by the Profile of Female sexual Function, sexual Activity Log, and Personal Distress Scale in Postmenopausal Women with hypoactive sexual desire …
      16. … Decarbonylative Ring Contraction of Quinoxalinediones: Application to the Synthesis of Flibanserin, A Drug for Treating hypoactive sexual desire Disorder in Women …
      17. … desire and the Female sexual Function Index (FSFI): A sexual desire cutpoint for clinical interpretation of the FSFI in women with and without hypoactive sexual desire …
      18. … estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire
      19. … factors for major adverse cardiovascular events in subjects with sexual dysfunction: low education and reported partner’s hypoactive sexual desire in comparison with …
      20. … HYPOTENSION-AND-SYNCOPE-RELATED ADVERSE EVENTS IN FLIBANSERIN-TREATED PREMENOPAUSAL WOMEN WITH hypoactive sexual desire …
      21. … lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for …
      22. … of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the hypoactive sexual desire Disorder Registry for …
      23. … perspective on clinical trials and end points for female sexual dysfunction, in particular, hypoactive sexual desire disorder: formulating recommendations in an …
      24. … randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire …
      25. … sexual Interest Diagnostic Interview—Short Form (WSID-SF) and a Daily Log of sexual Activities (DLSA) in Postmenopausal Women with hypoactive sexual desire …
      26. … sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire …
      27. … single-center pilot study of HIV-infected men who have sex with men on highly active anti-retroviral therapy (HAART) with hypoactive sexual desire disorder and raised …
      28. “Adopting self-sacrifice”: how Iranian women cope with the sexual problems during the menopausal transition? An exploratory qualitative study
      29. “And now I’m just different, but there’s nothing actually wrong with me”: Asexual marginalization and resistance
      30. “Asexy and we know it”: The Emergence of Asexual Activism as a sexual and Gender Social Movement
      31. “Do I really have to talk about sex?” Encouraging beginning therapists to integrate sexuality into couples therapy
      32. “I am no male or female or any other, I have no sex”: a case report on asexuality
      33. “I Just Go with It”: Negotiating sexual desire Discrepancies for Women in Partnered Relationships
      34. “I want to feel like I used to feel”: a qualitative study of causes of low libido in postmenopausal women
      35. “Informed choice” in a time of too much medicine—no panacea for ethical difficulties
      36. “It takes two to tango”: The relational domain in a cohort of subjects with erectile dysfunction (ED)
      37. “Macho” beliefs moderate the association between negative sexual episodes and activation of incompetence schemas in sexual context, in gay and heterosexual men
      38. “Online” and “at-home” versus traditional models of health care: enhancing access or impeding optimal therapeutics?
      39. “She exploded into a million pieces”: a qualitative and quantitative analysis of orgasms in contemporary romance novels
      40. “The pleasure is better as I’ve gotten older”: sexual health, sexuality, and sexual risk behaviors among older women living with HIV
      41. “This is Torah, and I Must Learn”: Evaluation of Women’s Premarital sexual Education and sexual Satisfaction in the Orthodox Jewish Community.
      42. “Til’I can get my satisfaction”: The Role of sexual Assertiveness in the Relationship between Attachment Orientation and sexual Satisfaction
      43. “Ukuthwala” the sexual-cultural practice with negative effects on the personality of adolescent females in Africa
      44. “Was It Good for You?”: Recasting Catholic sexual Ethics in Light of Women’s sexual Pain Disorders
      45. “What do you mean when you say that you are sexually satisfied?” A mixed methods study
      46. “You Freud, Me Jane?” The Representation of Trauma and Asexuality in Hitchcock’s Marnie
      47. (2009) Self-reported sexual difficulties and their association with depression and other factors among gay men attending high-HIV-caseload general practices in …
      48. @ TOG
      49. 001 Composite Endpoints for Clinical Trials of Women with HSDD: Content, Responder Values, and Remitter Cutoffs
      50. 003 Two-Arm, Prospective, Open-Label, Pilot Study of Flibanserin versus Flibanserin and sex Therapy in Pre-and Postmenopausal Women with HSDD
      51. 003 Use of Ospemifene is Associated with Improvements to the Vulva, Vestibule, and Vagina in Women with Genitourinary Syndrome of Menopause (GSM): A …
      52. 004 Safety and Efficacy of High Intensity Focused Ultrasound Treatment for Vagina-3 Months Results
      53. 005 Neuromodulation for Female sexual Dysfunction: Preliminary Pilot Clinical Trial and Patient Interest Survey
      54. 005 The effects of learned sex-disgust associations on female sexual response
      55. 006 Bremelanotide for hypoactive sexual desire Disorder: Integrated Subgroup Analysis According to FSFI Total Score at Screening
      56. 006 Genital and subjective sexual response in women with the Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome with a non-surgically created neo-vagina
      57. 007 A Review of Microorganisms Isolated at Salvage or Explant of IPPs: Are We Covering the Correct Bugs?
      58. 007 Use of Neurogenital Testing to Assess for Cauda Equina-Based Sacral and Lumbar Pathologies Potentially Causing Unusual sexual Dysfunctions
      59. 008 Investigating Peripheral Nerve Stimulation as a Treatment for Female sexual Dysfunction using a Preclinical Model
      60. 009 Comparing symptom networks of women with reduced, increased, and stable sexual desire
      61. 009 Retrospective Chart Review of Treatment Outcome Following Low-Intensity Shockwave Therapy for the Treatment of Vestibulodynia with Urogold 100™ MTS
      62. 009 The Fertility Quality of Life (FertiQol) in Chinese Infertile Women: The First Validation Study of Mainland China Ferti-Qol
      63. 01. Prevalence and Risk Factor Profile for Human Papillomavirus Infection Among Uyghur Women in Xinjiang
      64. 010 A Team-based Model of Care for Management of Female sexual Dysfunction
      65. 010 New Drug for Treatment of Female hypoactive sexual desire Disorder-Results of Phase I Clinical Study
      66. 010 The Moderation Effect of Couple-level sexual Satisfaction on Physiological Synchrony During Conversation-based Tasks
      67. 011 Correlation Between Validated Instruments Used in the RECONNECT Studies
      68. 011 Hormonal and Psychosocial Factors Associated to sexual Dysfunctions in Premenopausal Women
      69. 012 Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With hypoactive sexual desire Disorder
      70. 012 Eye Dynamics in Patients with Female hypoactive sexual desire Disorder (HSDD): Evidence towards the Top-Down NeuroFunctional Self-Attention-Model (SAM) …
      71. 012 Meta-Analysis of Orgasmic and Overall sexual Function Post Mid-Urethral Sling Surgery
      72. 012 Potential sexual Changes Resulting from LEEP
      73. 013 Associations Between Partner Responses to Low Interest/Arousal and the sexual and Relationship Wellbeing of Women with sexual Interest/Arousal Disorder …
      74. 013 Product Acceptability and Women’s Satisfaction with a Low-dose Solubilized Vaginal Estradiol Softgel Capsule, TX-004H
      75. 013 The Development and Implementation of a Gynecologic Cancer Survivorship Tool
      76. 014 A Phase 2 Program on Female sexual Arousal Disorder and hypoactive sexual desire Disorder: Patient Characteristics and Implications for Diagnosis and …
      77. 014 Do experts for vulva diseases integrate sexual health problems in daily diasease-managment _ self-assessment results at the 10th anniversary of the …
      78. 014 The Investigational Drug Bremelanotide for hypoactive sexual desire Disorder (HSDD): Efficacy Analyses from the RECONNECT Studies
      79. 015 A randomized, wait list-controlled trial suggests that two psychobehavioral interventions are effective for women’s hypoactive sexual desire
      80. 015 Combined Data of Intravaginal Prasterone against Vulvovaginal Atrophy of Menopause
      81. 015 The Impact of Incontinence Procedures at the Time of Vaginal Vault Suspension on Pelvic Pain and Dyspareunia: A Study of sexually Active Women with Post …
      82. 016 Antifibrotic effect of mycophenolate mofetil experimentally induced Peyronie’s Disease with TGF-B
      83. 016 Effectiveness of Medications for Female sexual Dysfunction: Number Needed To Treat (NNT)
      84. 016 Fidgetin-like 2, a Novel Microtubule Regulator, can be Targeted to Promote Nerve Regeneration and Improve Erectile Function after Cavernous Nerve Injury
      85. 016 Vulvoscopic Findings, Patient Reported Outcome (PRO) Measures, and Hormonal Blood Test Values in Menopausal Women with Female sexual Dysfunction Pre …
      86. 017 Bremelanotide (BMT) for hypoactive sexual desire Disorder (HSDD) in the RECONNECT Study: Efficacy Analyses in Study Completers and Responders
      87. 020 Bremelanotide Treatment Provided Clinically Meaningful Benefits in Premenopausal Women With hypoactive sexual desire Disorder
      88. 020 sexual Distress and Vaginal Symptom Severity in Women Diagnosed with Cancer: Impact of a Vaginal Health Workshop
      89. 021 Do Prior Anti-incontinence Procedures Influence the Success of Artificial Urinary Sphincter Placement?
      90. 021 Flibanserin in Premenopausal Women With hypoactive sexual desire Disorder: Pooled Analysis of Safety From Phase 3, Placebo-Controlled Studies
      91. 022 Predictors and Moderators of sexual Distress in Women with Persistent Genital Arousal Disorder
      92. 022 The Importance of the Developmental Stage of Nonconsensual sexual Experiences in Women’s sexual Adjustment
      93. 023 Reflections of Women Successfully Treated by Flibanserin at a Single Center
      94. 024 Motivations for sexual Intercourse among Women with a History of Childhood sexual Abuse
      95. 025 Direct Determination of Kinetic and Equilibrium Binding of Flibanserin to 5HT1A and 5HT2A Receptors
      96. 025 Lysis of Vulvar Adhesions for Lichen Sclerosus: A Series of 5 Patients
      97. 027 Effect of Alcohol Consumption on the Safety and Tolerability of Flibanserin in Premenopausal Female Volunteers
      98. 027 Preliminary Evidence for a Relationship between Physiological Synchrony and sexual Satisfaction
      99. 028 A Novel Technique for Assessing Vaginal Lubrication
      100. 028 What is the Relation Between Depressive Disorders, Dyspareunia and Other sexual Dysfunctions?
      101. 029 Bremelanotide for hypoactive sexual desire Disorders in the RECONNECT Studies: Analysis of Baseline Free Testosterone Level Quartile Subgroups
      102. 030 Improving Practitioner Knowledge and Clinical Competence in Managing Menopause-Associated Dyspareunia and Female sexual Dysfunction Through …
      103. 035 Patient Reported Outcomes of a Robotic-Assisted Double-Skin Flap Vaginoplasty Technique for Transfeminine Genital Reconstructive Surgery
      104. 036 Two-Arm, Prospective, Open-Label, Pilot Study of Flibanserin versus Flibanserin and sex Therapy in Pre-and Postmenopausal Women with HSDD
      105. 037 Open-Label Pilot, Prospective Vulvoscopic Study of Daily Administration of Prasterone Vaginal Inserts in Women with Moderate to Severe Dyspareunia
      106. 038 Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies
      107. 039 Effects of sex Steroids on Relaxant/Contractile Pathways in Rat Vagina
      108. 043 Hormonal and Psychosocial Characteristics of Female sexual Dysfunction
      109. 044 FSFI Assessment of Minimally invasive, Fractional CO2 laser treatment for Vulvovaginal Atrophy and Dyspareunia
      110. 045 An Association between the Pain Domain of the Female sexual Function Index (FSFI) and Its Other Domains in Postmenopausal Women with Vulvar and Vaginal …
      111. 046 Cervical Ectropion may be a Cause of Desquamative Inflammatory Vaginitis
      112. 047 Responder Values for Clinical Trials in Female sexual Interest/Arousal Disorder
      113. 048 Evaluation of Common sexual Dysfunctions and Treatment Outcome in a Canadian sexual Medicine Practice
      114. 049 A Double-Blind, Sham Controlled Prospective Pilot Study of Urinary Stress Incontinence and sexual Function in Women After 6 Treatments with HIFEM …
      115. 050 The Effects of Radiofrequency on Female sexual Health
      116. 055 Does Participation in Faith-Based sexual Abstinence Programs Lead to Female sexual Dysfunction
      117. 056 Inflammation May Alter Perception of sexual Arousal and Pleasure in Healthy Women
      118. 057 Mercy sex: How Much Is “Normal” Depends Upon Where You Live
      119. 058 The Impact of Childhood Experiences on Emotional Responses to Partnered Genital Touch in the Laboratory
      120. 062 ColorDoppler Ultrasound in the Evaluation of the Cardiometabolic Profile in Women With sexual Dysfunction: A Gender Perspective
      121. 062 Temperature Controlled Radiofrequency Electrocoagulation for the Treatment of Vulvovaginal Tissue Laxity
      122. 063 Brain Dynamics of Female hypoactive sexual desire Disorder (HSDD)
      123. 063 Flibanserin: Enhanced Pharmacovigilance Study to Assess and Analyze the Risks of Adverse Events of Special Interest
      124. 064 Attitude of Women Nurse Practitioners for Embarrassing Female sexual and Urinary Symptoms in Korea
      125. 064 Brain Dynamics and Predictors of Female hypoactive sexual desire Disorders (HSDD): Two Routes in the Top-Down Neurofunctional Self-Attention Model (SAM) …
      126. 065 Vulvar Findings in GSM Patients Correlate with Severity of Overactive Bladder
      127. 066 Anatomic Sites and Risk Factors for Deep Dyspareunia
      128. 066 Pudendal Neuromodulation for Treatment of Female Orgasmic Disorder
      129. 067 Number Needed to Harm for Treatments of Female sexual Dysfunction
      130. 068 Female sexual Dysfunctions Associated With Male Premature Ejaculation
      131. 069 Hormonal Contraceptive Use and sexual Functioning among Young Women Who Experienced sexual Victimization
      132. 076 Perceptions and Attitudes About Low sexual desire Among Premenopausal Women: Results From a Consumer Survey
      133. 077 On the Initial Treatment Experience of CO2 Fractional Laser for Vulvovaginal Atrophy Symptom in a Single Institute
      134. 078 Exo-clinical Trials to Test Nutraceuticals for sexual Dysfunction
      135. 078 Why Core Emotions Matter: Understanding Subcortical Affective Circuits as Key to Treatment of sexual Disorders
      136. 079 Evaluating the Performance of a Low-cost Mobile Phone Attachable Microscope in Cervical Cytology
      137. 079 Temporal Frequency-Based Typology of Female Orgasm
      138. 079 Vulvar Crohn’s: A Rare Presentation of Crohn’s Disease
      139. 080 Patient Reported Satisfaction Rating After Attending a Multidisciplinary Psychoeducational sexual Wellness Program
      140. 080 Successful Management of Clitorodynia Closed Compartment Syndrome
      141. 080 Women’s Experiences With Bremelanotide Administered, On Demand, for the Treatment of hypoactive sexual desire Disorder
      142. 081 Lorexys Phase 2a Results: Patient’s Global Impression of Change (PGIC)
      143. 082 Nomegestrol Acetate/17beta-estradiol does not Negatively alter the Vascular Resistance of Clitoral Arteries
      144. 083 The Effect of Ristela Supplementation on Female sexual Function in Women Taking Antidepressants: An Open Label Trial
      145. 084 Improvements in Female sexual Function Index (FSFI) Domains Over Time after Flibanserin Treatment in Premenopausal Women with hypoactive sexual desire …
      146. 090 Effects of Bipolar Radiofrequency Treatment on Subjective and Objective Endpoints in Post-Partum Pelvic Floor Disorders
      147. 095 Rethinking the Techno Vagina: A Case Series of Patient Complications Following Vaginal Laser Treatment for Atrophy
      148. 096 Effect of CO2 Fractional Laser on Female Lower Urinary Tract Symptoms by Genitourinary Syndrome of Menopause
      149. 099 Flibanserin vs. Mini-Dose Trazodone for Female sexual Dysfunction? A Challenge
      150. 1 PREVALENCE OF ADULT DISORDERS
      151. 1, 25 dihydroxyvitamin D3 disorganizes actin fibers in human immortalized uterine leiomyoma cells
      152. 1.6 THE SOCIAL ORIGINS OF sexual DEVELOPMENT
      153. 10 Female sexual Dysfunction
      154. 10 Hormone Treatment of Adult Transgender People
      155. 10 Jahre Women’s Health Initiative (WHI): Was haben wir gelernt?
      156. 10 Lust, Romance, Attachment: Do the Side Effects of Serotonin-Enhancing Antidepressants Jeopardize Romantic Love, Marriage, and Fertility?
      157. 10 sexuality and ageing
      158. 10 Things You Aren’t Telling Him
      159. 10 Years in History
      160. 10. Testosteronbehandling till kvinnor
      161. 103 The Effect of Evening Alcohol Consumption and Bedtime Administration of Flibanserin on the Safety of Flibanserin
      162. 104 Flibanserin Subset Analyses and the Androgenics of hypoactive sexual desire Disorder
      163. 105 Preoperative Evaluation
      164. 105 Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Genital Arousal Disorder
      165. 1075: ATM Sequence Variants are Predictive of the Development of Erectile Dysfunction Among Patients Treated for Prostate Cancer with 125Iodine Brachytherapy
      166. 1076: Smooth Muscle Specific Expression of HSLO Restores Erectile Dysfunction in Diabetic and Aged Rats
      167. 1077: Facilitation of Proceptivity/sexual Motivation in Female Rats by a Serotonin 2A/2C (5-HT2A/2C) Receptors Agonist
      168. 1078: Increase in Proceptivity/sexual Motivation by Melanotan-II (MT-II) in Female Rats
      169. 10Evaluation and management of neurogenic sexual dysfunction
      170. 11 sex Steroids and Mood
      171. 11.4 Two Fundamental Human Motivations: Eating and Mating
      172. 118: THE ASSOCIATION BETWEEN BODY IMAGE AND hypoactive sexual desire DISORDER AMONG REPRODUCTIVE AGE WOMEN: AN IRANIAN …
      173. 12 Asexualities and Disabilities in Constructing sexual Normalcy
      174. 12 How altruism undermines mental health and happiness
      175. 12 sexual Disorders
      176. 12 sexual Disorders among sexual and Gender Minority Populations
      177. 12. M. Workshop: Health and integration of young refugees in Nordic Welfare countries–an equity perspective
      178. 13 ‘More Labels Than a Jam Jar’: The Gendered Dynamics of Diagnosis for Girls and Women with Autism1
      179. 13 Asexuality and Disability
      180. 13 sexual Counseling and Infertility
      181. 13 sexual Response
      182. 13.6 Somatoform, Factitious, and sexual Disorders
      183. 136 Cross-sectional Association between Testosterone and Metabolic Syndrome
      184. 139 Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose, Seven-Way Crossover Study
      185. 14 sexual Distress in Obesity
      186. 14 Testosterone and sexual Function
      187. 14 The Female sexual Dysfunction Debate: Different ‘Problems,’New Drugs–More Pressures?
      188. 146 Conversations With Participants in the RECONNECT Studies About Their Experiences With Bremelanotide for Treatment of hypoactive sexual desire Disorder
      189. 148 Retrospective Study of the Prevalence and Risk Factors of Clitoral Adhesions: Why Women’s Health Providers Should Routinely Examine the Glans Clitoris
      190. 15 Neurocognitive Disorders
      191. 150 BP101 New Molecule for HSDD Treatment-Results of Proof-of-concept Phase 2a Study
      192. 15Chapter
      193. 16 Toward an Asexual Narrative Structure
      194. 16 Treatment of psychosexual problems
      195. 17β-Estradiol and testosterone levels in axillary perspiration of men: Environmental factors, inter-and intra-individual variation
      196. 18 sexual disorders
      197. 18 Vulvovaginal Pain after Breast Cancer Treatment
      198. 19 Female sexual Dysfunction
      199. 19 Female sexual dysfunctions: Future of medical therapy
      200. 19 sexuality in Older Adults
      201. 19 Transgender Health Care and Human Rights
      202. 19. A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF LIBIGEL® FOR …
      203. 193 Bremelanotide for hypoactive sexual desire Disorder: Contraceptive Subgroups Efficacy Analysis
      204. 194 Effect Size of Bremelanotide Treatment in the Phase 3 RECONNECT Studies
      205. 1Chapter
      206. 2 Inhibition, Lack of Excitation, or Suppression
      207. 2 Seven Leadership Skills for sexuality Educators
      208. 2007 UK guidelines for the management of sexual and reproductive health (SRH) of people living with HIV infection
      209. 2010 Sandra Leiblum Presidential Address
      210. 2011 Sandra Leiblum Presidential Address
      211. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
      212. 2016 NEI SYNAPSE—NEW!
      213. 2017-2018 NAMS President
      214. 2018 ICD-10-CM Hospital Professional Edition-E-Book
      215. 2018 ICD-10-CM Physician Professional Edition-E-Book
      216. 2018 ICD-10-CM Standard Edition-E-Book
      217. 2019 FDA TIDES (peptides and oligonucleotides) harvest
      218. 2020 FDA TIDES (Peptides and Oligonucleotides) Harvest
      219. 21 Ejaculatory Disorders
      220. 21 Evolutionary Cognitive Neuroscience
      221. 21 sex and Gender Disorders
      222. 21 The Endocrinology of Female Competition
      223. 213 A Prosthesis-Specific Survey Study: The sexual Quality of Life Benefits of the Inflatable Penile Prosthesis are Generalizable Across Multiple Patient …
      224. 221 A Retrospective Single Center Study of Vulvoscopic Findings, Female sexual Function Index (FSFI) Scores and Hormonal Blood Test Values in Menopausal …
      225. 223 How much Girth is too much Girth? Dimensions of Bestselling Insertive sex Toys to Guide Maximal Phalloplasty Dimensions
      226. 225 Unlocking Female sexual Dysfunction in Muslim Women in America: A Retrospective Look at the Incidence of Vaginismus in this Population
      227. 226 Effect of Flibanserin on Body Weight During Treatment for hypoactive sexual desire Disorder in Premenopausal and Postmenopausal Women
      228. 23 Implications for training, research and service provision
      229. 238 A 10-Year Interval Study to compare the Prevalence and Risk Factors of Female sexual Dysfunction in Korea
      230. 239 sexual and Non-sexual Improvements in Women with HSDD: Personal Experiences with Flibanserin Treatment
      231. 24 DIRECTED MASTURBATION: A TREATMENT OF FEMALE ORGASMIC DISORDER
      232. 24-Hour Urine Comprehensive Hormone Profile Handbook
      233. 240 Alcohol Use and sexual Health Concerns in a sexual Health Clinic
      234. 25 sexual Function, Dysfunction, and Difficulties
      235. 25 years and sex is still hot.
      236. 260 Diabetes and level of fasting blood sugar has no relationship to the development of subsequent penile prosthesis infection in Korean men
      237. 261 Efficacy of metacognitive therapy for hypoactive sexual desire disorder among Iranian couples
      238. 262 Viewing time and penile plethysmography measurement in a group of admitting pedophiles
      239. 27 Mental Health for Asexual Individuals
      240. 27. EVALUATION OF sexual DYSFUNCTION
      241. 28th Annual Meeting of The North American Menopause Society October 11-14, 2017, Philadelphia, PA
      242. 29Arthritis
      243. 2D: 4D digit ratio and its relations to cross-sex and same-sex friendship choices
      244. 2nd Joint Puerto Rican SPED/AACE International Endocrine Update and 28th SPED Post Graduate Diabetes Course: December 8–11, 2005, San Juan, Puerto Rico …
      245. 3 “There’s No Such Thing as a sexual Relationship”
      246. 3-Oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments
      247. 3-oxopiperazinium derivatives as agonists of nerve growth factor receptors and their use as medicaments
      248. 31 Days to Great sex: Love. Friendship. Fun.
      249. 32 Integrative Medicine in Gynecologic Oncology
      250. 341 Mercy sex: How Much Is “Normal”
      251. 376 Vasal Vessels Preserving Microsurgical Vasoepididymostomy
      252. 4 Hypnotherapy and depression
      253. 4.8. G03X Other sex Hormones and Modulators of the Genital System
      254. 40 Psychological abnormalities of male sexual function
      255. 490 HANDBOOK OF CLINICAL INTERVIEWING WITH ADULTS
      256. 4th International Consultation on sexual Medicine June 19–21, 2015 Melia Castilla Hotel, Madrid, Spain
      257. 5 th EURASIAN ANDROLOGY SUMMIT
      258. 5-HT 2A receptor gene polymorphism is associated with food and alcohol intake in obese people
      259. 5-HT1A and 5-HT2A receptors affinity, docking studies and pharmacological evaluation of a series of 8-acetyl-7-hydroxy-4-methylcoumarin derivatives
      260. 5-HT1A receptor ligands and their therapeutic applications: review of new patents
      261. 5-HT1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer
      262. 50+ INCREDIBLE Benefits (And Warnings) for Women When They Take Natural Progesterone (P4)
      263. 54 SENSATE FOCUS FOR sexual DYSFUNCTION
      264. 5α-Reductase-2 deficiency: is gender assignment recommended in infancy? Two case-reports and review of the literature
      265. 6. sexual Medicine in Finland
      266. 61 SENSATE FOCUS
      267. 62nd Annual Meeting of the American Society for Reproductive Medicine: October 23–25, 2006, New Orleans, LA, USA
      268. 689 Illustrated evaluation of scientific productions of sexual medicine researchers during 2012 till the end of 2016
      269. 690 HIV-related healthcare needs and access barriers for Brazilian transgender and gender diverse people
      270. 691 High serum testosterone is associated with poor pathological outcomes in patients with prostate cancer in Japanese populations
      271. 7 Keys to Lifelong sexual Vitality: The Hippocrates Institute Guide to sex, Health, and Happiness
      272. 7Chapter
      273. 882: Relationship of Self-Diagnosed Premature Ejaculation to Other Indicators of Male sexual Function
      274. 883: The Utility of “Estimated Intra-Vaginal Ejaculatory Latency Time” and “DSM-IV Criteria” in Identifying Premature Ejaculation
      275. 884: Phase I, Double-Blind, Placebo-Controlled Study in Healthy Male Subjects to Investigate the Safety, Tolerability, and Pharmacokinetics of DA-8159
      276. 885: Prevalence of Female sexual Dysfunction in Germany
      277. 9 Hypnotherapy and sexual problems
      278. 910 THE ROLE OF MAJOR PELVIC GANGLION IN THE NEURAL PATHWAY OF ELECTRICAL STIMULATION OF LESSER SPLANCHNIC NERVE-INDUCED …
      279. 911 SCREENING FOR hypoactive sexual desire DISORDER (HSDD) IN THE UROLOGY OFFICE SETTING
      280. 912 IN-VITRO ANALYSIS OF THE EFFICACY OF PENILE TRACTION ON PEYRONIE’S DISEASE: ASSESSING CELLULAR CHANGES IN PEYRONIE’S PLAQUE IN A …
      281. 9Chapter
      282. 9th International Congress on Psychopharmacology & 5th International Symposium on Child and Adolescent Psychopharmacology
      283. A 15-item short form of the psychological and interpersonal relationship scales
      284. A 60-year-old woman with sexual difficulties
      285. A baseline-controlled, open-label, flexible dose-escalation study to assess the safety and efficacy of sildenafil citrate (Viagra®) in patients with erectile …
      286. A Bedroom of One’s Own: Morality and sexual Privacy after Lawrence v. Texas
      287. A behavioral systems approach to romantic love relationships: Attachment, caregiving, and sex
      288. A Bibliography of 34 Counter-Narrative Sources Prepared for the FDA ‘Patient-Focused Drug Development Public Meeting and Scientific workshop on Female …
      289. A Bibliography of Randomized Controlled Experiments in Social Work (1949–2013) Solvitur Ambulando
      290. A biopsychosocial approach to women’s sexual function and dysfunction at midlife: A narrative review
      291. A Brief Description of the Disorders
      292. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer
      293. A Brief Version of the sexual Interest and desire Inventory–Female With 4 Core Items
      294. A Canadian Cost-Utility Analysis of two Trabecular Micro-Bypass Stents in Patients with Mild-to-Moderate Open-Angle Glaucoma
      295. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder
      296. A Case of desire Disparity
      297. A case of enhancing sexual confidence: both the client and the therapist are the experts
      298. A case of inguinal endometriosis in the absence of previous gynecologic surgery
      299. A case of premature ejaculation: too little, too late?
      300. A case series of androgen use in breast cancer survivors with sexual dysfunction
      301. A Case with Male Erectile Disorder and hypoactive sexual desire Disorder Treated by Psychotherapy Using Hypnosis
      302. A clinical update on female androgen insufficiency—testosterone testing and treatment in women presenting with low sexual desire
      303. A clinician’s guide to systemic sex therapy
      304. A clinician’s guide to systemic sex therapy
      305. A Clinician’s Guide to Systemic sex Therapy
      306. A cognitive-behavioral approach to sex therapy
      307. A cognitive-motivational approach to understanding gendered sexual response: The role of attentional mechanisms
      308. A combined-constructionist therapeutic approach to couples experiencing erectile dysfunction: Part II
      309. A commentary on sexual well-being, happiness and satisfaction in women: The case for a new conceptual paradigm
      310. A commentary on transdermal drug delivery systems in clinical trials
      311. A Comparative study of sexual Dysfunction in Remitted Patients Taking Antipsychotics Versus Antidepressants
      312. A comparative study of the sexual functioning of women with primary headache in India
      313. A comparative study using orgasm consistency training in the treatment of women reporting hypoactive sexual desire
      314. A Comparison between Males/Females and Divorcing ones on sexual Functioning in Isfahan
      315. A comparison of 19th century and current attitudes to female sexuality
      316. A comparison of DSM‐IV‐TR and DSM‐5 definitions for sexual dysfunctions: Critiques and challenges
      317. A comparison of five-factor personality dimensions in males with sexual dysfunction and males with paraphilia
      318. A comparison of medical comorbidities, psychosocial, and sexual well-being in an online cross-sectional sample of women experiencing persistent genital arousal …
      319. A comparison of mindfulness-based cognitive therapy vs cognitive behavioral therapy for the treatment of provoked vestibulodynia in a hospital clinic setting
      320. A comparison of sexual desire in opiate-dependent men receiving methadone and buprenorphine maintenance treatment
      321. A comparison of sexual function in primiparous and multiparous women
      322. A Comparison of Spontaneous and Responsive Models of sexual desire in Women Who Meet Screened Criteria for Female sexual Interest/Arousal Disorder
      323. A Comparison of the sexual Well-Being of New Parents With Community Couples
      324. A COMPREHENSIVE GUIDE TO UNDERSTANDING LESBIAN sexual HEALTH: REACHING A VULNERABLE POPULATION
      325. A comprehensive review of erectile dysfunction in men with diabetes
      326. A comprehensive review of sexual health concerns after cancer treatment and the biopsychosocial treatment options available to female patients
      327. A Comprehensive Review of the Phytochemical, Pharmacological, and Toxicological Properties of Tribulus terrestris L.
      328. A COST EFFECTIVENESS ANALYSIS OF A GENERAL VACCINATION PROGRAMME WITH THE NEW 10-VALENT PNEUMOCOCCAL NON-TYPEABLE …
      329. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment—a systematic review
      330. A critical discourse analysis of herbal sexual medicine websites marketing to women: a thesis presented in partial fulfilment of the requirements for the degree of …
      331. A critical evaluation of the evidence for ovarian conservation versus removal at the time of hysterectomy for benign disease
      332. A critical examination of popular assumptions about the benefits and outcomes of monogamous relationships
      333. A critical examination of the relationship between vaginal orgasm consistency and measures of psychological and sexual functioning and sexual concordance in …
      334. A critical feminist analysis of madness
      335. A critical review of repurposing apomorphine for smoking cessation
      336. A cross-cultural study of midlife relational and sexual health: Comparing Ukraine to the US and Turkey
      337. A cross-national examination of sexual desire: The roles of ‘gendered cultural scripts’ and ‘sexual pleasure’in predicting heterosexual women’s desire for sex
      338. A cross-sectional study of female sexual function and dysfunction during pregnancy
      339. A Culturally Grounded Approach to Psychotherapy with Chaldean Americans
      340. A current perspective into young female sex hormone replacement: a review
      341. A Current Study on Benzimidazole Derivatives
      342. A Delicate Balance
      343. A Descriptive Analysis of sexual Problems in Long-Term Heterosexual Relationships
      344. A diagnosis of denial: How mental health classification systems have struggled to recognise family violence as a serious risk factor in the development of mental …
      345. A discordant monozygotic twin approach to testing environmental influences on sexual dysfunction in women
      346. A discursive look at the friend/partner distinction: Implications for asexual people
      347. A dose-response and meta-analysis of dehydroepiandrosterone (DHEA) supplementation on testosterone levels: perinatal prediction of randomized clinical trials
      348. A double blind placebo controlled study of granisetron in antidepressant induced sexual dysfunction
      349. A double blind randomized control trial, comparing effect of drospirenone and gestodene to sexual desire and libido
      350. A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women
      351. A double-blind, randomised-placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil …
      352. A dvances in cancer screening and treatments have resulted in an increase
      353. A Dyadic Examination of Female Partners’ Accommodation of Male Service Members’ Posttraumatic Stress Symptoms and Caregiver Burden as Correlates of Military …
      354. A dyadic longitudinal study of child maltreatment and sexual well-being in adult couples: the buffering effect of a satisfying relationship
      355. A dyadic perspective on childhood maltreatment for women with provoked vestibulodynia and their partners: Associations with pain and sexual and psychosocial …
      356. A facile route of synthesis for making Flibanserin
      357. A Feminist Contestation of Ableist Assumptions: Implications for Biomedical Ethics, Disability Theory, and Phenomenology
      358. A feminist perspective on sexuality and body image in females with colorectal cancer: an integrative review
      359. A feminist revision of contemporary sex therapy
      360. A field trial of the effectiveness of behavioral treatment for sexual dysfunctions
      361. A further examination of Levine’s model of sexual desire
      362. A general look at female orgasm and anorgasmia
      363. A grounded theory study of the psychological impact of taking part in sexual actions which are accepted versus those which are desired
      364. A group therapy format for the simultaneous treatment of marital and sexual dysfunctions: A case illustration
      365. A history of erotic philosophy
      366. A holistic treatment approach to male erectile disorder
      367. A journey into the dangers of orthodoxy from the former director of the Freud Archives
      368. A Journey Through Psyche’s sexual Energy
      369. A language and methodology for studying the hierarchies in the DSMs
      370. A large-scale test of the replicability and generalizability of survey measures in close relationship and sexuality science
      371. A lexicon of lunacy
      372. A literature review and case reports series on the use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction
      373. A literature review on the relationship between infertility and sexual dysfunction: does fun end with baby making?
      374. A literature review on vulvodynia and distress
      375. A Longitudinal Examination: The Relationship between sexuality and Mental Health-Related Quality of Life for Breast Cancer Survivors
      376. A longitudinal study of problems in sexual functioning and related sexual distress among middle to late adolescents
      377. A longitudinal study of sexual function in women with newly diagnosed inflammatory bowel disease
      378. A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause
      379. A MedFT-informed sex therapy for treating sexual problems associated with chronic illness
      380. A methodology study to validate a structured diagnostic method used to diagnose female sexual dysfunction and its subtypes in postmenopausal women
      381. A mindfulness psychoeducational group intervention targeting sexual adjustment for women with multiple sclerosis and spinal cord injury: a pilot study
      382. A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women
      383. A Mixed Methods Analysis of the Concept of Female sexual Health
      384. A Mixed-Methods Inquiry into the Intimate Practices of Partnered Mature Students and Influences on Relationship, sexual, and School Satisfaction.
      385. A model for the capacity building of Somalia midwifery educators through a blended, web-based Master Programme
      386. A model for the management of female sexual dysfunctions
      387. A model of female sexual desire: Internalized working models of parent–child relationships and sexual body self-representations
      388. A model of physician intentions toward initiating a dialogue about sexual health with women
      389. A more radical proposal: Dyspareunia is not a mental disorder
      390. A multidisciplinary approach to sexual behavior profiles: The sex360 model
      391. A multidisciplinary approach to sexual dysfunction in female athletes
      392. A multidisciplinary approach to the evaluation and management of interstitial cystitis/bladder pain syndrome: an ideal model of care
      393. A multivariate analysis of the factors that influence the modification of sexual desire in oral hormonal contraceptive (OC) users
      394. A mystery wrapped in an enigma–asexuality: a virtual discussion
      395. A nationwide study on breast cancer risk in postmenopausal women using hormone therapy in Finland
      396. A neglected issue: The sexual side-effects of current treatments for breast cancer.
      397. A neutral odor may become a sexual incentive through classical conditioning in male rats
      398. A new deal on disease definition
      399. A new editorial structure for sexual and Marital Therapy
      400. A new female rat animal model for hypoactive sexual desire disorder; behavioral and pharmacological evidence
      401. A new glucose monitoring option
      402. A new instrument to measure sexual competence and interaction competence in youth: psychometric properties in female adolescents
      403. A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence sexual Questionnaire, IUGA-Revised …
      404. A new non-pharmacological vacuum therapy for female sexual dysfunction
      405. A new view of women’s sexual problems: Why new? Why now?
      406. A novel collaborative protocol for successful management of penile pain mediated by radiculitis of sacral spinal nerve roots from Tarlov cysts
      407. A novel design and facile synthesis of nature inspired poly (dopamine-Cr3+) nanocubes decorated reduced graphene oxide for electrochemical sensing of flibanserin
      408. A Novel LC-ESI-MS/MS Method for the Quantification of Flibanserin in Bulk and Pharmaceutical Formulations
      409. A Panoramic View
      410. A Phase 2a Multicenter, Double‐Blind, Placebo‐Controlled, Crossover Trial to Investigate the Efficacy, Safety, and Toleration of CP‐866,087 (a High‐Affinity Mu …
      411. A phenomenological defense of sexual pharmakotherapy
      412. A phenomenological inquiry into the lived experience of low sexual desire in women: Implications for clinical practice
      413. A phenomenological study of women in same-sex relationships who were previously married to men
      414. A phenomenology of sexual experiencing
      415. A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy
      416. A pilot study of a topical intervention for treatment of female sexual dysfunction
      417. A pilot study of eight-session mindfulness-based cognitive therapy adapted for women’s sexual interest/arousal disorder
      418. A pilot study of soft gel technology: a new vaginal device to improve the symptomatology of vulvovaginal atrophy in post-partum, menopause and in patients …
      419. A Pilot Study on Evaluation of Standardized Ayurveda formulation Ashwagandhadi lehya as Aphrodisiac and in treatment of Oligospermia
      420. A place for sexual dysfunctions in an empirical taxonomy of psychopathology
      421. A place of androgen deficiency in a clinical portrait of the modern urological patient
      422. A Placebo-Controlled, Randomized, Double-Blind, Three Period, Three-Way Crossover Study on the Hemodynamic and Pharmacokinetic Interactions of …
      423. A PLISSIT-model intervention in people with type 2 diabetes with sexual problems: results from a cluster-randomized controlled trial in primary care
      424. A population-based epidemiologic study of female sexual dysfunction risk in Mainland China: prevalence and predictors
      425. A PORTFOLIO OF STUDY, PRACTICE AND RESEARCH
      426. A positive approach toward asexuality: Some first steps, but still a long way to go
      427. A potential aphrodisiac for female macaques
      428. A practical approach to desire problems
      429. A practical approach to managing hypoactive sexual desire disorder in women with diabetes
      430. A Practical Cognitive-Behavioral Treatment Approach
      431. A practical guide to female sexual dysfunction: An evidence-based review for physicians in Canada
      432. A practical guide to gynecologic and reproductive health in women undergoing hematopoietic stem cell transplant
      433. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial
      434. A practitioner’s toolkit for managing the menopause
      435. A preclinical model of menopause: the ovariectomized female rat
      436. A preliminary investigation of affective and cognitive response to erotic stimulation in men before and after sex therapy
      437. A preliminary investigation on the evaluation of psychopathologies in a group of ex-pet and ex-performer chimpanzees (Pan troglodytes): A rating approach based on …
      438. A preliminary study of women with persistent sexual arousal syndrome
      439. A program for the treatment of inhibited sexual desire in males.
      440. A Prospective Clinical Observational Study on Assessment of Risk Factors, Diagnosis and Prescribing Patterns of Medications for Migraine
      441. A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatment
      442. A prospective study of outcomes after hysterectomy in mid-aged Australian-born women
      443. A prospective study of psychiatric aspects of early HIV disease in women
      444. A Psychiatric Diagnosis Primer: An Easy Guide to Identifying Psychiatric Illness
      445. A psychiatrist’s guide to sexual dysfunction in women
      446. A psychobiosocial model for assessment, treatment, and relapse prevention for female sexual interest/arousal disorder
      447. A psychophysiological investigation of sexual arousal in women with lifelong vaginismus
      448. A psychophysiological perspective on vulvodynia.
      449. A qualitative comparison of young women’s maintained versus decreased sexual desire in longer-term relationships
      450. A qualitative exploration of factors that affect sexual desire among men aged 30 to 65 in long-term relationships
      451. A qualitative exploration of men’s experiences of sexual desire in heterosexual long-term relationships
      452. A Qualitative Exploration of the Distress and Consequences Experienced by Women with Low sexual desire and their Partners in Long-Term Relationships
      453. A qualitative exploration of the distress experienced by long-term heterosexual couples when women have low sexual desire
      454. A qualitative exploration of the meaning and experience of sexual desire among partnered women
      455. A qualitative investigation of male partners’ experience of relationships with women suffering from vaginismus
      456. A randomized clinical trial for women with vulvodynia: Cognitive-behavioral therapy vs. supportive psychotherapy
      457. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual
      458. A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized …
      459. A randomized controlled intervention trial of a sexual health approach to long-term HIV risk reduction for men who have sex with men: effects of the intervention on …
      460. A randomized pilot trial of a couple-based intervention addressing sexual concerns for breast cancer survivors
      461. A Randomized Study Comparing Video-Based Mindfulness-Based Cognitive Therapy With Video-Based Traditional Cognitive Behavioral Therapy in a Sample of …
      462. A randomized trial of low-cost mesh in groin hernia repair
      463. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido
      464. A randomized trial of the effect of testosterone and estrogen on verbal fluency, verbal memory, and spatial ability in healthy postmenopausal women
      465. A randomized, double‐blind, placebo‐controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women
      466. A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal …
      467. A randomized, placebo-controlled laboratory study of the effects of D-cycloserine on sexual memory consolidation in women
      468. A randomized, waiting-list-controlled study shows that brief, mindfulness-based psychological interventions are effective for treatment of women’s low sexual desire
      469. A rapid and sensitive stability-indicating green RP-HPTLC method for the quantitation of flibanserin compared to green NP-HPTLC method: Validation studies and …
      470. A rapid and sensitive UPLC-MS/MS method for the determination of flibanserin in rat plasma: application to a pharmacokinetic study
      471. A rare cause of difficulty with sexual intercourse: large retroperitoneal leiomyoma
      472. A rare cause of infertility: A late complication of female genital mutilation
      473. A reasoned action approach to understand vaccination intention among healthcare professions students
      474. A reflexive action research project to investigate the development of an educational public health website with an integrated online advice service
      475. A reintroduction to clinical sexuality
      476. A relational-feminist psychodynamic approach to sexual desire
      477. A replication study of obsessional followers and offenders with mental disorders
      478. A Rethinking of Gray Asexuality: What do we Learn from an Undefinable Identity?
      479. A Review of “Clinical Handbook of Couple Therapy” Alan S. Gurman (Ed).(2008). New York: Guilford Press, 736 pp., $90.00
      480. A review of affecting factors on sexual satisfaction in women
      481. A review of antidepressant therapy in primary care: current practices and future directions
      482. A review of anxiety and sexual arousal in human sexual dysfunction
      483. A review of breast cancer survivorship issues from survivors’ perspectives
      484. A review of experimental research on anxiety and sexual arousal: Implications for the treatment of sexual dysfunction using cognitive behavioral therapy
      485. A review of infrared thermography as applied to human sexual psychophysiology
      486. A review of male and female sexual function following colorectal surgery
      487. A review of mindfulness-based sex therapy interventions for sexual desire and arousal difficulties: From research to practice
      488. A review of patient-reported outcome labeling in the United States (2011–2015)
      489. A review of recent innovations in the treatment of low sexual desire
      490. A review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestris
      491. A review of treatment-related outcomes in female partners of men with Peyronie’s disease—an Opportunity for improved Assessment
      492. A Review of: “Principles and Practice of sex Therapy. Fourth Edition” edited by Sandra R. Leiblum, The Guilford Press, New York, New York; 2007; ISBN 978-1-59385 …
      493. A Review of” Systemic sex Therapy”
      494. A Review on the role of Tribulus terrestris in the reproductive biology
      495. A role for melanocortin agonists in treating male and female sexual dysfunction
      496. A rose by any other name: Should dyspareunia be reclassified?
      497. A s an extension of their study demonstrating that topira
      498. A Selection of Notable Papers from the Past 25 Years
      499. A selective role for right insula—basal ganglia circuits in appetitive stimulus processing
      500. A selective serotonin receptor agonist for weight loss and management of menopausal vasomotor symptoms in overweight midlife women: a pilot study
      501. A sex-specific dose-response curve for testosterone: could excessive testosterone limit sexual interaction in women?
      502. A sexual masquerade: the performance of desire and femininity in a Fifty Shades of Grey era: a thesis presented in partial fulfilment of the requirements for the degree …
      503. A sexual medicine health care model and nurse practitioner role.
      504. A short review on potential activities of benzimidazole derivatives
      505. A Short Term Cognitive and Behavorial Treatment Approach to sexual desire Phase Dysfunction
      506. A simple test for the treatment effect in clinical trials with a sequential parallel comparison design and negative binomial outcomes
      507. A skeptical view of desire norms and disorders promotes clinical success
      508. A slightly different idea
      509. A socio-cognitive approach of human sexual desire
      510. A Sociological Perspective on Impulsivity: Some Cautionary
      511. A specific nursing educational program in patients with Cushing’s syndrome
      512. A Standard for Terminology in Chronic Pelvic Pain Syndromes (CPPS): A Report from the Working Group of the International Continence Society …
      513. A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society
      514. A standardized diagnostic interview for hypoactive sexual desire disorder in women: standard operating procedure (SOP Part 2)
      515. A stepped-care approach to symptomatic endometriosis management: a participatory research initiative
      516. A streetcar named “Derousal”? A psychophysiological examination of the desire–arousal distinction in sexually functional and dysfunctional women
      517. A strong pelvic floor is associated with higher rates of sexual activity in women with pelvic floor disorders
      518. A structural equation modeling analysis of the relationships between depression, anxiety, and sexual problems over time
      519. A study assessing the quality of life related to voiding symptoms and sexual functions in menopausal women
      520. A Study of Correlation of sexual Dysfunction with Serum Uric Acid Level in Alcohol Dependent Individuals
      521. A study of marriage and family counselling services of Pentecostal and Charismatic churches in Cape Coast metropolis
      522. A study of possible associations between single nucleotide polymorphisms in the estrogen receptor 2 gene and female sexual desire
      523. A study of prevalence of sexual dysfunction & assessment of related factors in women referring to mother-baby clinics in Tehran
      524. A Study of sexual Dysfunction among Male Alcohol Dependent Patients.
      525. A Study of sexual Dysfunction in a Sample of Medicated and non Medicated Egyptian Female Patients with Schizophrenia
      526. A study of sexual related determinants and marital quality among married couple in Malaysia
      527. A STUDY OF THE CONNECTION BETWEEN INSECURE ATTACHMENT
      528. A study of the Libidinal impulses and its Management in adolescents
      529. A study of various factors associated with sexual dysfunction in males with type 2 diabetes mellitus
      530. A Study on the Development of
      531. A STUDY ON THE FACTORS THAT INFLUENCE ASCHENBACH’S sexual ORIENTATION IN MANN’S DEATH IN VENICE
      532. A study protocol of vaginal laser therapy in gynecological cancer survivors
      533. A Survey of Biological, Psychological, Sociological, and Cultural Factors
      534. A survey of Relate psychosexual therapy clients, January to March 2002
      535. A survey of urban middle-aged women’s sexual function and sexual distress
      536. A Swiss longitudinal study of the prevalence of, and overlap between, sexual problems in men and women aged 20 to 50 years old
      537. A symptomatic approach to understanding women’s health experiences: a cross-cultural comparison of women aged 20 to 70 years
      538. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal …
      539. A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal …
      540. A systematic review of sexual distress measures
      541. A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men
      542. A systematic review of the literature on female sexual dysfunction prevalence and predictors
      543. A systemic approach to sensate focus
      544. A Systemic Approach to sex Therapy
      545. A test of three hypotheses concerning attributions toward female promiscuity
      546. A Textual Analysis of Online Asexual Representation and Visibility on Reddit
      547. A theory of love and sexual desire
      548. A Traditional Masters and Johnson behavioral approach to sex therapy
      549. A Transdiagnostic Approach to sexual Distress and sexual Pleasure: A Preliminary Mediation Study with Repetitive Negative Thinking
      550. A Turkish study of prevalence and risk factors for low sexual function in women.
      551. A Typology of Women with Low sexual desire
      552. A unique patient presenting with concomitant Klinefelter syndrome, Alport syndrome, and craniopharyngioma
      553. A validated UPLC–MS/MS method for flibanserin in plasma and its pharmacokinetic interaction with bosentan in rats
      554. A Woman Complaining of Lack of sexual desire: sexological Counseling
      555. A-Identity Politics: Asexual Exceptionalism, Precarity, and Activism
      556. A172 Abstracts
      557. A182 Abstracts
      558. AB029. Meeting sexual health requirements in menopause
      559. AB033. Comparing male and female sexual arousal, utilizing fMRI: a theoretical perspective
      560. Abdullah A, Wolfe R, Mannan H, Stoelwinder JU, Stevenson
      561. Aberrant baseline brain activity in psychogenic erectile dysfunction patients: a resting state fMRI study
      562. Aberrant insula-centered functional connectivity in psychogenic erectile dysfunction patients: a resting-state fMRI study
      563. Aberrant topological patterns of structural cortical networks in psychogenic erectile dysfunction
      564. Abnormal degree centrality in lifelong premature ejaculation patients: an fMRI study
      565. Abnormal desire or normal for females? Addressing women’s disinterest in sex
      566. Abnormal Libido
      567. Abnormal psychology
      568. Abnormal sexuality in Parkinson’s disease: fact or fancy?
      569. Abnormalities of sexual function and interest: origins and interventions
      570. About Ochsner
      571. About Ochsner
      572. Above and beyond short-term mating, long-term mating is uniquely tied to human personality
      573. Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL, Francois B, Guy JS, Bruckmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N …
      574. ABSTR ACT PRESENTATIONS
      575. Abstracts 32nd Annual Meeting of the North American Society for Psychosocial Obstetrics and Gynecology
      576. Abstracts from the 2017 American College of Medical Toxicology (ACMT) annual scientific meeting
      577. Abstracts from the XVII World Congress of sexology
      578. Abstracts from Women’s Health 2012: The 20th Annual CongressMarch 16–18, 2012 Washington, DC
      579. Abstracts from Women’s Health 2016: The 24th Annual Congress April 14–17, 2016 Washington, DC
      580. Abstracts from Women’s Health 2017: The 25th Annual Congress April 28–30, 2017 Washington, DC
      581. Abstracts from Women’s Health 2018: Translating Research into Clinical Practice May 4–6, 2018 Washington, DC
      582. Abstracts fromWomen’s Health 2013: The 21st Annual CongressMarch 22–24, 2013Washington, DC
      583. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy
      584. Accessing health care on the asexual spectrum: A feminist analysis of patient-practitioner relationships and compulsory sexuality in medical discourse
      585. Accounts of the impact of erectile dysfunction on heterosexual couples from men seeking erectogenic treatment and their partners
      586. Accreditation rules safeguard continuing medical education from commercial influence
      587. Ace and aro: understanding differences in romantic attractions among persons identifying as asexual
      588. ACE angiotensin-converting enzyme AED anti-epileptic drug AFP α-fetoprotein ALT alanine transaminase
      589. Ace: What Asexuality Reveals About desire, Society, and the Meaning of sex
      590. Acetylcholinesterase inhibitory and antioxidant activities of Ferula caspica and F. halophila extracts
      591. Achievement of and Failure to Achieve Orgasm in sexual Relationship: Exploring Iranian Women’s Experiences
      592. Acknowledging female sexual dysfunction in women with cancer.
      593. ACOG guideline on sexual dysfunction in women
      594. ACR, ACRUX LIMITED
      595. Acromegaly is associated with higher frequency of female sexual dysfunction: experience of a single center
      596. ACT for Gender Identity: The Comprehensive Guide
      597. Activation of sensory cortex by imagined genital stimulation: an fMRI analysis
      598. Acupuncture and female sexual dysfunction: a time-series study of symptom relief
      599. Acupuncture in premenopausal women with hypoactive sexual desire disorder: a prospective cohort pilot study
      600. Acupuncture in premenopausal women with hypoactive sexual desire disorder: a prospective cohort study
      601. Acute Aortic Dissection in a Postmenopausal Female in the Setting of Parenteral Testosterone, Estradiol, and Progesterone Therapy
      602. Acute Cannabis Intoxication and the Brain’s Response to Visual Erotica: An Fmri Study
      603. Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women
      604. Acute exercise improves physical sexual arousal in women taking antidepressants
      605. Acute withdrawal but not long-term withdrawal from methamphetamine affects sexual behavior in female rats
      606. Adaptación, validación y fiabilidad del Cuestionario de funcionamiento sexual del Hospital General de Massachusetts en una muestra colombiana y equivalencia …
      607. Adaptation and validation of the sexual Assertiveness Scale (SAS) in a sample of male drug users
      608. Adaptation, validation and reliability of the Massachusetts General Hospital-sexual Functioning Questionnaire in a Colombian sample and factorial …
      609. Adapting a couple-based intimacy enhancement intervention to breast cancer: A developmental study.
      610. Addiction is not just a brain disease
      611. Addiction or compulsion: politics or illness?
      612. Adding insult to injury: The classification of dyspareunia as a sexual dysfunction in the DSM
      613. Addressing both genders in sexual medicine diagnosis and treatment
      614. Addressing sexual Dysfunction After Childhood sexual Abuse: A Clinical Approach from an Attachment Perspective
      615. Addressing sexual dysfunction in colorectal cancer survivorship care
      616. Addressing sexuality with clients: A manual for therapists in training
      617. Addressing the sexual function of women during first six month after delivery: Aquasi-experimental study
      618. Addressing the sexual problems of Iranian women in a primary health care setting: A quasi-experimental study
      619. Addressing vulvovaginal atrophy (VVA)/genitourinary syndrome of menopause (GSM) for healthy aging in women
      620. Adiposity, chronic inflammation, and the prepubertal decline of sex hormone binding globulin in children: evidence for associations with the timing of puberty …
      621. Adjudicating sex crimes as mental disease
      622. Adjuvant Rosa damascena has a small effect on SSRI-induced sexual dysfunction in female patients suffering from MDD
      623. Adolescence as a risk factor for maternal and perinatal complications in Cali, Colombia, 2002-2007: a cross-sectional study
      624. Adolescent and pediatric
      625. Adolescent stalking: A review
      626. Adrenal androgens and aging
      627. Adrenal androgens impact on neurosteroids
      628. Adrenal cortex
      629. Adrenal cortex
      630. Adrenal cortex
      631. Adrenal disorders, female androgen deficiency, hirsutism, and endocrine hypertension
      632. Adrenocortical effects of oral estrogens and soy isoflavones in female monkeys
      633. Adult hypothyroidism
      634. Adult-onset hypogonadism
      635. Adulteration of herbal sexual enhancers and slimmers: The wish for better sexual well-being and perfect body can be risky
      636. Adulteration of Synthetic Substances in Dietary Supplements
      637. Advanced symptom management in multiple sclerosis
      638. Advances in hormone replacement therapy: making the menopause manageable
      639. Advances in neurosteroids: role in clinical practice
      640. Advances in pharmacotherapy for treating female sexual dysfunction
      641. Advances in the treatment of vulvovaginal atrophy
      642. Advancing sexual Health for the Christian Client: Data and Dogma
      643. Advise Against Flibanserin
      644. Advocating for a transdisciplinary perspective in sexual medicine
      645. Aetiology, diagnostic algorithms and prognosis of female sexual dysfunction
      646. Affective and Autonomic Responses to Erotic Images among Young Women with and without sexual Difficulties
      647. Affective and autonomic responses to erotic images: evidence of disgust-based mechanisms in female sexual interest/arousal disorder
      648. Affirmative practice and alternative sexual orientations: Helping clients navigate the coming out process
      649. African American women living with HIV/AIDS: Mental health issues
      650. African and European HIV-positive women: psychological and psychosocial differences
      651. Aftershock: The lived experience of chemotherapy, induced menopause for breast cancer survivors and its impact on their sexuality
      652. Age and Decline of sexuality
      653. Age and gender considerations in psychiatric diagnosis: A research agenda for DSM-V
      654. Age and psychologic disorders: variables associated to post-infarction sexual dysfunction
      655. Age and sex
      656. Age-related changes in the male reproductive system
      657. Age-related differences in health complaints: the Hilo women’s health study
      658. Age-related prevalence rates of sexual difficulties, sexual dysfunctions and sexual distress in heterosexual men: results from an online survey in Flanders
      659. Age‐related prevalence rates of sexual difficulties, sexual dysfunctions, and sexual distress in heterosexual women: Results from an online survey in Flanders
      660. Age, gender, depression, and sexual dysfunction in Taiwan
      661. Ageing, infertility and gynaecological conditions: how do they affect sexual function?
      662. Ageratum conyzoides L. inhibits 5‐alpha‐reductase gene expression in human prostate cells and reduces symptoms of benign prostatic hypertrophy in otherwise …
      663. Aging and erectile function
      664. Aging and male sexuality
      665. Aging and pathogenesis of erectile dysfunction
      666. Aging and sexual response in the laboratory in patients with erectile dysfunction
      667. Aging and sexuality
      668. Aging is a powerful predictor of sexual dysfunction. Age-related changes in sexual behavior in men, with attention
      669. Aging, androgens, and female sexual desire: Can we restore what time takes away?
      670. Agreement of self-reported and genital measures of sexual arousal in men and women: A meta-analysis
      671. AIDS. Pediatr Pathol. 1988; 8: 417–421. Degano B, Guillaume M, Savale L, Montani D, et al. HIV-associated pul-monary arterial hypertension: survival and prognostic …
      672. Alcohol and drug effects on sexual response: Human experimental and clinical studies
      673. Alcohol and sexual health behavior:“What we know and how we know it”
      674. Alessandra Graziottin
      675. Alexithymia, negative emotions, and sexual behavior in heterosexual university students from Italy
      676. ali zobozdravniški poslanci v skupščini
      677. All his sexless patients: Persons with mental disabilities and the competence to have sex
      678. Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase II randomized, double-blind, placebo-controlled clinical trial
      679. Allosteric ligands for G protein‐coupled receptors: A novel strategy with attractive therapeutic opportunities
      680. Alterations in grip strength during male sexual arousal
      681. Alterations in sexual function
      682. Alterations of sexual function in women with cancer
      683. Alterations of the Monoaminergic Systems by Sustained Triple Reuptake Inhibition
      684. Altered sexual health and quality of life in women prior to hematopoietic cell transplantation
      685. Altered states of consciousness are related to higher sexual responsiveness
      686. Alternative formats
      687. Alternative therapies for male and female sexual dysfunction
      688. Alternative treatment modalities for the hypogonadal patient
      689. Alters and Schiff Essential Concepts for Healthy Living
      690. Am I a father? A husband’s miscarriage
      691. Amalgamation of stress degradation and metabolite profiling in rat urine and feces for characterization of oxidative metabolites of flibanserin using UHPLC-Q-TOF-MS …
      692. Ambulatory blood pressure
      693. Amelioration of erectile dysfunction following a switch from carbamazepine to oxcarbazepine: recent clinical experience
      694. Amelioration of sexual adverse effects in the early breast cancer patient
      695. Amenorrhoea, oligomenorrhoea and hypothalamic–pituitary dysfunction
      696. American Association for Cancer Research And American College of Obstetricians and Gynecologists
      697. American sexual histories
      698. Amit Garg A Mechanism Based Population Pharmacokinetic-Pharmacodynamic Model for Epoetin Alfa and Darbepoetin Alfa in Chronic Kidney Disease …
      699. Amygdala–frontal interactions and reward expectancy
      700. An Analysis of the Development and Validation of the Decreased sexual desire Screener for the Diagnosis of hypoactive sexual desire Disorder
      701. An analysis of the MMPI-2 profiles of individuals entering treatment at a sexual addiction treatment facility
      702. An Analysis of the Theoretical Origins and Persistance of Asexuality in Humans
      703. An approach to sexual dysfunction in menopausal women
      704. AN ARCHETYPAL AND INNER CAST OF CHARACTERS APPROACH TO sex THERAPY WITH WOMEN WHO HAVE LOW sexual desire
      705. An assessment of rates of psychiatric morbidity and functioning in HIV disease
      706. An Ayurvedic personalized prophylactic protocol in COVID-19
      707. An easy method to define the cervical borders during postpartum hysterectomy
      708. An epidemiological study of sexual disorders in south Indian rural population
      709. An Evaluation and Comparison of Methods Assessing Erectile Dysfunction
      710. An Evaluation of sexual Victimization History and Psychological Adjustment on sexual Health in Women
      711. An evaluation of the quality of life and sexual status functions of females with urinary incontinence
      712. An Evaluation of the Readability of Drug Trials Snapshots
      713. An evaluation of the relationship between body image and sexual avoidance
      714. An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction
      715. An evidence‐based unified definition of lifelong and acquired premature ejaculation: Report of the second International Society for sexual Medicine Ad Hoc …
      716. An evolutionary functional analysis of the hormonal predictors of women’s sexual motivation
      717. An Examination of Disgust, Its Measures, and Gender Differences in the Experience of Disgust Sensitivity
      718. An Examination of sexual Fantasy with Specific Emphasis on both Fluid and Constant Variables: The Effect of Gender, Age, sexual Orientation, Ethnicity …
      719. An Examination of sexuality in Women with an Elevated Risk for Breast Cancer Development
      720. An Examination Of The Effect Of Professional License Type And Gender On The Self-efficacy And Comfort Level Of Counseling Skills In Addressing sexual Issues …
      721. An Examination of the Negative Impact of the Western Cultural sex Paradigm on Female sexuality
      722. An Examination of the Relationship between Authenticity and Female sexual Dysfunction
      723. An examination of the sexual double standard pertaining to masturbation and the impact of assumed motives
      724. An Experimental Examination of Automatic Interpretation Biases in Major Depression
      725. An experimental investigation of the impact of body image on subjective sexual arousal among sexually dysfunctional women
      726. An exploratory study of the relationship between second toe length and androgen-linked behaviors.
      727. An exploratory study on the central nervous correlates of sexual excitation and sexual inhibition
      728. An immunological insight into premature ovarian failure (POF)
      729. An injury-induced cell model of early uterine fibroid development
      730. An intake interview and assessment instrument for adults presenting with a history of childhood sexual abuse
      731. An integrated model to assess and treat compulsive sexual behaviour disorder
      732. An integrative cognitive-behavioral approach to understanding, assessing, and treating female sexual dysfunction
      733. An integrative medicine approach to the treatment of HSDD: introducing the HURT Model™
      734. An integrative model for treatment of sexual desire disorders: An update of the masters and Johnson institute approach
      735. An integrative theoretical framework for understanding sexual motivation, arousal, and behavior
      736. An interactional approach to sexual dysfunctions
      737. An Internally Validated Nomogram for Predicting the Likelihood of Improvement of Clinical Global Impression in Patients With Lifelong Premature Ejaculation …
      738. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the assessment of sexual health of …
      739. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the conservative and …
      740. An introduction to psychology for attorneys
      741. An introduction to sexual Medicine
      742. An investigation of sexual dysfunction in female partners of men with erectile dysfunction: how interviews expand on questionnaire responses
      743. An investigation of sexual motivation in the female rat
      744. An investigation of the relationship between assertiveness, sex-role values, fantasy, sexual beliefs and sexual satisfaction in females
      745. An investigation of the relationship between physical fitness, self-concept, and sexual functioning
      746. An objective measure of vaginal lubrication in women with and without sexual arousal concerns
      747. An old problem with a new cause-5 alpha reductase inhibitors and persistent sexual dysfunction
      748. An online, mindfulness-based, cognitive-behavioral therapy for female sexual difficulties: impact on relationship functioning
      749. An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer
      750. An open‐label, randomized, flexible‐dose, crossover study to assess the comparative efficacy and safety of sildenafil citrate and apomorphine hydrochloride in men …
      751. An update on drugs for the treatment of menopausal symptoms
      752. An update on menopause management
      753. An update on sexual function and dysfunction in women
      754. An update on the pharmacological management of female sexual dysfunction
      755. Analysis of a French female sexuality reference population
      756. Analysis of factors that influence the quality of sexual life of climacteric women in China
      757. Analysis of low sexual desire in Chinese women: a national population-based epidemiological survey in mainland China
      758. Analysis Regarding Quality of Life of Menopausal Women on Clinical Disorders during Menopausal Period, on Sukomanunggal Sub-District Surabaya in 2019
      759. Anandamide transforms noncopulating rats into sexually active animals
      760. Anatomic variation and orgasm: Could variations in anatomy explain differences in orgasmic success?
      761. Anatomical study of the obturator foramen and dorsal nerve of the clitoris and their relationship to minimally invasive slings
      762. Anatomy and Physiology of Arousal
      763. Anatomy and physiology of female sexual function and dysfunction
      764. Anatomy and physiology of female sexual function and dysfunction
      765. Anatomy and physiology of genital organs–women
      766. Anatomy and Physiology of the Hypothalamic-Pituitary-Gonadal (HPG) Axis
      767. Anatomy and physiology of women’s sexual function
      768. Anatomy/physiology: Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without Vardenafil on physiological sexual …
      769. ANATOMY/PHYSIOLOGY: Induction of sexual Arousal in Women Under Conditions of Institutional and Ambulatory Laboratory Circumstances: A Comparative Study
      770. Anatomy/physiology: Satisfaction (sexual, life, relationship, and mental health) is associated directly with penile–vaginal intercourse, but inversely with other sexual …
      771. AND DEVIATION
      772. and Erectile Dysfunction
      773. and Long—Term Romantic Partners?
      774. and Mario Maggi
      775. and Paraphilic Disorders
      776. and reported less psychological distress than did those with eating disturbances. The findings suggest that eating problems may be more prevalent among males than …
      777. and Shah Dupesh
      778. And Spirit of My Father
      779. and the Placebo Effect: A Copyright ª by t he American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. Unauthorized …
      780. Androgen actions in the female-They don’t just make a man out of you
      781. Androgen and menopause
      782. Androgen Deficiency
      783. Androgen deficiency and phosphodiesterase type 5 expression changes in aging male: therapeutic implications
      784. Androgen deficiency and therapy in women
      785. Androgen Deficiency in Aging Male (ADAM)
      786. Androgen deficiency in men
      787. Androgen deficiency in menopause: should it be treated?
      788. Androgen deficiency in the aging male
      789. Androgen Deficiency in the Aging Male
      790. Androgen deficiency in women in urogynecologic practice: Pathophysiology, clinical «masks», and pharmacotherapy using transdermal testosterone formulations.
      791. Androgen deficiency in women; role of accurate testosterone measurements
      792. Androgen deficiency in women.
      793. Androgen Deficiency Syndromes in Men Guideline Task Force: Shalender Bhasin, Glenn R. Cunningham
      794. Androgen deficiency: effects on body composition
      795. Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life
      796. Androgen in postmenopausal women
      797. Androgen Insufficiency and Female sexual Motivation
      798. Androgen insufficiency in women
      799. Androgen insufficiency in women: summary of critical issues
      800. Androgen receptor expression in the human vagina under different physiological and treatment conditions
      801. Androgen receptor gene polymorphism and sexual function in midlife women
      802. Androgen receptor polymorphism and female sexual function and desire
      803. Androgen Replacement in Women: Safe and Efficacious?
      804. Androgen replacement therapy
      805. Androgen replacement therapy in androgen-deficient women with hypopituitarism
      806. ANDROGEN REPLACEMENT THERAPY IN POSTMENOPAUSE
      807. Androgen replacement therapy in postmenopause.
      808. Androgen replacement therapy in the aging male—a critical evaluation
      809. Androgen replacement therapy in women
      810. Androgen replacement therapy in women
      811. Androgen supplementation in practice: the treatment of erectile dysfunction associated with hypotestosteronemia
      812. Androgen synthesis, metabolism and action in the developing ovarian follicle
      813. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
      814. Androgen therapy for low female libido
      815. Androgen therapy for postmenopausal women
      816. Androgen Therapy for Women
      817. Androgen Therapy in Menopause
      818. Androgen therapy in women
      819. Androgen therapy in women
      820. Androgen therapy in women
      821. Androgen therapy in women, beyond libido
      822. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline
      823. Androgen therapy in women: an Endocrine Society Clinical Practice guideline
      824. Androgen therapy in women: for whom and when
      825. Androgen therapy in women: what we think we know
      826. Androgen Treatment for hypoactive sexual desire?
      827. Androgen treatment in women
      828. Androgen Treatment in Women
      829. Androgen treatment of postmenopausal women
      830. Androgen use for low sexual desire in midlife women
      831. Androgenassays: of mice and men
      832. Androgenetic alopecia: effects of oral finasteride on hormone profile, reproduction and sexual function
      833. Androgenic action of dehydroepiandrosterone (DHEA) on nerve density in the ovariectomized rat vagina
      834. Androgenic deficiency and its impact on womens health status
      835. Androgenic hormones and aging—the link with female sexual function
      836. Androgenic maintenance of rat penile erection
      837. Androgens and breast cancer in men and women
      838. Androgens and breast cancer risk
      839. Androgens and cardiovascular disease in postmenopausal women: a systematic review
      840. Androgens and cardiovascular disease in women and men
      841. Androgens and cardiovascular disease: gender-related differences
      842. Androgens and female sexual function
      843. Androgens and female sexual function and dysfunction—findings from the Fourth International Consultation of sexual Medicine
      844. Androgens and menopause: more fuel for the fire
      845. Androgens and psychosocial factors related to sexual dysfunctions in premenopausal women∗:∗ 2016 ISSM Female sexual Dysfunction Prize
      846. Androgens and sexual function during menopause
      847. Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction …
      848. Androgens and the breast
      849. Androgens are fundamental in the maintenance of male sexual health
      850. Androgens are vital to female sexual health
      851. Androgens from physiology, through pharmacy and pharmacology to the status of lifestyle drugs-are we going in the right direction?
      852. Androgens in Gynecological Practice
      853. Androgens in postmenopausal women
      854. Androgens in postmenopausal women: a review
      855. Androgens in premenopausal women and women with premature ovarian insufficiency
      856. Androgens in women after allogeneic hematopoietic cell transplantation: impact of chronic GvHD and glucocorticoid therapy
      857. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology
      858. Androgens in women before and after the menopause and post bilateral oophorectomy: clinical effects and indications for testosterone therapy
      859. Androgens in Women: Too Much, Too Little, Just Right
      860. Androgens in Women: Too Much, Too Little, Just Right, An Issue of Endocrinology and Metabolism Clinics of North America, E-Book
      861. Androgens inhibit the stimulatory action of 17β-estradiol on normal human breast tissue in explant cultures
      862. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa
      863. Androgens, health and sexuality in women and men
      864. Androgens, Use, Misuse, and Abuse
      865. Androgens/female clinical/female basic science
      866. Andrology and Infertility
      867. Anethum graveolens as a possible modulator of testicular steroidogenesis
      868. Anger and anxiety
      869. Anger and sexual behavior
      870. Animal models for the study of female sexual dysfunction
      871. Animal models in sexual medicine: The need and importance of studying sexual motivation
      872. Animal models of female sexual dysfunction: basic considerations on drugs, arousal, motivation and behavior
      873. Anodyspareunia, the unacknowledged sexual dysfunction: A validation study of painful receptive anal intercourse and its psychosexual concomitants in homosexual …
      874. Anorectic and bulimic patients suffer from relevant sexual dysfunctions
      875. Another major function of the anterior cingulate cortex: the representation of requirements
      876. Another Option for hypoactive sexual desire
      877. Another procrustean bed for female sexual functioning
      878. Antagonizing hepatitis
      879. Antecedents of sexual Infidelity in Romantic Relationships. A Literature Review of the Latest Empirical Results, Prevailing Explanatory Models, and Proposal of …
      880. Anterior pituitary failure
      881. Anterior pituitary hormone replacement therapy—a clinical review
      882. Anterior vaginal introitoplasty for an acquired sensation of wide vagina: a case report and new surgical intervention.
      883. Anti-insomniac Botanicals and Natural Products: Pre-clinical and Clinical Evidences
      884. Anti-tumor activities of Panax quinquefolius saponins and potential diagnostic markers in prostate cancer
      885. Anticonceptive problems in Bangladesh: An approach by case reports
      886. Antidepressant use during development may impair women’s sexual desire in adulthood
      887. Antidepressant-induced sexual dysfunction: review, classification, and suggestions for treatment
      888. Antidepressants
      889. Antidepressants and sexual dysfunction: mechanisms and clinical implications
      890. Antioxidants in Male sexual Dysfunctions
      891. Anxiety and female sexual functioning: An empirical study
      892. Anxiety attacks following surgical menopause
      893. Anxiety attacks following surgical menopause: a case report
      894. Anxiety in Natural and Surgical Menopause-Physiologic and Therapeutic Bases
      895. Anxiety, dispositional mindfulness, and sexual desire in men consulting in clinical sexology: A mediational model
      896. Anxiety, Dispositional Mindfulness, and sexual desire in Men Consulting in Clinical sexology: A Mediational Model Anxiety, Dispositional Mindfulness, and …
      897. AOFS NEWSLETTER
      898. Aphrodisiac activity and screening for acute toxicity of Asian swamp eel, Monopterus albus extracts on male mice
      899. Aphrodisiac and Spermatogenic Potential of Ayurveda Formulation-Ashwagandhadi Lehya
      900. Appendix 1 (as supplied by the authors): Full-text guidelines Multidisciplinary Canadian Clinical Practice Guideline on the Diagnosis and Management of …
      901. Appetitive responses to sexual stimuli are attenuated in individuals with low levels of sexual desire
      902. Apples and oranges:“sexual Medicine” and the effort to deny that counting and classifying are political acts
      903. Application of mesocolon rotation and reverse puncture in total laparoscopic sigmoid vaginoplasty
      904. Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route
      905. Application of sex aids in men with sexual dysfunction: a review
      906. Application of the intersystem approach for combat veterans experiencing sexual problems related to trauma and injuries of war
      907. Application of the sexual health model in the long-term treatment of hypoactive sexual desire and female orgasmic disorder
      908. Applications of Flow Chemistry in the Pharmaceutical Industry—Highlights of the Recent Patent Literature
      909. Applied Reproductive System: Scientific Aspects……. 83 Chapter 6 sexually Transmitted Infections and Associated Reproductive Tract Infections …
      910. Applying a sexual health model to the assessment and treatment of Internet sexual compulsivity
      911. Applying Machine Learning to Increase Efficiency and Accuracy of Meta-Analytic Review
      912. Approach of Evolutionary Psychology to Research of Human sexuality and Mate Choice
      913. Approaches to Human Behavior
      914. Appropriate Perspective and Context for Newly Approved Medications, Including Flibanserin
      915. Appropriate perspective and context for newly approved medications, including flibanserin
      916. Appropriate perspective and context for newly approved medications, including flibanserin—Reply
      917. Aptitudes and Attitudes among Licensed Professional Counselors Regarding Human sexuality and sexual Counseling in Puerto Rico: An Exploratory Study
      918. Arabic translation of Female sexual Function Index and validation in an Egyptian population
      919. Are all estrogens created equal? A review of oral vs. transdermal therapy
      920. Are aspects of study design associated with the reported prevalence of female sexual difficulties?
      921. Are gynaecologists confident addressing sexual issues with menopausal women?
      922. Are Healthy Parental Attachments and Resilience to Societal Objectification Basic to Women’s sexual Health?
      923. Are hormonal components of oral contraceptives associated with impaired female sexual function? A questionnaire-based online survey of medical students in …
      924. Are hormones the answer to low libido?
      925. Are meta-analyses clinically useful?
      926. Are our definitions of women’s desire, arousal and sexual pain disorders too broad and our definition of orgasmic disorder too narrow?
      927. Are Personality Traits Effective in Marital Adjustment in Couples with sexual Dysfunction? The Mediating Effect of sexual Satisfaction
      928. Are Personality Traits Effective in Marital Adjustment in Couples with sexual Dysfunction? The Mediating Effect of sexual Satisfaction.
      929. Are role and gender related to sexual function and satisfaction in men and women practicing BDSM?
      930. Are sexual problems a form of internalizing psychopathology? A structural equation modeling analysis
      931. Are some patients trying to” medicalize” chronic fatigue?
      932. Are the academic institutions of public health in Africa able to prepare graduates for UHC?
      933. Are the complexities of women’s sexual function reflected in the new consensus definitions of dysfunction?
      934. Are the Endocrine Society’s Clinical Practice Guidelines on Androgen Therapy in Women Misguided? A Commentary
      935. Are UK services meeting the need of patients with sexual problems and where should psychosexual services be provided?
      936. Are urology residents ready to treat premature ejaculation after their training?
      937. Are we ready for this classification system?
      938. Arginase: structure, mechanism, and physiological role in male and female sexual arousal
      939. Aromatase inhibitors are associated with low sexual desire causing distress and fecal incontinence in women: an observational study
      940. Aromatization is not required for the facilitation of appetitive sexual behaviors in ovariectomized rats treated with estradiol and testosterone
      941. Arousal and desire problems: Conceptual, research and clinical considerations or the more things change the more they stay the same
      942. Arousal and orgasm are intimately linked as important com-ponents in healthy female sexual function. Disorders of
      943. Arousal disorders in women: complaints and complexities
      944. Arousal, sexual
      945. Arriving at a “new view” of women’s sexual problems: Background, theory, and activism
      946. Arriving at the diagnosis of female sexual dysfunction
      947. Arterial hypertension and female sexual dysfunction in postmenopausal women
      948. Article 2 Computer-generated stimuli: Profile analysis and classification accuracy comparison based on penile plethysmography
      949. Articles That Could Change Your Practice
      950. AS: Classification, Interpellation
      951. Ascr: This review defines sexual desire, distinguishes sexual desire from other sexual experiences (eg arousal, activity), discusses common operationalizations …
      952. Asexual Activism
      953. Asexual Experiences of Microaggressions Scale: Instrument Development and Evaluation
      954. Asexual people’s experience with microaggressions
      955. Asexual scripts: A grounded theory inquiry into the intrapsychic scripts asexuals use to negotiate romantic relationships
      956. Asexual-identified clients in clinical settings: Implications for culturally competent practice.
      957. Asexual-Identified People’s Interactions with Health Care Practitioners
      958. Asexualities: Socio-cultural perspectives
      959. Asexuality
      960. Asexuality
      961. Asexuality
      962. Asexuality
      963. Asexuality and boundaries in online discourse
      964. Asexuality and disability: Strange but compatible bedfellows
      965. Asexuality and Its Discontents: Making the’Invisible Orientation’Visible in Comics
      966. Asexuality and its implications for LGBTQ-parent families
      967. Asexuality and its implications for sexuality studies
      968. Asexuality and sexual normativity: An anthology
      969. Asexuality and sexual normativity: an anthology, edited by Mark Carrigan, Kristina Gupta and Todd G. Morrison, London and New York, Routledge, 2014, 141 pp …
      970. Asexuality and the feminist politics of ‘not doing it’
      971. Asexuality and the Re/Construction of sexual Orientation
      972. Asexuality special theme issue editorial
      973. Asexuality, the Internet, and the changing lexicon of sexuality
      974. Asexuality: A mixed-methods approach
      975. Asexuality: A multidimensional approach
      976. Asexuality: A possible background and how it relates to autism and neurodiversity
      977. Asexuality: An extreme variant of sexual desire disorder?
      978. Asexuality: Classification and characterization
      979. Asexuality: Few facts, many questions
      980. Asexuality: From pathology to identity and beyond
      981. Asexuality: investigations into a lack of sexual attraction
      982. Asexuality: Prevalence and associated factors in a national probability sample
      983. Asexuality: sexual Health Does Not Require sex
      984. Asexuality: sexual orientation, paraphilia, sexual dysfunction, or none of the above?
      985. Asexuality: To Include or Not to Include a Slice of Cake in the LGBTQ+ Community
      986. Asexuality: Towards a Freudian-Lacanian Understanding
      987. Asexuality: What it is and why it matters
      988. Asexually: On being an ally to the asexual community
      989. Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino …
      990. ASKING OPEN-ENDED QUESTIONS CONNECTING WITH YOUNG MOTHERS
      991. Aspects of immorality in the depiction of urban Central European settings in the fiction by North American writers (1918-1939)
      992. ASPECTS OF MULTIDISCIPLINARY TREATMENT, METASTATIC DISEASE AND sexual FUNCTION
      993. ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan
      994. Assessing & managing female sexual dysfunction
      995. Assessing and addressing sexual concerns in individuals diagnosed with coronary artery disease
      996. Assessing and managing male sexual problems
      997. Assessing and treating sexual dysfunction
      998. Assessing and Treating sexual Problems in an Integrated Care Environment
      999. Assessing cognitive appraisals related to sexual function: A scenario-based approach
      1000. Assessing female sexual dysfunction in epidemiological studies: why is it necessary to measure both low sexual function and sexually-related distress?
      1001. Assessing Help-Seeking Attitudes, Service Utilization, and Provider Preferences Among Undergraduate Students With Self-Reported sexual Functioning Concerns
      1002. Assessing Mental Health Provider Bias toward Clients with Understudied Marginalized sexual Identities and Practices
      1003. Assessing predictors of sexual function in mid-aged sexually active women
      1004. Assessing psychiatric adverse effects during clinical drug development
      1005. Assessing sexual aversion in college students: The sexual Aversion Scale
      1006. Assessing sexual Dysfunction in Asian Clients
      1007. Assessing sexual dysfunction in Hispanic clients
      1008. Assessing sexual function and dyspareunia with the Female sexual Function Index (FSFI) in women with vulvodynia
      1009. Assessing sexual problems in women at midlife using the short version of the female sexual function index
      1010. Assessing the clinical efficacy of sildenafil for the treatment of female sexual dysfunction
      1011. Assessing the impact of pregnancy on sexuality using the pregnancy sexual response inventory
      1012. Assessing the role of relationship conflict in sexual dysfunction
      1013. Assessing women’s sexual arousal in the context of sexual assault history and acute alcohol intoxication
      1014. Assessment & management of sexual problems in women
      1015. Assessment and Context: Consideration of Client and Environmental Factors within the Assessment Process.
      1016. Assessment and management of sexual dysfunction in the context of depression
      1017. Assessment and sex counseling in libido disorders
      1018. Assessment and treatment of male and female sexual dysfunction
      1019. Assessment of a neuropathic factor in HIV-1 associated impotence: penile electrodiagnosis.
      1020. ASSESSMENT OF A PATIENT WITH sexual DYSFUNCTION History
      1021. Assessment of body image, sexual function, and attractiveness in women with genital prolapse: a cross-sectional study with validation of the Body Image in the Pelvic …
      1022. Assessment of brain metabolites change during visual sexual stimulation in healthy women using functional MR spectroscopy
      1023. Assessment of cerebrocortical regions associated with sexual arousal in premenopausal and menopausal women by using BOLD-based functional MRI.
      1024. Assessment of Female sexual Dysfunction
      1025. Assessment of female sexual function and quality of life among breast cancer survivors who underwenthormone therapy
      1026. Assessment of female sexual function and quality of life in predialysis, peritoneal dialysis, hemodialysis, and renal transplant patients
      1027. Assessment of health-related quality of life in menopause and aging
      1028. Assessment of life quality of menopausal women and its relative factors
      1029. Assessment of premature menopause on the sexual function and quality of life in women
      1030. Assessment of sexual activity and dysfunction in medically underserved women with gynecologic cancers
      1031. Assessment of sexual activity and menopausal symptoms in middle-aged Chinese women using the Menopause Rating Scale
      1032. Assessment of sexual behavior in rats: The potentials and pitfalls
      1033. Assessment of sexual desire for clinical trials of women with hypoactive sexual desire disorder: measures, desire-related behavior, and assessment of clinical …
      1034. Assessment of sexual difficulties associated with multi-modal treatment for cervical or endometrial cancer: A systematic review of measurement instruments
      1035. Assessment of sexual dysfunction in patients with inflammatory bowel disease
      1036. Assessment of sexual dysfunction in women diagnosed with breast cancer
      1037. Assessment of sexual fantasies in psychiatric inpatients with mood and psychotic disorders and comorbid personality disorder traits
      1038. Assessment of sexual function and related factors in mid-aged sexually active Spanish women with the six-item Female sex Function Index
      1039. Assessment of sexual function in the medically ill: psychosomatic approach to sexual functioning
      1040. Assessment of sexual function in women with neurological disorders: A review
      1041. Assessment of sexual function in women with pelvic floor dysfunction
      1042. Assessment of sexual function/dysfunction via patient reported outcomes
      1043. Assessment of sexual knowledge, attitude, and functioning among urology clinic patients in Imam Reza Hospital of Tehran
      1044. Assessment of sexual problems
      1045. Assessment of sexual satisfaction in fibromyalgia patients
      1046. Assessment of sexuality after hysterectomy using the Female sexual Function Index
      1047. Assessment of sexually related personal distress accompanying premenopausal sexual dysfunction with an Arabic version of the Female sexual Distress Scale
      1048. Assessment of the aging man with sexual dysfunction
      1049. Assessment of the effects of Tribulus terrestris on sexual function of menopausal women
      1050. Assessment of the relational factor in male patients consulting for sexual dysfunction: the concept of couple sexual dysfunction
      1051. Assessment Scales for sexual Disorders—A Review
      1052. Assessment, treatment, and relapse prevention: Male hypoactive sexual desire disorder
      1053. associated with female
      1054. Association among metabolic syndrome, testosterone level and severity of erectile dysfunction
      1055. Association between 5HT2A polymorphism and selective serotonin re‐uptake inhibitor (SSRI)‐induced sexual desire disorder (SDD) among M alaysian women
      1056. Association Between Alcohol Use and Female sexual Dysfunction From the Data Registry on Experiences of Aging, Menopause, and sexuality (DREAMS)
      1057. Association Between Body Mass Index and Female sexual Dysfunction: A Cross-sectional Study from the Data Registry on Experiences of Aging, Menopause, and …
      1058. Association between infertility and sexual dysfunction in men and women
      1059. Association between multiple sclerosis and risk of female sexual dysfunction: a systematic review and meta-analysis
      1060. Association between psychiatric symptoms and erectile dysfunction
      1061. Association between psychiatric symptoms and erectile dysfunction
      1062. Association Between PTSD Symptom Clusters, Substance Use, Hypersexuality, and Erectile Dysfunction in Service Members and Veterans
      1063. Association between the early maladaptive schemes and extra marital relationship among married people
      1064. Association between the hemodialysis adequacy and sexual dysfunction in chronic renal failure: a preliminary study
      1065. Association of ADHD and hypersexuality and paraphilias.
      1066. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic
      1067. Association of major depression with sexual dysfunction in men
      1068. Association of testosterone with estrogen abolishes the beneficial effects of estrogen treatment by increasing ROS generation in aorta endothelial cells
      1069. Associations Among Body Mass Index and sexual Behavior and sexual Health in Chinese Adults
      1070. Associations among everyday stress, critical life events, and sexual problems
      1071. Associations between affect, context, and sexual desire in depressed young women
      1072. Associations between altered cerebral activity patterns and psychosocial disorders in patients with psychogenic erectile dysfunction: A mediation analysis of …
      1073. Associations between androgens and sexual function in premenopausal women: a cross-sectional study
      1074. Associations between gender role conflict, sexual dysfunctions, and male patients’ wish for physician–patient conversations about sexual health.
      1075. Associations between testosterone secretion and sexual activity in women
      1076. Associations of body mass index and physical activity with sexual dysfunction in breast cancer survivors
      1077. Associations of VEGF gene polymorphisms with erectile dysfunction and related risk factors
      1078. Attachment Insecurities Bias the Functioning of the sexual Behavior System
      1079. Attachment Insecurity and sexual and Relational Experiences in Saudi Arabian Women: The Role of Perceived Partner Responsiveness and sexual Assertiveness
      1080. Attachment styles and male sex addiction
      1081. Attachment styles in heterosexual males with sexual addiction in the United States
      1082. Attachment, sexual assertiveness, and sexual outcomes in women with provoked vestibulodynia and their partners: A mediation model
      1083. Attending to Subjective Effects to Improve Drug Safety
      1084. Attention and emotional responses to sexual stimuli and their relationship to sexual desire
      1085. Attention Bias and Recognition of sexual Images
      1086. Attention Bias for sexual Pictures Revisited
      1087. Attention bias for sexual words in female sexual dysfunction
      1088. Attention Deficit/Hyperactivity Disorder: Are We Fostering Overdiagnosis?
      1089. Attentional and affective processing of sexual stimuli in women with hypoactive sexual desire disorder
      1090. Attentional bias to body-and sexually-relevant stimuli
      1091. Attentional bias toward and distractibility by sexual cues: a meta-analytic integration
      1092. Attentional Processing of Visual sexual Stimuli and the Concordia sexual Image Dataset
      1093. Attitudes about sexual activity among postmenopausal women in different ethnic groups: a cross-sectional study in Jahrom, Iran
      1094. Attitudes toward and frequency of partner interactions among women reporting decreased sexual desire
      1095. Attitudes toward management of decreased sexual desire in premenopausal women: a national survey of nurse practitioners and physician assistants
      1096. Attitudinal survey of women living with low sexual desire
      1097. Attributions for sexual situations in men with and without erectile disorder: Evidence from a sex-specific attributional style measure
      1098. AUA guideline on the pharmacologic management of premature ejaculation
      1099. Auer K, Bachmayr-Heyda A, Aust S, Grunt TW, Pils D
      1100. Authors, Titles, and Subjects
      1101. Autoeroticism, mental health, and organic disturbances in patients with erectile dysfunction
      1102. Automatic and deliberate affective associations with sexual stimuli in women with superficial dyspareunia
      1103. Automatic thoughts during sexual activity, distressing sexual symptoms, and sexual orientation: Findings from a web survey
      1104. Automating Complex Data Analysis: A Disruptive Business Opportunity
      1105. Autonomic imbalance and female sexual arousal disorder: the identification of heart rate variability level as a marker and treatment target
      1106. Average associations between sexual desire, testosterone, and stress in women and men over time
      1107. Avoiding false positives: zones of rarity, the threshold problem, and the DSM clinical significance criterion
      1108. Avoiding the sexual: Visual attention and distraction in dyspareunia
      1109. Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis
      1110. B. Sc., The University of British Columbia, 1997 MA, The University of British Columbia, 1999
      1111. Back to stir it up: erectile dysfunction in an evolutionary, developmental, and clinical perspective
      1112. BACKGROUND AND ETIOLOGY
      1113. Bacterial vaginosis
      1114. Barriers and bridges to intimacy and mutuality: A critical review of sexual advice found in self-help bestsellers
      1115. Barriers in the bedroom: A feminist application for working with couples
      1116. Barriers to loving: A clinician’s perspective
      1117. Barriers to talking about sexual health issues with physicians
      1118. Basal ganglia lateralization in different types of reward
      1119. baseline and month 12 was statistically
      1120. Basic manual of sexology and sexual pathology
      1121. BASIC SCIENCE: A Prospective Study Examining the Anatomic Distribution of Nerve Density in the Human Vagina
      1122. BASIC SCIENCE: Acute and Repeated Flibanserin Administration in Female Rats Modulates Monoamines Differentially Across Brain Areas: A Microdialysis Study
      1123. BASIC SCIENCE: I. Slow Oscillations in Vaginal Blood Flow: Alterations during sexual Arousal in Rodents and Humans
      1124. BASIC SCIENCE: Initial Characterization of Hydrogen Sulfide Effects in Female sexual Function
      1125. BASIC SCIENCE: The Associations among GNB3 C825T Polymorphism, Erectile Dysfunction, and Related Risk Factors
      1126. Basic sexual therapy for physicians. SIAD in women.
      1127. Bayesian Adaptive Trials for Drug Safety
      1128. Bayesian methods for design and analysis of safety trials
      1129. BDSM, sex, and stress: The impact of stress on sexual activity within BDSM and non-BDSM practitioners
      1130. Beauty and Attractiveness in the Human Voice
      1131. Beauty of humans
      1132. Becoming a sexual being: The ‘elephant in the room’of adolescent brain development
      1133. Becoming a sexual being: The ‘elephant in the room’of adolescent brain development
      1134. Becoming an Onion: The Extra-Human Nature of Genital Difference in the Old English Riddling and Medical Traditions
      1135. Becoming impossible: Asexual narratives of identity, experience, and importance
      1136. Behavior and sexual Attraction
      1137. Behavior and sexual Attraction
      1138. Behavior and symptom change among women treated with placebo for sexual dysfunction
      1139. Behavior and symptom change among women treated with placebo for sexual dysfunction
      1140. Behavior Change After HIV/AIDS Diagnosis of Female sexuality in The Yogyakarta City
      1141. Behavioral addiction: Screening, assessment, and treatment
      1142. Behavioral counseling
      1143. Behavioral interventions for sexual dysfunction in the elderly
      1144. Behavioral neuroendocrinology of reproduction in mammals
      1145. Behavioural correlates of testosterone
      1146. Behavioural therapy and counselling
      1147. Behind common symptoms and psychosocial implications of endometriosis: the role of cognitive and personality factors
      1148. Beliefs and sexual Education Influence the Development of Female sexual Dysfunctions-A Literature Review
      1149. Bench to Bedside
      1150. Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016
      1151. Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS)
      1152. Beneficial Effects of Tibolone on sexual Dys-function in Women with Premature Ovarian Failure (POF)
      1153. Benefits and Adverses Effects of Testosterone Therapy
      1154. Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding …
      1155. Benefits of female” libido” drug flibanserin are marginal, systematic review finds
      1156. Benign prostatic hyperplasia evaluation, association with sexual dysfunction, treatment, and practice patterns according to physician specialty
      1157. Benign prostatic hyperplasia evaluation, treatment and association with sexual dysfunction: practice patterns according to physician specialty
      1158. Benzyne‐Induced Ring Opening Reactions of DABCO: Synthesis of 1, 4‐Disubstituted Piperazines and Piperidines
      1159. BEST ABSTRACTS FOR ROBERT GREENBLATT PRIZES OC1.
      1160. Best of the 2008 sexual Medicine Society of North America: Highlights From the sexual Medicine Society of North America, October 16–19, 2008, Toronto …
      1161. Betrayal of the body: group approaches to hypo-sexuality for adult female sufferers of childhood sexual abuse
      1162. Between DSM and ICD: Paraphilias and the transformation of sexual norms
      1163. Between the local and the global: Chronicles for understanding the field of sexology in Mexico
      1164. Beyond dysfunction: A new view of women’s sexual problems
      1165. Beyond Gender Identity Disorder Diagnoses Codes: An Examination of Additional Methods to Identify Transgender Individuals in Administrative Databases
      1166. Beyond masculinity: Testosterone, gender/sex, and human social behavior in a comparative context
      1167. Beyond the bedroom: Cognitive, affective, and behavioral responses to partner touch in women with and without sexual problems
      1168. Beyond the disease model of mental disorders
      1169. Beyond the pleistocene: Using phylogeny and constraint to inform the evolutionary psychology of human mating.
      1170. Beyond the Valley of the Genitals: Using eye-tracking to analyze sexual arousal and desire in women and men
      1171. Beyond theoretical orientations: The emergence of a unified scientific framework in professional psychology.
      1172. Beyond tribulus (Tribulus terrestris L.): The effects of phytotherapics on testosterone, sperm and prostate parameters
      1173. Beyond Western paradigms: A culturally grounded approach to psychotherapy with Chaldean Americans.
      1174. Biased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disorders
      1175. Biases for affective versus sexual content in multidimensional scaling analysis: An individual difference perspective
      1176. Bibliotherapy for low sexual desire: Evidence for effectiveness.
      1177. Bibliotherapy for sexual dysfunction
      1178. Bibliotherapy for sexual Dysfunctions: A Systematic Review and Meta-Analysis
      1179. Bibliotherapy in the treatment of sexual dysfunctions: A meta-analysis.
      1180. Bibliotherapy interventions for female low sexual desire: erotic fiction versus self-help
      1181. Bibliotherapy: An effective therapeutic tool for female sexual dysfunction?
      1182. Big enough for an aromatase inhibitor? How adiposity affects male fertility
      1183. Big pharma, women, and the labour of love
      1184. Bill 10 Court Challenge
      1185. Bio-Psycho-Social factors affecting women’s sexual function during pregnancy: A Narrative review
      1186. Bio-sexual Profile of Wives of Males with sexual Dysfunction
      1187. Bioavailability of Compounded Bioidentical Hormone Therapy Preparations
      1188. Biocultural Correlates of Chronic Pelvic Pain in Women
      1189. Bioidentical Hormone Therapy: A Look at Standard of Practice, Attitudes, and Knowledge
      1190. Bioidentical hormone therapy: a review of the evidence
      1191. Bioidentical hormones
      1192. Bioidentical hormones for menopausal therapy
      1193. Bioidentical Hormones in the News
      1194. Bioidentical hormones: an evidence-based review for primary care providers
      1195. Bioidentical testosterone cream: A rare cause of postmenopausal virilisation
      1196. Biointerface Research in Applied Chemistry
      1197. Biologic basis for female orgasm: A retrospective report
      1198. Biologic basis of serotonin reuptake inhibitor antidepressant-associated female sexual dysfunction: A novel signaling perspective
      1199. Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition
      1200. Biological Determinants of sexual desire in Women
      1201. Biological markers of asexuality: Handedness, birth order, and finger length ratios in self-identified asexual men and women
      1202. Biology International 46 (July, 2004)
      1203. Biology of the sexual response.
      1204. Biomarkers, erectile dysfunction, and cardiovascular risk prediction: the latest of an evolving concept
      1205. Biomedicalization: Technoscience, Health, and Illness in the US
      1206. Biopharmaceuticals: New Frontier
      1207. Biopsy Procedures in Patients with Primary Lung Cancer
      1208. Biopsychosocial assessment and treatment of sexual problems in older age
      1209. Biopsychosocial determinants of hypoactive sexual desire in women: a narrative review
      1210. Biopsychosocial determinants of men’s sexual desire: Testing an integrative model
      1211. Biopsychosocial evaluation of sexual dysfunctions
      1212. Biopsychosocial factors in the sexual desire of contraception-using couples and trans persons
      1213. Biopsychosocial models of women’s sexual response: applications to management of ‘desire disorders’
      1214. Biopsychosocial treatment of sexual dysfunctions
      1215. Biosynthesis of DHEAS by the human adrenal cortex and its age‐related decline
      1216. Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour
      1217. Birth Control Pills and Hormonal Contraception Effects on Female sexual desire and Pleasure
      1218. Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms
      1219. Blast Concussion mTBI, Hypopituitarism, and Psychological Health in OIF/OEFVeterans
      1220. Blindspot: An Exploration of Countertransference Reactions and Management of Licensed Counseling Professionals Without sexuality Training Around …
      1221. Block-3 Disorders of Personality, Paraphilic and Substance-Related Disorders
      1222. Blueprints Urology
      1223. BMI and Male Fertility
      1224. Bodies that Matter: Calixthe Beyala’s Female Bodies and Strategies of Hegemonic Subversion
      1225. Body composition and bone mineral density in male-to-female transsexuals during cross-sex hormone therapy using gonadotrophin-releasing hormone agonist
      1226. Body composition characteristics predict sexual functioning in obese women with or without PCOS
      1227. Body image and female sexual functioning and behavior: A review
      1228. Body Image and hypoactive sexual desire Disorder Relationship in a Representative Sample of Iranian Women
      1229. Body Image and Psychosexual Functioning in Late Identified Indonesian Treated and Untreated Patients with a Disorders of sex Development
      1230. Body image and sexuality in Indonesian adults with a disorder of sex development (DSD)
      1231. Body image and sexuality in Indonesian adults with disorders of sex development
      1232. Body Image Disturbance and Self-Esteem after Hysterectomy in Egyptian Women.
      1233. Body image in dyadic and solitary sexual desire: The role of encoding style and distracting thoughts
      1234. Body Image Self-Consciousness during Physical Intimacy and sexual Dissatisfaction in Women: The Mediating Role of sexual Self-Esteem
      1235. Body image, self-compassion and sexual distress in patients with mastectomy
      1236. Body imagen, sexual function and dysfunction in men with obstructive sleep apnea syndrome
      1237. Body mass index and sexual dysfunction in males and females in a population study
      1238. Body mass index, urinary incontinence, and female sexual dysfunction: how they affect female postmenopausal health
      1239. Body-identical Hormone Replacement Therapy: Micronised Progesterone is Finally Available in Australia
      1240. Boehringer Ingelheim withdraws libido drug for women
      1241. BONAFIDE CERTIFICATE
      1242. Book review: asexuality and sexual normativity: an anthology edited by Mark Carrigan et al.
      1243. Book Review: Disorders of sexual desire, Vol. II: And Other New Concepts and Techniques in sex Therapy
      1244. Book Review: Principles and Practice of sex Therapy
      1245. Book Review: sexual Dysfunctions: Handbook of sexual Dysfunction
      1246. Boosting Female sexual Response by RECONNECTing the Dots
      1247. Born with a Junk Food Deficiency: How Flaks, Quacks, and Hacks Pimp the Public Health
      1248. Botanical Medicine and Natural Products Used for Erectile Dysfunction
      1249. Botanical therapies in sexual dysfunction
      1250. Both comorbidity burden and low testosterone can explain symptoms and signs of testosterone deficiency in men consulting for sexual dysfunction
      1251. Botulinum toxin type A—a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study
      1252. Bowel preparation for colonoscopy may decrease the levels of testosterone in Korean men
      1253. Bowel preparation for colonoscopy may decrease the levels of testosterone in Korean men
      1254. Bowel preparation for colonoscopy may decrease the levels of testosterone in Korean men
      1255. BP101 peptide promotes female sexual receptivity in the rat
      1256. Brain activation patterns in women with acquired hypoactive sexual desire disorder and women with normal sexual function: a cross-sectional pilot study
      1257. Brain activity during episodic retrieval of autobiographical and laboratory events: an fMRI study using a novel photo paradigm
      1258. Brain circuits for mating behavior in cats and brain activations and de-activations during sexual stimulation and ejaculation and orgasm in humans
      1259. Brain effects of melanocortins
      1260. Brain functional imaging studies of sexual desire and arousal in human males.
      1261. Brain imaging of human sexual response: recent developments and future directions
      1262. Brain Morphological Changes With Functional Deficit Associated With sexual Arousal in Postmenopausal Women
      1263. Brain neuronal activation induced by flibanserin treatment in female rats
      1264. Brain potentials related to the human penile erection
      1265. Brain processing of audiovisual sexual stimuli inducing penile erection: a positron emission tomography study
      1266. Brain processing of visual sexual stimuli in healthy men: a functional magnetic resonance imaging study
      1267. Brain processing of visual sexual stimuli in men with hypoactive sexual desire disorder
      1268. Brain processing of visual sexual stimuli in treated and untreated hypogonadal patients
      1269. Brain RegionSpecific Transcriptomic Markers of Serotonin1A Receptor Agonist Action Mediating sexual Rejection and Aggression in Female Marmoset Monkeys
      1270. Brain response to visual sexual stimuli in heterosexual and homosexual males
      1271. Brain responses to erotic and other emotional stimuli in breast cancer survivors with and without distress about low sexual desire: a preliminary fMRI study
      1272. Brain structures involved in the sexual behaviour of Ile de France rams with different sexual preferences and levels of sexual activity
      1273. Brain-Behavioral Systems and Psychological Distress in Women with hypoactive sexual desire Disorder
      1274. Bravissimo-F Tablet: A Scientifically Formulated Potent Female Aphrodisiac
      1275. Bravissimo-F tablet: A scientificallyFormulated Daily Health Supplement for women For Mental, Physical & sexual Health.
      1276. BRAVISSIMO-M Tablets: Scientifically Formulated Male Libido Enhancer Helps to Restore sexual Vitality
      1277. break, and disappointment. Additionally, they
      1278. Breast Cancer and sexuality with Focus in Young Women: From Evidence-Based Data to Women’s Wording to Treatment Perspectives
      1279. Breast Cancer and sexuality: Multi‐modal Treatment Options (CME)
      1280. Breast cancer in young women and its impact on reproductive function
      1281. Breast cancer vaccine prevents and arrests tumor growth in animal study
      1282. Breast cancer, aromatase inhibitor therapy, and sexual functioning: a pilot study of the effects of vaginal testosterone therapy
      1283. Breast Cancer, Aromatase Inhibitors, and sexual Functioning: A Pilot Study on the Effects of Vaginal Testosterone Therapy
      1284. BREMELANOTIDE (continued)
      1285. Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial
      1286. Bremelanotide for female sexual dysfunctions: responder analyses from a phase 2B dose-ranging study
      1287. Bremelanotide for hypoactive sexual desire disorder
      1288. Bremelanotide for hypoactive sexual desire Disorder: Age and Weight Subgroup Efficacy Analyses [1Q]
      1289. Bremelanotide for hypoactive sexual desire disorder: analyses from a phase 2B dose-ranging study
      1290. Bremelanotide for hypoactive sexual desire Disorder: Contraceptive Subgroups Efficacy Analysis [15OP]
      1291. Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials
      1292. Bremelanotide Injection (Vyleesi)
      1293. Bremelanotide is safe and well-tolerated in premenopausal women with hypoactive sexual desire disorder (HSDD): safety results from the reconnect studies …
      1294. Bremelanotide Provides Meaningful Treatment Benefits for Premenopausal Women With hypoactive sexual desire Disorder
      1295. Bremelanotide: an overview of preclinical CNS effects on female sexual function
      1296. Bremelanotide: first approval
      1297. Bremelanotide: new drug approved for treating hypoactive sexual desire disorder
      1298. Brenner and Rector’s The Kidney
      1299. Brief but comprehensive psychotherapy: The multimodal way
      1300. Brief psychotherapies
      1301. Brief report: sexual wellbeing in heterosexual, mostly heterosexual, and bisexually attracted men and women
      1302. Bright Light Therapy and Circadian Neuroendocrine Function in Seasonal Afiective Disorder
      1303. Bringing sex Back In: sexual Expression and Relationship Happiness In Married, Cohabiting and Living Apart Together Partnerships In Britain
      1304. Bringing sex research into the 21st century: genetic and epigenetic approaches on female sexual function
      1305. Bringing sexy back: CPD-erectile dysfunction
      1306. British Menopause Society Tools for Clinicians: Testosterone replacement in menopause.
      1307. Broadening your horizons: Self-expanding activities promote desire and satisfaction in established romantic relationships.
      1308. Bullying, Self-Disclosure and sexual Incompatibility as Correlates of Marital Instability among Newly Married Adults in Nigeria
      1309. Bupropion and bupropion analogs as treatments for CNS disorders
      1310. Bupropion and sexual function: a placebo-controlled prospective study on diabetic men with erectile dysfunction
      1311. Bupropion and SSRI-induced side effects
      1312. Bupropion improves sexual functioning in depressed minority women: an open-label switch study
      1313. Bupropion in methadone induced erectile dysfunction
      1314. Bupropion in the depression-related sexual dysfunction: a systematic review
      1315. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women
      1316. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women
      1317. Bupropion-associated movement disorders: A systematic review
      1318. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant
      1319. Bupropion: pharmacology and therapeutic applications
      1320. Bupropion.
      1321. Burden of misconception in sexual health care setting: a cross-sectional investigation among the patients attending a psychiatric sex clinic of Bangladesh
      1322. C 7 8AHL sexual pain disorder}~(0. TE” E (o
      1323. C-tactile mediated erotic touch perception relates to sexual desire and performance in a gender-specific way
      1324. Calvarial intraosseous leiomyoma: Another consideration in children with suspected esosinophilic granuloma
      1325. Cambios electroencefalográficos y niveles de testosterona en un modelo animal de estrés puberal: efectos sobre la motivación sexual adulta
      1326. Can a woman with sexual dysfunction take sildenafil citrate?
      1327. Can a woman with sexual dysfunction take sildenafil citrate?
      1328. Can Botox Offer Help Women With Vaginismus? A Systematic Review and Meta-Analysis
      1329. Can methods developed for interpreting group-level patient-reported outcome data be applied to individual patient management?
      1330. Can perinatal SSRI exposure affect sexual behavior later in life? Early Developmental Fluoxetine Exposed Female Rats Observed in a Seminatural Environment
      1331. Can sexual offenders be treated?
      1332. Can we treat anorgasmia in women? The challenge to experiencing pleasure
      1333. Can written information material help to increase treatment motivation in patients with erectile dysfunction? A survey of 1188 men
      1334. Cancer and sexual health
      1335. Cannabinoid receptor antagonism increases female sexual motivation
      1336. Cannabinoids, reproduction, and sexual behavior
      1337. Cannabis and male fertility: A systematic Review
      1338. Cannabis Usage Pre-masturbation in Women: Effects on Orgasm and Pleasure
      1339. Cant a mother sing the blues
      1340. CAPS, 80 cost and physical barriers, 91 IES (15-item self-report scale), 81 PTSD self-report assessments, 13 measures, 80 t
      1341. Capturing the sexual side effects of hormonal contraception
      1342. Carbon dioxide (CO 2) laser ablation of symptomatic vaginal endometriosis: a pilot study
      1343. Carbon dioxide laser treatment for vulvovaginal atrophy in women treated for breast cancer: Preliminary results of the feasibility EPIONE trial
      1344. Cardiometabolic disorders and menopausal hormone therapy
      1345. Cardiometabolic risk and female sexual health: the Princeton III Summary (CME)
      1346. Cardiometabolic risk and female sexuality—Part I. Risk factors and potential pathophysiological underpinnings for female vasculogenic sexual dysfunction syndromes
      1347. Cardioprotection by low-dose of estrogen and testosterone at the physiological ratio on ovariectomized rats during ischemia/reperfusion injury
      1348. Cardiovascular and cancer safety of testosterone in women
      1349. Cardiovascular and sexual health effects of postmenopausal testosterone therapy
      1350. Cardiovascular effects of transdermal testosterone in postmenopausal women
      1351. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists …
      1352. Cardiovascular issues in male and female sexual dysfunction
      1353. Cardiovascular physiology of androgens and androgen testosterone therapy in postmenopausal women
      1354. Cardiovascular risk and erectile dysfunction
      1355. Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis
      1356. Care of Individuals With
      1357. Care of the Patient with sexual Concerns
      1358. Care of women in menopause: sexual function, dysfunction and therapeutic modalities
      1359. Carpolobia lutea roots restore sexual arousal and performance in paroxetine-induced sexually impaired male rats
      1360. Case 3: Joanne, age 74 Joanne has been on hormone therapy (HT) since her early 50s. About 10 years ago, she tried to stop her HT after reading about the …
      1361. Case for vaginal pain induced by multiple sclerosis
      1362. Case presentation: the object relations approach
      1363. Case report: Clinical, sexual and psychopathological changes after clitoral reconstruction in a Type II female genital mutilation/cutting: A case report
      1364. CASE REPORT: Possible Correlation Between Type 1 Diabetes Mellitus and Female sexual Dysfunction: Case Report and Literature Review
      1365. Catastrophe theory and the human sexual response
      1366. Categorical and multi-axial diagnosis of male erectile disorder
      1367. Categories of female sexual dysfunction.
      1368. Cathleen Morrow, MD
      1369. Causes and indications of hysterectomy in AL-Kadhymia teaching hospital
      1370. Causes and Threatments of sexual desire Discrepancies in Male Couples
      1371. CBT Benefits Adults With ADHD Taking Medication
      1372. CBT Effective in Adolescents with Depression Who Do Not Want Medication
      1373. Celebrating or Mourning Patriarchal Love: The Case of Curious Courtships in Marquez’s Love in the Time of Cholera
      1374. Celibacy in marriage: Female object relations and their adult manifestations
      1375. Cell therapy products in Alzheimer disease
      1376. Cengage Learning
      1377. Central nervous system anatomy and neurochemistry of sexual desire
      1378. Centrally Active Treatment for Premenopausal Women with sexual Interest/Arousal Disorder
      1379. Cerebral white matter deficiencies in pedophilic men
      1380. Certain socio% cultural aspects of prevalence and treatment of vaginismus in Georgia
      1381. Cervix removal at the time of hysterectomy: factors affecting patients’ choice and effect on subsequent sexual function
      1382. Challenges and opportunities in dermal/transdermal delivery
      1383. Challenges in conducting multicenter clinical trials in female sexual dysfunction: baseline differences between study populations
      1384. Challenges in designing psychological treatment studies for sexual dysfunction
      1385. Challenges in sexual medicine
      1386. Challenges in the gynecologic care of premenopausal women with breast cancer
      1387. Challenges in the identification and management of HSDD
      1388. Challenges in the Practice of sexual Medicine in the Time of COVID-19 in the United States
      1389. Challenging Aging The Anti-senescence Effects of Hormesis, Environmental Enrichment and Information Exposure
      1390. Change to either a nonandrogenic or androgenic progestin‐containing oral contraceptive preparation is associated with improved sexual function in women with oral …
      1391. Changes in assertiveness and changes in orgasmic response occurring with sexual therapy for preorgasmic women
      1392. Changes in autonomic nervous system activity are associated with changes in sexual function in women with a history of childhood sexual abuse
      1393. Changes in prenatal testosterone and sexual desire in expectant couples
      1394. Changes in sexual distress, depression and sexual function after clitoral reconstruction in women with female genital mutilation/cutting
      1395. Changes in sexual function after medical or surgical termination of pregnancy
      1396. Changes in sexual function after the midurethral sling procedure for stress urinary incontinence: long-term follow-up
      1397. Changes in sexual function among midlife women:“I’m older… and I’m wiser.”
      1398. Changes in sexual function among women with polycystic ovary syndrome: a pilot study
      1399. Changes in sexual function and comparison of questionnaires following surgery for pelvic organ prolapse
      1400. Changes in sexual function in middle‐aged and older men: Longitudinal data from the Massachusetts Male Aging Study
      1401. Changes in sexual function: hormonal treatment
      1402. Changes in sexual functioning in the bremelanotide RECONNECT study
      1403. Changes in sexual functioning in women after neuromodulation for voiding dysfunction
      1404. Changes in sexuality and quality of couple relationship during the Covid-19 lockdown
      1405. Changes in the Diagnosing of sexual Dysfunctions of Women in ICD-11 Classification
      1406. Changes in the sexual function during pregnancy
      1407. Changes in women’s sexual desire in middle life: the longitudinal study of women in Gothenburg
      1408. Changes of androgens levels in menopausal women
      1409. Changing the political landscape of a nation
      1410. Changing with the times: sex therapy to sexual health
      1411. Chapter draft for a volume on the psychology of love, edited by Robert J. Sternberg and Karin Weis. Please do not quote this draft without the authors’ …
      1412. Chapter Eight Painful Genital sexual Activity
      1413. Chapter Female pelvic floor dysfunctions and evidence-based physical therapy| 7|
      1414. Chapter Seven Women’s Difficulties with Low sexual desire and sexual Avoidance
      1415. Chapter Six When Do We Say A Woman’s sexuality is Dysfunctional?
      1416. CHAPTER TEN “PSYCHICAL IMPOTENCE”: WHAT PSYCHOANALYSIS CAN TELL US ABOUT MEN’S sexual DYSFUNCTIONS MICHAEL D. BERRY
      1417. CHAPTER TEN THE QUEER IDENTITY FOR THE TWENTY-FIRST CENTURY? AN EXPLORATION OF AsexualITY ANNA KUROWICKA
      1418. CHAPTER TWELVE LIMITS OF FLUIDITY: FLOATING SKYSCRAPERS AND A PATHOSOPHY OF desire
      1419. Characteristics and specificities of adolescent sexual offenders
      1420. Characteristics of an Egyptian sample of patients with female sexual dysfunction: a cross-sectional study
      1421. Characteristics of compensated hypogonadism in patients with sexual dysfunction
      1422. Characteristics of couples applying for bibliotherapy via different recruitment strategies: a multivariate comparison
      1423. Characteristics of genital dissatisfaction among a nationally representative sample of US women
      1424. Characteristics of male sexual dysfunction subjects from a sociocultural perspective: Analysis of 18 years
      1425. Characteristics of men undergoing testosterone replacement therapy and adherence to follow-up recommendations in metropolitan multicenter health care system
      1426. Characteristics of women who experience mood and sexual side effects with use of hormonal contraception
      1427. Characterization of hypoactive sexual desire disorder (HSDD) in men
      1428. Characterization of MC3 and the other melancortin receptors (MC) in the hypothalamo-pituitary-gonadal system of the mouse
      1429. Characterization of orgasmic difficulties by women: focus group evaluation
      1430. Characterizing Pelvic-Floor Muscle Function and Morphometry in Survivors of Gynecological Cancer Who Have Dyspareunia: A Comparative Cross-Sectional Study
      1431. Charmaine Borg, Peter J. de Jong &
      1432. Chasing aces: Asexuality, misinformation and the challenges of identity
      1433. Chemical composition and health effects of maca (Lepidium meyenii)
      1434. Chemotherapy-induced versus natural menopause: A comparison of menopausal symptoms and sexual functioning
      1435. Child and adolescent psychiatry for the specialty board review
      1436. Childhood sexual Abuse and sexual Risk-Taking Among Men Who Have sex with Women: The Roles of Alcohol, Mental Health Symptoms, and sex Motives
      1437. Childhood sexual abuse as a predictor of adult female sexual dysfunction: A study of couples seeking sex therapy
      1438. Childhood sexual abuse moderates the association between sexual functioning and sexual distress in women
      1439. Chiropractic Insights
      1440. Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration
      1441. Choosing Love
      1442. chosocial Interventions for Male sexual
      1443. Chronic disease and sexuality: a generic conceptual framework
      1444. Chronic disease, disability, and sexuality
      1445. Chronic fatigue syndromes: the limbic hypothesis
      1446. Chronic flibanserin treatment increases solicitations in the female rat
      1447. Chronic hypopituitarism associated with increased postconcussive symptoms is prevalent after blast-induced mild traumatic brain injury
      1448. Chronic illnesses and disabilities affecting women’s sexuality
      1449. Chronic irisin exposure decreases sexual incentive motivation in female rats
      1450. Chronic pain and depression in low back (spinal) injured patients
      1451. Chronic pain and family: A clinical perspective
      1452. Chronic Pain and sexual Relations
      1453. Chronic pain, opioid therapy, sexual desire, and satisfaction in sexual life: a population-based survey
      1454. Chronic paroxetine treatment does not affect sexual behavior in hormonally sub-primed female rats despite 5-HT
      1455. Chronic paroxetine treatment does not affect sexual behavior in hormonally sub‐primed female rats despite 5‐HT1A receptor desensitization
      1456. Chronic pelvic pain and sexual dysfunction: cause and effect
      1457. Chronic pelvic pain: pathogenesis and validated assessment
      1458. Chronic renal failure and sexual functioning: clinical status versus objectively assessed sexual response.
      1459. Chronic stress influences sexual motivation and causes damage to testicular cells in male rats
      1460. Chronic systemic administration of serotonergic ligands flibanserin and 8-OH-DPAT enhance HPA axis responses to restraint in female marmosets
      1461. Cigarette smoking is significantly linked to sexual dissatisfaction in chinese heroin-dependent patients receiving methadone maintenance treatment
      1462. Cinsellikten tiksinti duyma bozukluğu: Davranışçı tedaviye olumlu ve hızlı yanıt veren bir olgu
      1463. Circuits of desire: Science, Therapy, Trauma, Femininity
      1464. Circuits of sexual desire in hypoactive sexual desire disorder
      1465. Circular and linear modeling of female sexual desire and arousal
      1466. Circulating androgen levels and self-reported sexual function in women
      1467. CITATION
      1468. Citation analysis did not provide a reliable assessment of core outcome set uptake
      1469. Classical conditioning of sexual response in women: A replication study
      1470. Classical Conditioning of sexual Response in Women: A Replication Studyjsm_2453
      1471. Classification and Pathogenesis of Female sexual Dysfunction
      1472. Classification of sexual disorders
      1473. Classification of sexual dysfunctions: towards DSM-V and ICD-11
      1474. Classification, comorbidity, heredity, and risk factors of female sexual dysfunctions
      1475. Classification, disease, and diagnosis
      1476. Classification, etiology, and key issues in female sexual disorders
      1477. Classifying female sexual dysfunction
      1478. Classifying pain: What’s at stake for women with dyspareunia
      1479. Cleveland Clinic Names Two Cancer Advances among Top 10 Medical Innovations for 2016
      1480. Clients in sexually open relationships: Considerations for therapists
      1481. Climacteric
      1482. Climacteric And sexuality [climatério E sexualidade]
      1483. Climacteric Symptoms: Importance and Management
      1484. Clinical and Experimental Evidence for the Pathological Mechanisms Underlying Aspects of sexual Dysfunction: Impact of Adiposity and Chronic Kidney Disease
      1485. Clinical and Instrumental diagnosis of sexual disorders
      1486. Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart
      1487. Clinical and research evaluations of sexual dysfunctions
      1488. Clinical and Research Perspective
      1489. Clinical and Social Correlates of sexual Disorders in Bahawalpur
      1490. Clinical and statistical classification of sexual disorders: The case of unintegrated sexuality applied to a clergy sample
      1491. Clinical and therapeutic aspects of Klinefelter’s syndrome: sexual function
      1492. Clinical application of CNS‐acting agents in FSD
      1493. Clinical Assessment of the Male Presenting with sexual Dysfunction
      1494. Clinical Assessment of Tribulus terrestris Extract in the Treatment of Female sexual Dysfunction
      1495. Clinical Case Studies for the Family Nurse Practitioner
      1496. Clinical Cases
      1497. Clinical Cases and Self-Study Review for the Mental Health
      1498. Clinical Cases and Self-Study Review for the Mental Health of Military and Veteran Populations
      1499. Clinical characteristics, health care utilization and costs among men with primary or secondary hypogonadism in a US commercially insured population
      1500. Clinical consult for psychiatric mental health care
      1501. Clinical Consult to Psychiatric Mental Health Management for Nurse Practitioners
      1502. Clinical consult to psychiatric nursing for advanced practice
      1503. Clinical consultation guide on imaging in male infertility and sexual dysfunction
      1504. Clinical correlates of erectile dysfunction and premature ejaculation in men with couple infertility
      1505. Clinical effects of cross-sex hormone therapy in adult trans persons
      1506. Clinical effects of early or surgical menopause
      1507. CLINICAL EVALUATION & DIFFERENTIAL DIAGNOSIS OF ERECTILE DYSFUNCTION (IMPOTENCY)
      1508. Clinical evaluation and management strategy for sexual dysfunction in men and women
      1509. Clinical evaluation of women presenting with low libido and determination of whether androgen therapy might be appropriate
      1510. Clinical factors associated with sexual dysfunction among men in methadone maintenance treatment and buprenorphine maintenance treatment: a meta …
      1511. Clinical Features Associated with Female Genital Mutilation/Cutting: A Pilot Longitudinal Study
      1512. Clinical features of and couple’s attitudes towards premature ejaculation: a multicenter cross-sectional study
      1513. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice
      1514. Clinical guide to the diagnosis and treatment of mental disorders
      1515. Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD
      1516. Clinical hypnosis in treating sexual abulia
      1517. Clinical implications of measuring prolactin levels in males of infertile couples
      1518. Clinical interviewing techniques and sexuality questionnaires for male and female cancer patients
      1519. Clinical Investigations in Andrology
      1520. Clinical management of hypoactive sexual desire disorder
      1521. Clinical manual of sexual disorders
      1522. Clinical outcome measurement tools
      1523. Clinical pattern of Dhat Syndrome
      1524. CLINICAL PEARLS 196 MYTHS OF AGING AND sexualITY 197
      1525. Clinical pearls to managing men’s health conditions during the COVID-19 pandemic
      1526. CLINICAL PRACTICE GUIDELINE: Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
      1527. Clinical Practice Guidelines for management of sexual disorders in elderly
      1528. Clinical practice guidelines for management of sexual dysfunction
      1529. Clinical psychology and evolutionary psychology: Toward a dialogue
      1530. CLINICAL PSYCHOLOGY: Psychophysiological Assessment in Premenopausal sexual Arousal Disorder
      1531. Clinical Remission in a Multi-Ethnic Urban Population of Older Adults With Schizophrenia
      1532. Clinical research trials and the treatment of hypoactive sexual desire disorder
      1533. Clinical sexology: an integrated approach between the psychosomatic and the somatopsychic
      1534. CLINICAL STUDIES
      1535. Clinical trial development in female sexual dysfunction
      1536. Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies—Part I—Defining and selecting the study …
      1537. Clinical vignette
      1538. Clinically relevant changes in sexual desire, satisfying sexual activity and personal distress as measured by the PFSF, SAL & PDS in postmenopausal women …
      1539. Clinician Resources
      1540. Clinician’s Guide to Psychopharmacology
      1541. Clitoral circulation in postmenopausal women with sexual dysfunction: A pilot randomized study with hormone therapy
      1542. Clitoral frenuloreduction: A new surgical intervention
      1543. Clitoral hemodynamic changes after a topical application of alprostadil
      1544. Clitorally stimulated orgasms are associated with better control of sexual desire, and not associated with depression or anxiety, compared with vaginally stimulated …
      1545. Clitorodynia: a descriptive study of clitoral pain
      1546. Clobazam/oxcarbazepine
      1547. Clomipramine as daily dose in the treatment of patients with premature ejaculation: prospective placebo-controlled study
      1548. CME information: sexual health and religion: a primer for the sexual health clinician (CME)
      1549. CME information: sexuality education in North American medical schools: Current status and future directions (CME)
      1550. CME stands for commercial medical education: and ACCME still won’t address the issue
      1551. CNS Agents Emerge as Frontrunners in FDA-Approved Treatments for Low Libido in Women
      1552. CNS drug development: lessons learned part 3: psychiatric and central nervous system drugs developed over the last decade—implications for the field
      1553. Coaching Women on the Impact of Alcohol Intake on Mental Well-Being: A Systematic Literature Review
      1554. Cocaine and sexual Dysfunction
      1555. Cognitions, emotions, and sexual response: Analysis of the relationship among automatic thoughts, emotional responses, and sexual arousal
      1556. Cognitive analytic therapy for borderline erotomania: Forensic romances and violence in the therapy room
      1557. Cognitive and emotional predictors of female sexual dysfunctions: Preliminary findings
      1558. Cognitive aspects of sexual functioning: Differences between East Asian-Canadian and Euro-Canadian women
      1559. Cognitive aspects of sexual functioning: differences between East Asians and Euro-Caucasians
      1560. Cognitive Behavioral Factors Relevant to Treatment
      1561. Cognitive behavioral therapy as an adjunct treatment for Pakistani men with ED
      1562. Cognitive behavioral therapy for sexual dysfunctions in women
      1563. Cognitive behavioral therapy in sexual dysfunction
      1564. Cognitive factors in women hypoactive sexual desire disorder
      1565. Cognitive hypnotherapy for major depressive disorder
      1566. Cognitive hypnotherapy for treating depression
      1567. Cognitive orientation and sexual dysfunctions in women
      1568. Cognitive processing in women with dyspareunia: What is more salient, the pain or the sex?
      1569. Cognitive processing of sexual cues in asexual individuals and heterosexual women with desire/arousal difficulties
      1570. Cognitive schemas activated in sexual context: a comparative study with homosexual and heterosexual men and women, with and without sexual problems
      1571. Cognitive schemas associated with negative sexual events: A comparison of men and women with and without sexual dysfunction
      1572. Cognitive structures in women with sexual dysfunction: the role of early maladaptive schemas
      1573. Cognitive-behavioral and mindfulness-based therapy for low sexual desire
      1574. Cognitive-behavioral therapy for sexual dysfunction
      1575. Cognitive-behavioral therapy for women with lifelong vaginismus: A randomized waiting-list controlled trial of efficacy.
      1576. Cognitive-behavioral treatment of sexual dysfunctions
      1577. Cognitive‐behavioral bibliotherapy for sexual dysfunctions in heterosexual couples: A randomized waiting‐list controlled clinical trial in the Netherlands
      1578. Coital incontinence: a factor for deteriorated health-related quality of life and sexual function in women with urodynamic stress urinary incontinence
      1579. Collaborative care to improve treatment of co-occurring diabetes mellitus and psychiatric disorders
      1580. College virgins: How men and women perceive their sexual status
      1581. Colorectal cancer patients’ experiences with cancer life and medical care
      1582. Colorectal cancer: aspects of multidisciplinary treatment, metastatic disease and sexual function
      1583. Combination alpha blocker and phosphodiesterase 5 inhibitor versus alpha-blocker monotherapy for lower urinary tract symptoms associated with benign …
      1584. Combination of Testosterone and Vardenafil Increases Female sexual Functioning in Sub‐Primed Rats
      1585. Combination therapy for sexual dysfunction: integrating sex therapy and pharmacotherapy
      1586. Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women
      1587. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women
      1588. Combined oral contraceptives and sexual function in women—a double-blind, randomized, placebo-controlled trial
      1589. Combined oral contraceptives with natural estrogen and sexual function: the optimal method of contraception for women of different ages
      1590. Coming out of the sex therapy closet: Using experiential psychotherapy with sexual problems and concerns
      1591. Coming to an asexual identity: Negotiating identity, negotiating desire
      1592. Coming to understand
      1593. Comment on Janssen et al.(2008)
      1594. Commentary on “Critical Flaws in the FSFI and IIEF”
      1595. Commentary on David Rowland’s “Will medical solutions to sexual problems make sexological care and science obsolete?”
      1596. Commentary on Rowland’s article
      1597. Commentary on Spurgas’s “Interest, arousal, and shifting diagnoses of female sexual dysfunction”
      1598. Commentary to McCarthy’s Bridges to sexual desire
      1599. Commentary: approved hormonal treatments for HSDD: an unmet medical need
      1600. COMMENTARY: Are the Endocrine Society’s Clinical Practice Guidelines on Androgen Therapy in Women Misguided? A Commentary
      1601. Commentary: hypoactive sexual desire in men
      1602. Commentary: Management of hypoactive sexual desire Disorder (HSDD)
      1603. Commentary: The future of erectile dysfunction therapy II-novel pharmacotherapy and innovative technology
      1604. Commentary: The stagnation of sex therapy
      1605. Commentary:“will medical solutions to sexual problems make sexological care and science obsolete?”
      1606. Common Childhood Masturbation, But Different sexual Attitudes in Three Male-at-Birth Adolescents: Possible Implications for sexual Development
      1607. Common complications
      1608. Common mental disorders
      1609. Common sexual Disorders: A Clinical Review
      1610. Common therapeutic strategies in the management of sexual dysfunction and cardiovascular disease
      1611. Communication and sexual desire
      1612. Comorbid LUTS and erectile dysfunction: optimizing their management
      1613. Comparative analysis of copper intrauterine device impact on female sexual dysfunction subtypes
      1614. Comparative effectiveness and impact on health-related quality of life of hysterectomy vs. levonorgestrel intra-uterine system for abnormal uterine bleeding
      1615. Comparative Safety of Sleep Prescriptions and Suicide Attempts in Veterans
      1616. Comparative study of Psychiatric Morbidity among HIV Positive patients and Leprosy patients.
      1617. Compare the effectiveness of PLISSIT and sexual health models on Women’s sexual problems in Tehran, Iran: a randomized controlled trial
      1618. Comparing different thinking styles and marital satisfaction among engineers of urban and nonurban areas
      1619. Comparing male and female sexual arousal, utilizing fMRI: a theoretical perspective
      1620. Comparing Male and Female sexual Function and Dysfunction
      1621. Comparing sildenafil alone vs. sildenafil plus brief couple sex therapy on erectile dysfunction and couples’ sexual and marital quality of life: A pilot study
      1622. Comparing the effects of the second-and third-generation oral contraceptives on sexual functioning
      1623. Comparing the effects of two methods of group education and peer education on sexual dysfunction of menopausal women: A randomized controlled trial
      1624. Comparing the relative amount of testosterone required to restore sexual arousal, motivation, and performance in male rats
      1625. Comparing two books and establishing probably efficacious treatment for low sexual desire.
      1626. Comparison among some effects of sexual dysfunction in female spouses of fertile and infertile couples
      1627. Comparison of 2 methods of vaginal cuff closure at laparoscopic hysterectomy and their effect on female sexual function and vaginal length: a randomized clinical …
      1628. Comparison of anogenital distance and correlation with vulvo-vaginal atrophy: a pilot study on premenopausal and postmenopausal women
      1629. Comparison of biopsychosocial functioning of women of different nationalities in the perimenopausal period
      1630. Comparison of Effect of Anterior Colporrhaphy and Transobturator Tape Surgeries on Urinary Incontinence and sexual Performance in Women
      1631. Comparison of efficacy, safety, and tolerability of on‐demand tadalafil and daily dosed tadalafil for the treatment of erectile dysfunction
      1632. Comparison of Elaeagnus angustifolia extract and sildenafil citrate on female orgasmic disorders: a randomized clinical trial
      1633. Comparison of female sexual function in women who underwent abdominal or vaginal hysterectomy with or without bilateral salpingo-oophorectomy
      1634. Comparison of interactive voice response (IVR) with paper administration of instruments to assess functional status, sexual function, and quality of life in elderly men
      1635. Comparison of marital satisfaction, intimacy and sexual function in female nurses with fixed and changing shiftwork
      1636. Comparison of prevalence of hypoactive sexual desire disorder (HSDD) in women after five different hysterectomy procedures
      1637. Comparison of primipara women’s pre-pregnancy, pregnancy, and postpartum sexual lives
      1638. Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo
      1639. Comparison of serum level of Brain-Derived Neurotrophic factor and Hypothalamus-Pituitary-Adrenal axis functioning in clinical burnout with controls
      1640. Comparison of sexual dysfunction in women using depo-medroxyprogesterone acetate (DMPA) and cyclofem
      1641. Comparison of sexual dysfunction using the Female sexual Function Index following surgical treatments for uterine fibroids
      1642. Comparison of sexual Dysfunctions among Employed Women and Housewives Attending’s to Tabriz Counseling Crescent Center Iran
      1643. Comparison of the effect of Elaeagnus angustifolia flower capsule and sildenafil citrate tablet female sexual interest/arousal disorder in clinical trial study
      1644. Comparison of the effect of intermittent and continuous aerobic physical training on sexual function of women with polycystic ovary syndrome: randomized controlled …
      1645. Comparison of the Effects of Elaeagnus angustifolia Flower Capsule and Sildenafil Citrate Tablet on Anxiety Resulting From sexual Dysfunction in Women Referring …
      1646. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol+ drospirenone and tibolone, on sexual function in healthy …
      1647. Comparison of the Effects of the PLISSIT Model Versus the sexual Health Model on Quality of Life Among Women with Breast Cancer
      1648. Comparison of vaginal penetration cognitions and metacognitions between women with genito-pelvic pain and penetration disorder and healthy controls
      1649. Comparisons of depression, marital intimacy, sexual function and quality of life in sexual active or inactive groups of post-menopausal married women
      1650. Compile and standardization of Tehran married women sexual function questionnaire (Tehran-SFQ)
      1651. Complex pelvic floor failure and associated problems
      1652. Complications of opioid therapy
      1653. COMPOSITE ENDPOINTS FOR CLINICAL TRIALS
      1654. COMPOSITE ENDPOINTS FOR CLINICAL TRIALS
      1655. COMPOSITE ENDPOINTS FOR CLINICAL TRIALS
      1656. Compounded bioidentical hormones in endocrinology practice: an Endocrine Society scientific statement
      1657. Comprehensive Assessment of Women’s sexual Arousal Requires Both Objective and Subjective Measurement
      1658. Comprehensive molecular characterization of papillary renal-cell carcinoma
      1659. Comprehensive Review of Psychiatry
      1660. Comprehensive review of the anatomy and physiology of male ejaculation: Premature ejaculation is not a disease
      1661. Comprehensive self-management reduces the negative impact of irritable bowel syndrome symptoms on sexual functioning
      1662. Comprehensive sexual health assessment
      1663. Compulsive sexual Behavior Disorder: Understanding, Assessment, and Treatment
      1664. Compulsory sexuality
      1665. Compulsory sexuality and Amatonormativity in Higher Education: A Photovoice Study with Asexual and Aromantic Students
      1666. Compulsory sexuality and asexual/crip resistance in John Cameron Mitchell’s Shortbus
      1667. Compulsory sexuality and Its Discontents: The Challenge of Asexualities
      1668. Computerized behavioral activation treatment for major depressive disorder and the effects on sexual desire
      1669. Concept Analysis of Female sexual Subjectivity based on Walker and Avant’s Method
      1670. Concept of ʻIhtiraqʼ in Unani Medicine–A correlation with oxidative stress, and future prospects
      1671. Conceptions of Psychopathology
      1672. Conceptions of psychopathology
      1673. Conceptual approach to developing quality measures for transgender patients
      1674. Conceptual bases of sexual health
      1675. Conceptualization of the sexual response models in men: Are there differences between sexually functional and dysfunctional men?
      1676. Conceptualization, History, and Future of the Paraphilias
      1677. Conceptualizing women’s sexual problems
      1678. Concise Review for Clinicians—CME Credit Offered
      1679. Concordance in the perception of couples recovering from primary surgical treatment of prostate cancer
      1680. CONDITIONS NOT RECOMMENDED FOR APPROVAL
      1681. Conditions of servitude: Woman’s peculiar role in the master-slave dialectic in Beauvoir’s The Second sex
      1682. CONFERENCE PROCEEDINGS (In bold are undergraduate research assistants)
      1683. Confirmatory factor analysis of a Spanish version of the sex Fantasy Questionnaire: Assessing gender differences
      1684. Confirmatory factor analysis of the female sexual function index
      1685. Conflicts within the family and within the couple as contextual factors in the determinism of male sexual dysfunction
      1686. Confluent Education in a Counseling Psychology Program
      1687. Confronting the challenges of postmenopausal urogenital health
      1688. Congenital penile curvature presenting as unconsummated marriage. Repair by 16-dot plication with subjectively reported patient and partner satisfaction
      1689. Connect the Dots—November 2019
      1690. Consensus guidelines on male sexual dysfunction
      1691. Consensus Position Statement on the Use of Testosterone in Women
      1692. Consensus statement for non-estrogen-based treatments for menopausal symptoms
      1693. Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO
      1694. Consequences of impaired female sexual functioning: Individual differences and associations with sexual distress
      1695. Consequences of premature ovarian insufficiency on women’s sexual health
      1696. Consequences of rape: injuries, posttraumatic stress and neuroendocrinological changes
      1697. Conservative Christianity, partnership, hormones, and sex in late life
      1698. Consideration of a spiritual role in sex and sex therapy
      1699. Considerations for national public health leadership in advancing sexual health
      1700. Considering asexuality as a sexual orientation and implications for acquired female sexual arousal/interest disorder
      1701. Consistency of three different questionnaires for evaluating sexual function in healthy young women
      1702. Constructing illness: How the public in eight Western nations respond to a clinical description of “schizophrenia”
      1703. Constructing women’s sexual health: A feminist critique of selected topics in college human sexuality textbooks
      1704. Constructions of Asexual Identity in China: Intersections of Class, Gender, Region of Residence, and Asexuality
      1705. Consulting “Dr Google” for sexual dysfunction: a contemporary worldwide trend analysis
      1706. Consumer’s guide to dietary supplements and alternative medicines: servings of hope
      1707. Contemporary Considerations in the Pathophysiology of Low sex Drive in Men
      1708. Contemporary drugs and biologics with special significance
      1709. Contemporary psychiatric-mental health nursing
      1710. Contemporary Review of BPH Medical and Surgical Treatments on sexual Function
      1711. Contemporary sex Therapy: Skills in Managing sexual Problems
      1712. Contemporary treatment of sexual dysfunction: Reexamining the biopsychosocial model
      1713. Contemporary vistas in geriatric sexuality
      1714. Content Analysis of Patient Voices at the FDA’s “Female sexual Dysfunction Patient-Focused Drug Development Public Meeting”
      1715. Content and valence of sexual cognitions and their relationship with sexual functioning in Spanish men and women
      1716. Content validity of the Female sexual Function Index (FSFI) in pre‐and postmenopausal women with hypoactive sexual desire disorder
      1717. Contested psychiatric ontology and feminist critique: ‘Female sexual Dysfunction’ and the Diagnostic and Statistical Manual
      1718. Continued efficacy and safety of flibanserin in premenopausal women with hypoactive sexual desire disorder (HSDD): results from a randomized withdrawal trial
      1719. Continuing medical education and the marketing of fentanyl for breakthrough pain: marketing messages in an industry‐funded CME module on breakthrough pain
      1720. Continuing Medical Education: Key Methodological Issues in sexual Medicine Research (CME)
      1721. Continuing medical education: sexual functioning in transsexuals following hormone therapy and genital surgery: a review (CME)
      1722. Continuing medical education: the use of estrogen therapy in women’s sexual functioning (CME)
      1723. Continuing Medical Education: Urogenital Complaints and Female sexual Dysfunction (Part 1)(CME)
      1724. Continuing Medical Education: Urogenital Complaints and Female sexual Dysfunction (Part 2)(CME)
      1725. Continuous one-flow multi-step synthesis of active pharmaceutical ingredients
      1726. Contraception and sexual health
      1727. Contraception, sex and sexual wellbeing: a reflective account
      1728. Contraceptive effect of ethanolic extract of Dioscorea villosa tuber on reproductive hormones of female wistar rats
      1729. Contraceptive usage patterns in North American medical students
      1730. Contribution of androgen receptor sensitivity to the relation between testosterone and sexual desire: an exploration in male-to-female transsexuals
      1731. Contribution of imaging to our understanding of sexual function and dysfunction
      1732. Contribution of psychosexual approach to assessment and treatment of sexual dysfunction: a working model
      1733. Contributor Biographies
      1734. Contributors to Optimal sexual Experiences
      1735. Controlled studies on women presenting with sexual drive disorder: I. Endocrine status
      1736. Controversial aspects of testosterone in the regulation of sexual function in late‐onset hypogonadism
      1737. Controversies about hypersexual disorder and the DSM-5
      1738. Controversies in sexual Medicine: Clinical and Basic Science Research in sexual Medicine Must Rely, in Part, on Pharmaceutical Funding?
      1739. Controversies in sexual medicine: Is sex just fun? How sexual activity improves health
      1740. Controversies in sexual medicine: Organic vs. psychogenic? The Manichean diagnosis in sexual medicine
      1741. Controversies of women’s sexual arousal and desire
      1742. Controversies regarding transdermal androgen therapy in postmenopausal women
      1743. Convenient and Robust Metal-Free Synthesis of Benzazole-2-Ones Through the Reaction of Aniline Derivatives and Sodium Cyanate in Aqueous Medium
      1744. Conventional and unconventional cardiovascular risk factors in men with erectile dysfunction
      1745. Convergent-divergent validity and correlates of the Day-to-Day Impact of Vaginal Aging domain scales in the MsFLASH vaginal health trial
      1746. Conversations With Women About Female sexual Dysfunction (FSD) and Treatment With Bremelanotide
      1747. Conversion of Benzimidazoles, Imidazothiazoles and Imidazoles into more Potent Central Nervous System Acting Drugs
      1748. Conversion Tables for ICD-10 and DSM-IV
      1749. Coping with pain in intimate situations: Applying the avoidance-endurance model to women with vulvovaginal pain
      1750. Core document on erectile dysfunction: key aspects in the care of a patient with erectile dysfunction
      1751. CORRECTION OF URINARY DISCOMFORT BY M-CHOLINOLYTIC SPASMEX IN WOMEN WITH sexual DYSFUNCTIONS AND HYPERACTIVE URINARY …
      1752. Correlated genetic and non-shared environmental influences account for the co-morbidity between female sexual dysfunctions
      1753. Correlates of circulating androgens in mid-life women: the study of women’s health across the nation
      1754. Correlates of extra-dyadic sex in Czech heterosexual couples: Does sexual behavior of parents matter?
      1755. Correlates of lesbian sexual functioning
      1756. Correlates of men’s sexual interest: a cross-cultural study
      1757. Correlates of placebo response in the treatment of sexual dysfunction in women: a preliminary report
      1758. Correlates of sexual function following vulvar excision
      1759. Correlates of sexual functioning in Italian menopausal women
      1760. Correlates of sexual satisfaction among sexually active postmenopausal women in the Women’s Health Initiative-Observational Study
      1761. Correlates of sexual satisfaction in marriage
      1762. Correlation between ejaculatory and erectile dysfunction
      1763. Correlation between flow-mediated dilation and erectile dysfunction
      1764. Correlation between general health and sexual function in older women in an Iranian setting
      1765. Correlation between insula activation and self-reported quality of orgasm in women
      1766. Correlation of Online Physician Reviews and Overall Patient Satisfaction
      1767. Correlation of oxytocin with male sexual dysfunction: An update
      1768. Correlation of question 15 of the FSDS-DAO with clinician evaluation of female orgasmic disorder
      1769. Correlation of sexual dysfunction with sex hormone and estrogen receptor gene polymorphism in Chinese Han women with epilepsy
      1770. Correlation of sexual knowledge and attitude with sexual function in female nurses
      1771. Correspondence (letter to the editor): Absence of desire
      1772. Corresponding author (Email: bimilo@ hanmail. net)
      1773. Corresponding author (Email: uropark@ gmail. com)
      1774. Corresponding author (Email: wowhana@ ewha. ac. kr)
      1775. Corresponding author: Kwangsung Park. Email: uropark@ gmail. com
      1776. Cortisol, sexual arousal, and affect in response to sexual stimuli
      1777. Cosmetic gynecology in the view of evidence-based medicine and ACOG recommendations: a review
      1778. Cosmetic Medicine
      1779. Cost implications of sexual dysfunction: the female picture
      1780. Cost-Effectiveness Analysis of High-Sensitivity Troponin T Versus Conventional Troponin I Testing for Acute Myocardial Infarction
      1781. Cost–effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA
      1782. Costs of pleasure and the benefits of pain: self-perceived genital sensation, anatomy and sexual dysfunction
      1783. Could diabetes mellitus affect female sexual function: a comparative study
      1784. Counseling and Antibody Testing to Prevent HIV Infection-Reply
      1785. Counseling asexual clients
      1786. Counseling Couples Before, During, and After Pregnancy: sexuality and Intimacy Issues
      1787. Counseling HIV-positive gay men
      1788. Counselling Women in Midlife: A Sociocultural Framework
      1789. Counting Chickens before the Eggs Hatch: On the Valuation of New Drug (Product) Development Portfolios in the Pharmaceutical Sector
      1790. Couple Attachment and sexual desire Discrepancy: A Longitudinal Study of Non-Clinical Married Couples at Mid-Life
      1791. Couple sex therapy versus group therapy for women with genito-pelvic pain
      1792. Couple therapy and the treatment of sexual dysfunction
      1793. Couple therapy for low sexual desire: A systemic approach
      1794. Couple therapy for premature ejaculation
      1795. Couple therapy, family therapy and systemic interventions for adult‐focused problems: The current evidence base
      1796. Couple‐Based Interventions for the Treatment of Depressive and Anxiety Disorders
      1797. Couplepause: a new paradigm in treating sexual dysfunction during menopause and andropause
      1798. Couples and kinky sexuality: The need for a new therapeutic approach
      1799. Couples in collusion: Short-term, assessment-based strategies for helping couples disarm their defenses
      1800. Couples Research & Therapy NEWSLETTER
      1801. Couples Therapy and Counseling
      1802. Couples’ sexual communication and dimensions of sexual function: A meta-analysis
      1803. Couples’ sexuality: Relation to gender role attitudes and division of household labor
      1804. COUPLES’sexual DYSFUNCTION: Vardenafil Improves sexual Function and Treatment Satisfaction in Couples Affected by Erectile Dysfunction (ED): A …
      1805. COUPLES’sexual DYSFUNCTIONS: Female sexual Dysfunction, sexual Distress, and Compatibility with Partner
      1806. COUPLES’sexual DYSFUNCTIONS: The Effects of Treating Male Hypogonadism on Couples’ sexual desire and Function
      1807. COUPLES’sexual DYSFUNCTIONS: Women’s sexual Function Improves When Partners Are Administered Vardenafil for Erectile Dysfunction: A Prospective …
      1808. Covariation of sexual desire and sexual arousal: The effects of anger and anxiety
      1809. COVID-19
      1810. Creating and Validating the DESEA Questionnaire for Men and Women
      1811. Creating the’dis-ease’of high cholesterol: A sociology of diagnosis reception analysis
      1812. Creation and Validation of the Self-esteem/Self-image Female sexuality (SESIFS) Questionnaire
      1813. Crisis and safety: The asexual in sexusociety
      1814. Critical analyses
      1815. Critical flaws in the female sexual function index and the international index of erectile function
      1816. Critical overview of the new consensus-based definitions and classification of female sexual dysfunction
      1817. Critical review of group interventions for sexual dysfunction: Advances in the last decade
      1818. Critiques and challenges to old and recently proposed American psychiatric Association’s website DSM 5 diagnostic criteria for sexual dysfunctions
      1819. Cross Sectional Study of Age Profile of Alleged Accused and Victims of sexual Offence
      1820. Cross-cultural adaptation of the female sexual function index
      1821. Cross-Cultural Analysis of sexual Response and Relationship Satisfaction in Women With and Without Orgasmic Difficulty During Partnered sex
      1822. Cross-cultural psychotherapy
      1823. CSA survivors: What heals and what hurts in a couple relationship
      1824. CSBD in Women
      1825. Cues resulting in desire for sexual activity in women
      1826. Cultivating healthy skepticism towards help-seeking advertisements: Dispelling the illusion of unique invulnerability
      1827. Cultural and organizational aspects of application of the Americans with Disabilities Act to persons with psychiatric disabilities
      1828. Cultural attitudes and female sexual desire
      1829. Cultural Considerations in the Treatment of sexual Dysfunction
      1830. Cultural factors and sexual dysfunction in clinical practice
      1831. Culturally sensitive sex therapy
      1832. Culture and sexuality: cognitive–emotional determinants of sexual dissatisfaction among Iranian and New Zealand women
      1833. Curation and bioinformatic analysis of strabismus genes supports functional heterogeneity and proposes candidate genes with connections to RASopathies
      1834. Curing sexual desire with the Lust Enhancing Pill for Women: Where Medicine Meets Normality
      1835. Current and future pharmacotherapies of premature ejaculation
      1836. Current approaches to the evaluation of sexual desire disorders
      1837. Current challenges in recognizing and treating eating disorders.
      1838. Current diagnosis and management of erectile dysfunction
      1839. Current Literature Review
      1840. Current literature review
      1841. Current Literature Review
      1842. Current Literature Review
      1843. CURRENT MANAGEMENT OPTIONS FOR WOMEN WITH HSDD (hypoactive sexual desire DISORDER)
      1844. Current management strategies of the postmenopausal patient with sexual health problems
      1845. Current perspectives on the clinical assessment and diagnosis of female sexual dysfunction and clinical studies of potential therapies: A statement of concern
      1846. Current Practice in Hysterectomy for Benign Reasons and Its Effect on sexual Function
      1847. Current Research Journal of Social Sciences
      1848. Current research on how infertility affects the sexuality of men and women
      1849. Current research on sexual response and sexual functioning among lesbian women
      1850. Current Resources for Evidence-Based Practice, November/December 2016
      1851. Current status and future directions in couple therapy
      1852. Current therapies for premature ejaculation
      1853. Current therapies for premature ejaculation
      1854. Current Treatment Modalities for the Genitourinary Syndrome of Menopause
      1855. Current updates on salpingectomy for the prevention of ovarian cancer and its practice patterns worldwide
      1856. Curriculum Vitae Alessandra H. Rellini, Ph. D Associate Professor in Clinical Psychology The University of Vermont-UVM arellini@ uvm. edu-(802) 419-0820
      1857. CURRICULUM VITAE JOHN M. THORP, JR., MD.
      1858. Currituck County
      1859. Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use
      1860. Cutoff score of the sexual interest and desire inventory-female for diagnosis of hypoactive sexual desire disorder
      1861. Cutting-Edge Work
      1862. Cyclodextrin-based drug delivery systems
      1863. Daily affect and female sexual function
      1864. Daily diary study of adult men’s and women’s event-level sexual motivations and sexual behaviour
      1865. Daily hassles in the family-work system and life satisfaction: the moderating effect of sexual satisfaction
      1866. Dancing with Science, Ideology, and Technique: Treating sexual desire Disorders: A Clinical Casebook Edited by Sandra R. Leiblum New York, NY: Guilford, 2010 …
      1867. Dangerous Bedfellows, Industry and Medicine: Life Savers Or Disease Makers
      1868. Danilo Antonio Baltieri
      1869. Dapoxetine
      1870. Darwin’s legacy: An evolutionary view of women’s reproductive and sexual functioning
      1871. Darwinian psychiatry
      1872. Data based medicine and clinical judgement
      1873. David B. Vodušek
      1874. DAY 4 25TH JANUARY 2020 ABSTRACTS
      1875. Declining consumption of added sugars and sugar-sweetened beverages in Australia: a challenge for obesity prevention
      1876. Declining gonadal function in elderly men
      1877. Decreased sexual desire Screener
      1878. Decreased sexual desire Screener©
      1879. Decreased sexual motivation and heightened anxiety in male Long-Evans rats are correlated with the memory for a traumatic event
      1880. Defining Asexuality Into (Or Out Of) Its Radical Potential
      1881. Defining normal
      1882. Defining premature ejaculation for experimental and clinical investigations
      1883. Defining the Challenge: Epidemiology of Mental Disorders in British Columbia: Estimating the Prevalence of Mental Disorders in Adults
      1884. Definition and classification of female sexual disorders.
      1885. Definition and diagnosis of sexual problems
      1886. Definition and diagnosis of sexuality in the XXI century
      1887. Definition and Epidemiology
      1888. Definition, etiology, and treatment of absent/low desire in women.
      1889. DEFINITIONS AND HISTORY
      1890. Definitions of sexual dysfunctions in women and men: a consensus statement from the Fourth International Consultation on sexual Medicine 2015
      1891. Definitions of women’s sexual d ysf u nct i on recons id ered: advocating expansion and revision
      1892. Definitions of women’s sexual dysfunction reconsidered: advocating expansion and revision
      1893. Degarelix: An Antagonist to GnRH—Theoretical and Treatment Considerations in Paraphilia
      1894. Dehydroepiandrosterone and cortisol as markers of HPA axis dysregulation in women with low sexual desire
      1895. Dehydroepiandrosterone for women in the peri‐or postmenopausal phase
      1896. Dehydroepiandrosterone potentiates the effect of vitamin D on thyroid autoimmunity in euthyroid women with autoimmune thyroiditis: A pilot study
      1897. Dehydroepiandrosterone replacement therapy—panacea, snake oil, or a bit of both?
      1898. Dehydroepiandrosterone use in postmenopausal women: an androgenic option for managing sexual pain caused by vulvovaginal atrophy
      1899. Delayed ejaculation
      1900. Delayed ejaculation and alexithymia: what is the relationship?
      1901. Delayed ejaculation and alexithymia: what is the relationship?[version 2; referees: 2 approved]
      1902. Delayed ejaculation and orgasm
      1903. Delayed orgasm and anorgasmia
      1904. Demographic and psychological factors related to sexual desire among heterosexual women in a relationship
      1905. Demographics, cancer-related factors, and sexual function in rectal cancer patients in taiwan: preliminary findings
      1906. Demystifying love: Plain talk for the mental health professional
      1907. Demystifying Steroids
      1908. Dendritic arbor of neurons in the hypothalamic ventromedial nucleus in female prairie voles (Microtus ochrogaster)
      1909. Department of Dynamic and Clinical Psychology Doctorate course in Dynamic and Clinical Psychology XXX Cycle
      1910. Departures from linearity in the relationship between measures of muscular strength and physical performance of the lower extremities: the Women’s Health and Aging …
      1911. Depiction of Mental Illness in Film and Association with Financial and Critical Success
      1912. Deployment and its Effects on sexual Functioning and Relationships of United States Military Members
      1913. Depressed mood and sexual functioning
      1914. DEPRESSION AMONG WOMEN WITH hypoactive sexual desire: ORGASM CONSISTENCY TRAINING ANALYSIS AND EFFECT ON TREATMENT OUTCOME …
      1915. Depression and antidepressant-associated erectile dysfunction
      1916. Depression and female sexual dysfunction
      1917. Depression and sexual dysfunction
      1918. Depression and sexual Function: pocketbook
      1919. Depression and sexual functioning in minority women: current status and future directions
      1920. Depression as an outcome or cause of sexual dysfunctions: A review study
      1921. Depression in premenopausal women with HSDD: baseline findings from the HSDD Registry for Women
      1922. Depression mood stabilisation: novel concepts and clinical management
      1923. Depression, antidepressants, and sexual functioning
      1924. Depression, sexual Functioning and the Life Satisfaction of Pakistani Women with and without Polycystic Ovary Syndrome
      1925. Depression, sexual Functioning, & Relationship with Primary Care Providers among Female Veterans: A Pilot Study
      1926. Depression, sexuality and fibromyalgia syndrome: clinical findings and correlation to hematological parameters
      1927. Depression: the ambivalence of diagnosis
      1928. Depressive disorders and the menopause transition
      1929. Depressive symptoms and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: the Dogo Study
      1930. Depressive symptoms are not associated with long-term integrated testosterone concentrations in hair
      1931. DESCRIPTION OF THE DISORDER AND CLINICAL PICTURE
      1932. DESCRIPTION OF THE DISORDERS
      1933. Descriptive Study of Some Egyptian Females Having sexual Dysfunction and Attending Al-Azhar University Hospitals: Results of a Clinical Study with the Aid of …
      1934. Design, Preparation And in vitro Characterization of a biodegradable injectable form of testosterone
      1935. Designing drugs for the treatment of female sexual dysfunction
      1936. desire AND AROUSAL DISORDERS IN WOMEN: AN UPDATE ON ASSESSMENT AND EVIDENCE-BASED TREATMENTS
      1937. desire emerges from excitement: A psychophysiological perspective on sexual motivation
      1938. desire lost, desire feared, desire never named
      1939. desire Thinking and Metacognition Associated with Dysregulated sexuality
      1940. desire-Phase Problems and the Search for Explanations
      1941. Desk reference to the diagnostic criteria from DSM-5®
      1942. Detection, identification and quantification by 1H NMR of adulterants in 150 herbal dietary supplements marketed for improving sexual performance
      1943. Determinants of female sexual function in breastfeeding women
      1944. Determinants of sexual desire problems in women: Testing a cognitive-emotional model
      1945. Determinants of sexual dysfunction and interventions for patients with obstructive sleep apnoea: a systematic review
      1946. Determinants of women’s sexual dissatisfaction: Assessing a cognitive-emotional model
      1947. Determination of flibanserin and tadalafil in supplements for women sexual desire enhancement using high-performance liquid chromatography with tandem mass …
      1948. Determination of flibanserin in the presence of confirmed degradation products by a third derivative emission spectrofluorometric method: Application to …
      1949. Determination of menopausal status in women: the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study
      1950. Determine the rule of gender in relation between sexual desire and quality of life in patients with major depression
      1951. Determining a Bayesian predictive power stopping rule for futility in a non-inferiority trial with binary outcomes
      1952. Determining the correlation between sexual satisfaction and loneliness levels in patients with hemodialysis in a Muslim community
      1953. Determining the effects of androgen therapy on sexual well-being: a complex challenge
      1954. Determining the Role of Occupational Therapists for Improving Interventions Related to sexual Health for Women Ages 45–64 who have a Chronic Medical Condition
      1955. Detrimental effects of testosterone addition to estrogen therapy involve cytochrome P-450-induced 20-HETE synthesis in aorta of Ovariectomized …
      1956. DeŪnition and classiŪcation of erectile dysfunction: Report of the Nomenclature Committee of the International Society of Impotence Research
      1957. Developing a biased unmatched bivalent ligand (BUmBL) design strategy to target the GPCR homodimer allosteric signaling (cAMP over β-arrestin 2 recruitment) …
      1958. Developing Cognitive Bias Modification Scenarios for Women with sexual Interest Arousal Disorder and Comparing Effectiveness with Mindfulness Therapy
      1959. Developing guidelines for adapting questionnaires into the same language in another culture
      1960. Developing Serotonergic Antidepressants Acting on More Than the Serotonin Transporter
      1961. Developing treatments for female sexual dysfunction
      1962. Development and Characterization of a Rat Model of Female sexual Dysfunction
      1963. Development and evaluation of a curriculum targeting emotional components of women’s sexual health
      1964. Development and feasibility of a group-based therapeutic yoga program for women with chronic pelvic pain
      1965. Development and Greenness Evaluation of Spectrofluorometric Methods for Flibanserin Determination in Dosage Form and Human Urine Samples
      1966. Development and Implementation of the sexual and Vaginal Health After Cancer (SVHC) Care Pathway in a Rural Oncology Clinic
      1967. Development and Psychometric Evaluation of a Scale to Assess
      1968. Development and Psychometric Evaluation of a Scale to Assess sexual Difficulties in Gay Men
      1969. Development and Psychometric Performance of the Self-Efficacy to Communicate About sex and Intimacy (SECSI) Scale in Women Treated for Cancer
      1970. Development and psychometric properties of the Female sexual desire Questionnaire (FSDQ)
      1971. Development and Validation of a Measure of Responsive sexual desire
      1972. Development and validation of a new screening tool for hypoactive sexual desire disorder: The Brief Profile of Female sexual Function© (B-PFSF©)
      1973. Development and validation of Chinese version of female sexual function index in a Chinese population—a pilot study
      1974. Development and validation of liquid chromatography–electrospray–tandem mass spectrometry method for determination of flibanserin in human plasma: Application …
      1975. Development and validation of the Attitudes Towards Asexuals (ATA) scale
      1976. Development and validation of the Korean version of the Female sexual Function Index-5 (FSFI-5)
      1977. Development and validation of the Polish version of the Female sexual Function Index in the Polish population of females
      1978. Development and Validation of the Polish Version of the Female sexual Function Index in the Polish Population of Femalesjsm_12012
      1979. Development and validation of the pretending orgasm reasons measure
      1980. Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction
      1981. Development and validation of Turkish version of the female sexual distress scale-revised
      1982. Development and Validation of Turkish Version of The Female sexual Distress Scale-Revised.
      1983. Development of a Self-Report Instrument for Use in the Clinical Setting that Describes Symptoms related to Urogenital Atrophy in Women with Breast Cancer
      1984. Development of a sexual dysfunction scale for women with inflammatory bowel disease
      1985. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction
      1986. Development of an evidence-based classification system for uterine fibroids
      1987. Development of hMC1R Selective Small Agonists for Sunless Tanning and Prevention of Genotoxicity of UV in Melanocytes
      1988. Development of novel frog‐skin peptide scaffolds with selectivity towards melanocortin receptor subtypes
      1989. Development of the ‘Perceived sexual Distress Scale-Hindi’for measuring sexual distress following spinal cord injury
      1990. Development of the Occupational Performance Inventory of sexuality and Intimacy (OPISI): Phase One
      1991. Development of the psychopathology instrument for mentally retarded adults—sexuality scale (PIMRA-S)
      1992. Development of the sexual Arousal and desire Inventory (SADI) for the assessment of the psychological and subjective experience of sexual arousal and desire
      1993. Development of the sexual Five-Facet Mindfulness Questionnaire (FFMQ-S): Validation among a community sample of French-speaking women
      1994. Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making
      1995. Development, implementation, and evaluation of a multidisciplinary oncology sexual health clinic in a Canadian cancer care setting
      1996. Development, validity and reliability of sexual health measures for spinal cord injured patients in iran
      1997. Developmental fluoxetine exposure facilitates sexual behavior in female offspring
      1998. Developments and new vistas in the field of melanocortins
      1999. Developments in sexology and sex Therapy
      2000. Deviant Men, Prostitution, and the Internet: A Qualitative analysis of Men who killed Prostitutes whom they met online.
      2001. Devices and methods to measure female sexual arousal
      2002. DHEA for postmenopausal women: a review of the evidence
      2003. DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA’s antidepressant action
      2004. DHEA supplementation in Menopause
      2005. DHEA therapy in postmenopausal women: the need to move forward beyond the lack of evidence
      2006. Diabetes and Female sexual Dysfunction
      2007. Diabetes and female sexual dysfunction: moving beyond” benign neglect”
      2008. Diabetes and female sexual function: A critical review
      2009. Diabetes and sexual Disorders
      2010. Diabetes and sexual dysfunction: current perspectives
      2011. Diabetes and sexual dysfunction: current perspectives
      2012. Diabetes and sexuality
      2013. Diabetes and the endocrine pancreas II
      2014. Diabetes mellitus and female sexuality: a review of 25 years’ research
      2015. Diabetes mellitus and sexual dysfunction
      2016. Diabetes, sexual dysfunction and therapeutic exercise: a 20 year review
      2017. Diabetic autonomic neuropathy
      2018. Diabetic autonomic neuropathy resulting in sexual dysfunction
      2019. DIABETIC PANDEMONIUM: A REVIEW
      2020. Diagnoses are not diseases
      2021. Diagnosing desire: Biopolitics and Femininity Into the Twenty-first Century
      2022. Diagnosing sexual dysfunction in men and women: sexual history taking and the role of symptom scales and questionnaires
      2023. Diagnosis and Assessment of Female sexual Dysfunction (s)
      2024. Diagnosis and classification
      2025. Diagnosis and clinical features of major neuropsychiatric disorders in HIV infection
      2026. Diagnosis and management of female Orgasmic disorder
      2027. Diagnosis and management of female sexual arousal disorder
      2028. Diagnosis and management of macrosomia
      2029. Diagnosis and management of premature ovarian failure
      2030. Diagnosis and management of sexual pain disorders: dyspareunia
      2031. Diagnosis and treatment of erectile dysfunction
      2032. Diagnosis and treatment of female sexual dysfunction
      2033. Diagnosis and treatment of hypoactive sexual desire disorder
      2034. Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes
      2035. Diagnosis and treatment of testosterone deficiency: recommendations from the Fourth International Consultation for sexual Medicine (ICSM 2015)
      2036. Diagnosis and treatment of urinary and sexual dysfunction in hereditary TTR amyloidosis
      2037. DIAGNOSIS AND TREATMENT OF WOMEN WITH hypoactive sexual desire DISORDER AND DEPRESSION/ANXIETY
      2038. Diagnosis of acute vertigo
      2039. diagnosis of female
      2040. Diagnosis of female arousal disorder
      2041. Diagnosis of female hypoactive sexual desire disorder using the p300 EEG auditory/visual method
      2042. Diagnosis of Female sexual Dysfunction
      2043. Diagnosis of Female sexual Dysfunction
      2044. Diagnosis of sexual dysfunction: relationships between DSM-III (R) and the GRISS
      2045. Diagnosis of sexual Dysfunctions in Psychiatric Population: Lights and Shadows of DSM-5 Taxonomy of sexual Disorders
      2046. Diagnosis, epidemiology, and course of sexual disorders.
      2047. Diagnosis: A symptom-based approach in internal medicine
      2048. Diagnosis: truths and tales
      2049. Diagnostic and statistical manual of mental disorders
      2050. Diagnostic and statistical manual of mental disorders (DSM-5®)
      2051. Diagnostic and Statistical Manual of Mental Disorders and the Buddhist Jathaka Stories
      2052. Diagnostic and treatment strategies for erectile dysfunction: the ‘Process of Care’model
      2053. Diagnostic controversy: female sexual dysfunction
      2054. Diagnostic Evaluation of the Female Patient
      2055. Diagnostic Systems and Their Use
      2056. Did parents have it right all along? Parents, risk, and living kidney donation: Revisiting the arguments for and against parental living donation of kidneys
      2057. Diet and Female sexual Health
      2058. Dietary supplements for female sexual dysfunction
      2059. Difference or dysfunction?: Deconstructing desire in the DSM-5 diagnosis of Female sexual Interest/Arousal Disorder
      2060. Differences between sexually functional and dysfunctional women in childhood experiences and individual and relationship domains
      2061. Differences in automatic thoughts presented during sexual activity between sexually functional and dysfunctional men and women
      2062. Differences in female attitudes toward sex across three generations
      2063. Differences in orgasm frequency among gay, lesbian, bisexual, and heterosexual men and women in a US national sample
      2064. Differences in Personality Beliefs of Emerging Adults in Two Distinct Online Asexual Communities
      2065. Differences in sexual desire between women with clinical versus biochemical signs of hyperandrogenism in polycystic ovarian syndrome
      2066. Differences in sexual guilt and desire in East Asian and Euro-Canadian men
      2067. DIFFERENCES IN SOME DIABETIC INDICATORS AMONG PATIENTS WITH sexual DYSFUNCTION
      2068. Differences in the sexual Function and sexual Healthcare Needs of Pregnant Women Who Underwent in Vitro Fertilization and Women Who Conceived …
      2069. Different characteristics of the Female sexual Function Index in a sample of sexually active and inactive women
      2070. Different profile of endothelial cell apoptosis in patients with Klinefelter’s syndrome
      2071. Different testosterone levels are associated with ejaculatory dysfunction
      2072. Different ways to get there: Evidence of a variable female sexual response cycle
      2073. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in …
      2074. Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples
      2075. Differential effects of sympathetic activation on sexual arousal in sexually dysfunctional and functional women.
      2076. Differential effects of testosterone and estradiol on clitoral function: an experimental study in rats
      2077. Differentiating components of sexual well-being in women: Are sexual satisfaction and sexual distress independent constructs?
      2078. Differentiation, negative attributions and sexual desire in committed relationships
      2079. Difficult Cases in Primary Care: Women’s Health
      2080. Difficulties in achieving vs maintaining erection: organic, psychogenic and relational determinants
      2081. Difficulty in Vaginal Intercourse and its Correlates: A Survey Study among Chinese Women in Hong Kong.
      2082. Diffuse alveolar haemorrhage with ANCA associated vasculitis: review of literature
      2083. Diffusion-tensor MR imaging and fiber tractography: a new method of describing aberrant fiber connections in developmental CNS anomalies
      2084. Digging in my secret garden: Disinhibitory effects of the” Hidden Observer” on reported sexual fantasies.
      2085. Dilators, Q-tips, and Extortion: How to Train a Woman for Intercourse in the “Post-Feminist” Era
      2086. Dilemmas encountered by the sexual and Gender Identity Disorders Work Group for DSM-5: an interview with Kenneth J. Zucker
      2087. Dimensionality and transcultural specificity of the sexual Attraction Questionnaire (SAQ)
      2088. Dimensions of sexual health
      2089. Diminished functional connectivity on the road to child sexual abuse in pedophilia
      2090. Diminished sexual activity, interest, and feelings of attractiveness among HIV-infected women in two eras of the AIDS epidemic
      2091. direct to consumer telemedicine: is healthcare From home Best?
      2092. DIRECTED MASTURBATION: 26 A TREATMENT OF FEMALE ORGASMIC DISORDER
      2093. Directed masturbation: A treatment of female orgasmic disorder
      2094. Directions in Marriage and
      2095. DIS News
      2096. Discovery of novel isoliquiritigenin analogue ISL-17 as a potential anti-gastric cancer agent
      2097. Discovery series: Human sexuality
      2098. Discrepant attentional biases toward sexual stimuli
      2099. Discussion of Premature Ejaculation
      2100. Disease-branding and drug-mongering: Could pharmaceutical industry promotional practices result in tort liability
      2101. Disentangling desire and arousal: a classificatory conundrum
      2102. Disgust and sexual arousal in young adult men and women
      2103. Disgust and sexual Arousal in Young Adult Men and Women Andrea Grauvogl 16, Peter de Jong 2, Madelon Peters, Silvia Evers 3, Mark van Overveld 4 & …
      2104. Disgust sensitivity, sexual trauma history, and female sexual functioning
      2105. Disgust versus lust: Exploring the interactions of disgust and fear with sexual arousal in women
      2106. Disorders in sexual desire and sexual arousal in women, a 2010 state of the art
      2107. Disorders of Ejaculation and Male Orgasm
      2108. Disorders of Female Orgasm
      2109. Disorders of Female sexual Arousal
      2110. Disorders of male sexual desire
      2111. Disorders of orgasm and ejaculation in men
      2112. Disorders of orgasm in women: A literature review of etiology and current treatments
      2113. Disorders of reproduction
      2114. Disorders of sex development in Indonesia: The course of psychological development in late identified patients
      2115. Disorders of sexual desire and arousal.
      2116. Disorders of sexual desire and subjective arousal in women.
      2117. Disorders of the male sexual response cycle
      2118. Disorders related to sexuality and gender identity in the ICD-11: Revising the ICD-10 classification based on…
      2119. Disorders related to sexuality and gender identity in the ICD‐11: revising the ICD‐10 classification based on current scientific evidence, best clinical practices, and …
      2120. Disposition of urinary and serum steroid metabolites in response to testosterone administration in healthy women
      2121. Dissatisfaction with male sexual performance and female sexual dysfunction in women with type 1 diabetes
      2122. Distinctive Acne Entities
      2123. Distinguishing premature ejaculation from other sexual function disorders
      2124. Distress about sex: A national survey of women in heterosexual relationships
      2125. Distress reduction in female sexual dysfunctions: a dose-ranging study of subcutaneous bremelanotide
      2126. Distress, sexual dysfunctions, and DSM: dialogue at cross purposes?
      2127. Distressing sexual difficulties in heterosexual and non-heterosexual Croatian men: assessing the role of minority stress
      2128. Distressing sexual function at midlife: unmet needs, practical diagnoses, and available treatments
      2129. Distressing sexual problems in United States women revisited: prevalence after accounting for depression
      2130. Distribution and codistribution of TAC-2 and ERα in neurons of the adult female murine brain
      2131. Diverse Women’s sexualities: A Contemporary View
      2132. Diversity in family life
      2133. Divinely Attuned: Using Brain Science, Psychology, and Spiritual Practice to Maximize Spirituality, Improve Intimacy, and Make Good Rela
      2134. Divorce in the Christian society and a prescriptive model to rekindle the marriage bond
      2135. Do Clinicians Conceptualize DSM‐IV Disorders Hierarchically?
      2136. Do dehydroepiandrosterone, progesterone, and testosterone influence women’s depression and anxiety levels? Evidence from hair-based hormonal measures of …
      2137. Do drugs have a role in turning indifference into passion?
      2138. Do gynecologists talk about sexual dysfunction with their patients?
      2139. Do men and women with asexual identities show low category specificity in their patterns of sexual attraction and attention to male and female swimsuit …
      2140. Do patients lie? An open interview vs. a blind questionnaire on sexuality
      2141. Do psychosocial factors moderate the relation between testosterone and female sexual desire? The role of interoception, alexithymia, defense mechanisms, and …
      2142. Do stressful life events impact women’s sexual desire?
      2143. Do women with endometriosis have to worry about sex?
      2144. Do women’s orgasms function as a masculinity achievement for men?
      2145. Do You Feel in Control? sexual desire, sexual Passion Expression, and Associations with Perceived Compulsivity to Pornography and Pornography Use Frequency
      2146. Doctor in My Bedroom: Physicians’ lack of sexual health education, its effects on patient welfare and the development of a new paradigm
      2147. Doctors and drug companies: Is the dangerous liaison drawing to an end?
      2148. Documentation of the impact of spinal cord injury on female sexual function: the female spinal sexual function classification
      2149. Does endometriosis affect sexual activity and satisfaction of the man partner? A comparison of partners from women diagnosed with endometriosis and controls
      2150. Does flibanserin have a future
      2151. Does HIV matter when you are poor and how?: the impact of HIV/AIDS on the psychological adjustment of South African mothers in the era of HAART
      2152. Does hypertension and its pharmacotherapy affect the quality of sexual function in women?
      2153. Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and overactive bladder syndrome? An Australian …
      2154. Does Loneliness Following Empty Nest Impair sexual Function and Satisfaction of Middle-Aged Iranian Women?
      2155. Does Marriage Really Improve sexual Satisfaction? Evidence from the Pairfam Dataset
      2156. Does monogamy harm women? Deconstructing monogamy with a feminist lens
      2157. Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women?
      2158. Does physical intimate partner violence affect sexual health? A systematic review
      2159. Does repeated testing impact concordance between genital and self-reported sexual arousal in women?
      2160. Does severe maternal morbidity affect female sexual activity and function? Evidence from a Brazilian cohort study
      2161. Does sex really matter? Examining the connections between spouses’ nonsexual behaviors, sexual frequency, sexual satisfaction, and marital satisfaction
      2162. Does Studying Circumstances of the Woman Affect Her sexual Life?
      2163. Does subjective tinnitus cause sexual disturbance?
      2164. Does surgical menopause affect sexual performance differently from natural menopause?
      2165. Does the Female sexual Distress Scale‐Revised cover the feelings of women with HSDD?
      2166. Does transdermal testosterone increase the risk of developing breast cancer? A systematic review
      2167. Does type 1 diabetes modify sexuality and mood of women and men?
      2168. Does Type of Menopause Affect the sex Lives of Women?
      2169. Does vaginal anti-incontinence surgery affect sexual satisfaction? A comparison of TVT and Burch-colposuspension
      2170. Does vaginal size impact sexual activity and function?
      2171. Does varicocelectomy improve gonadal function in men with hypogonadism and infertility? Analysis of a prospective study
      2172. Domestic violence: a worldwide exploration
      2173. Dopamine and norepinephrine responses to film-induced sexual arousal in sexually functional and sexually dysfunctional women
      2174. Dopamine receptor genes are associated with age at first sexual intercourse
      2175. DOROTHY M. GRIFFITHS, PAUL FEDOROFF
      2176. Dose-finding study of Lorexys for hypoactive sexual desire disorder in premenopausal women
      2177. DOSING AND USE
      2178. Double blind trial of yohimbine hydrochloride in the treatment of erection inadequacy: an update
      2179. Dove Press
      2180. Dr. Mohamed Abbas Eid
      2181. Dramatizing Doubt in Hamlet1
      2182. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development
      2183. Drug for low sexual desire carries significant harms, FDA advisers find
      2184. Drug maker urges group to lobby FDA on testosterone for women
      2185. Drug Repurposing Patent Applications January–March 2019
      2186. Drug treatments for women’s sexual disorders
      2187. Drug Utilization of Intrinsa [superscript]®[/superscript](Testosterone Patch) in England
      2188. Drug Utilization of Intrinsa®(Testosterone Patch) in England
      2189. Drug-associated spontaneous orgasm: A case report and systematic review of literature
      2190. Drug-Induced Acne
      2191. Drug-induced acne
      2192. Drug-induced sexual dysfunction in men and women
      2193. Drugs and sexual health
      2194. Drugs for the treatment of menopausal symptoms
      2195. Drugs in early clinical development for the treatment of female sexual dysfunction
      2196. Drugs that affect sexual function
      2197. DSM-5 and beyond: A critical feminist engagement with psychodiagnosis
      2198. DSM-5 Changes in Diagnostic Criteria of sexual Dysfunctions. Reprod Sys sexual Disorders 2: 122. doi: 10.4172/2161-038X. 1000122 Page 2 of 3 Reprod Sys …
      2199. DSM-5 CRITERIA AND TERMINOLOGY
      2200. DSM-5 CRITERIA AND TERMINOLOGY
      2201. DSM-5 handbook of differential diagnosis
      2202. DSM-5 Insanely Simplified: Unlocking the Spectrums within DSM-5 and ICD-10
      2203. DSM-5 learning companion for counselors
      2204. DSM-5: call for commentaries on gender dysphoria, sexual dysfunctions, and paraphilic disorders
      2205. DSM-III-R: Professional Implications and Revisions for Mental Health Counselors.
      2206. DSM-IV training guide
      2207. DSM-IV-TR and the Paraphilias: An Argument for Removal
      2208. DSM-IV-TR in Action: DSM-5 E-Chapter Update
      2209. Dual Special Issue: Surface Electromyography and Rehabilitation, and Surface Electromyography and Pelvic Floor Muscle Disorders
      2210. Dupilumab Approved to Treat Chronic Rhinosinusitis with Nasal Polyposis
      2211. Duration of hypertension and antihypertensive agents in correlation with the phases of female sexual response cycle
      2212. Dyadic adjustment and sexual function in postmenopausal women
      2213. Dyadic adjustment in couples with hypoactive sexual desire
      2214. Dyadic adjustment, sexuality and psychological distress in older couples
      2215. Dyadic and solitary sexual desire in patients with fibromyalgia: a controlled study
      2216. Dyadic configurations of sexual problems among older US adults: A national study
      2217. Dynamics and Geometry of the Human sexual Response
      2218. Dysfunction of sexual and Accessory sex Organs
      2219. dysfunction reconsidered: advocating expansion and revision
      2220. dysfunctional self-concepts, as well as on presenting focal problems (Beck & Freeman, 1989; Ellis, 1985; Freeman, 1987). Reviews of principles and techniques for …
      2221. Dysfunctional sex Beliefs as an Inhibitor of Female Intercourse Experience
      2222. Dysfunctional sexual beliefs as vulnerability factors for sexual dysfunction
      2223. Dysfunctional sexual beliefs: a comparative study of heterosexual men and women, gay men, and lesbian women with and without sexual problems
      2224. Dyspareunia among women subjected to normal vaginal delivery with episiotomy
      2225. Dyspareunia and DSM: A gynecologist’s opinion
      2226. Dyspareunia in a teenager reveals a rare occurrence: retroperitoneal cervical leiomyoma of the left pararectal space
      2227. Dyspareunia in gynaecological practice
      2228. Dyspareunia in the context of psychopathology, personality traits, and coping resources: results from a prospective longitudinal cohort study from age 30 to 50
      2229. Dyspareunia is associated with decreased frequency of intercourse in the menopausal transition
      2230. Dyspareunia is the only valid sexual dysfunction and certainly the only important one
      2231. Dyspareunia: a difficult symptom in gynaecological practice
      2232. Dyspareunia: a difficult symptom in gynaecological practice
      2233. Dyspareunia: a pain disorder or sexual dysfunction?
      2234. Dyspareunia: Another argument for removal
      2235. e toxpred: A machine learning-based approach to estimate the toxicity of drug candidates
      2236. Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at‐home setting: a randomized, double‐blind, placebo‐controlled trial
      2237. Early menarche and high parity contribute to better sexual-quality of life in perimenopausal women
      2238. Early‐stage cervical carcinoma, radical hysterectomy, and sexual function: A longitudinal study
      2239. Early, average adulthood, old age and education psychosexual
      2240. Eastern approaches for enhancing women’s sexuality: Mindfulness, acupuncture, and yoga (CME)
      2241. Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): A systematic review and meta‐analysis
      2242. EAU Guidelines on
      2243. EAU guidelines on chronic pelvic pain
      2244. Ebbs and Flows of desire: A Qualitative Exploration of Contextual Factors Affecting sexual desire in Bisexual, Lesbian, and Straight Women
      2245. ED PHARMACOTHERAPY: Comparing Vardenafil and Sildenafil in the Treatment of Men with Erectile Dysfunction and Risk Factors for Cardiovascular Disease: A …
      2246. ED PHARMACOTHERAPY: Efficacy and Safety of Flexible‐Dose Vardenafil in Men with Type 1 Diabetes and Erectile Dysfunction
      2247. ED PHARMACOTHERAPY: Efficacy and Safety of Mirodenafil, A New Oral Phosphodiesterase Type 5 Inhibitor, for Treatment of Erectile Dysfunction
      2248. ED PHARMACOTHERAPY: Flexible‐Dose Vardenafil in a Community‐Based Population of Men Affected by Erectile Dysfunction: A 12‐Week Open‐Label, Multicenter …
      2249. ED-71: a promising new candidate for the treatment of osteoporosis?
      2250. ED: Efficacy and Safety of Daily Tadalafil in Men with Erectile Dysfunction Previously Unresponsive to On‐demand Tadalafil
      2251. eDiary and Female sexual Distress Scale© in Evaluating Distress in hypoactive sexual desire Disorder (HSDD)
      2252. Edible halophytes of the Mediterranean basin: Potential candidates for novel food products
      2253. Editorial (Thematic Issue: Frontier View on Drug Discoveries for Different Diseases-Part I)
      2254. editorial boards of Emotion, Personality and Social Psychology Bul-letin, and Social and Personality Psychology Compass. Lisa Feldman Barrett, PhD, is …
      2255. Editorial Comment on “Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to …
      2256. Editorial comment on” Psychology treatment trials for hypoactive sexual desire disorder: A sexual medicine critique and perspective”.
      2257. Editorial comments on” The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.”
      2258. EDUCATION
      2259. Education among Iranian Women with Breast Cancer: A Randomized Clinical Trial
      2260. Education based on theory of planned behavior over sexual function of women with breast cancer in Iran
      2261. Education Committee Mission Statement
      2262. Education in sexual medicine: proceedings from the international consultation in sexual medicine, 2009
      2263. EDUCATION: sexual Counseling for Women in the Context of Physical Diseases—A Teaching Model for Physicians
      2264. Educational objectives for a junior psychiatry clerkship
      2265. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality
      2266. Effect of a change in housing conditions on body weight, behavior and brain neurotransmitters in male C57BL/6J mice
      2267. Effect of a multi-ingredient based food supplement on sexual function in women with low sexual desire
      2268. Effect of a single dose of levodopa on sexual response in men and women
      2269. Effect of acupuncture of different acupoints on electrical activities of hypothalamic sexual arousal stimulation-related neurons at different stages of oestrous cycle in …
      2270. Effect of androgens combined with hormone therapy on quality of life in post-menopausal women with sexual dysfunction
      2271. Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106
      2272. Effect of auriculotherapy on pain and sexual function of primary dysmenorrhea female patients
      2273. Effect of breast augmentation mammoplasty on self-esteem and sexuality: a quantitative analysis
      2274. Effect of Bremelanotide on Ambulatory Blood Pressure When Administered for Up to 16 Consecutive Days [14B]
      2275. Effect of Brexpiprazole on Prolactin and sexual Functioning: An Analysis of Short-and Long-Term Study Data in Major Depressive Disorder
      2276. Effect of bupropion on sexual dysfunction
      2277. Effect of Damiana extract on the electric activity of a female brain. A case report
      2278. Effect of depression and antidepressants on sexual dysfunction in men with diabetes: a national population-based cohort study
      2279. Effect of diabetes mellitus on female sexual function and risk factors
      2280. Effect of diabetes mellitus on sexual arousal and intercourse
      2281. Effect of educational program to encourage safe sexual behaviors among addicted men refered to substance abuse treatment centers in Hamadan, Western Iran …
      2282. Effect of Evidence-Based Nursing intervention on Quality of sexual Function among Vaginal introitus laxity Women
      2283. Effect of Flibanserin on sexual Functioning: An Analysis of Female sexual Function Index Domains [24H]
      2284. Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with hypoactive sexual desire Disorder: A Post Hoc Analysis
      2285. Effect of Genetic Polymorphism on the Response to PDE5 Inhibitors in Patients With Erectile Dysfunction: A Systematic Review and a Critical Appraisal
      2286. Effect of hormone replacement therapy on clitoral artery blood flow in healthy postmenopausal women
      2287. Effect of hyperprolactinemia in male patients consulting for sexual dysfunction
      2288. Effect of hyperprolactinemia in male patients consulting for sexual dysfunction
      2289. Effect of infertility on sexual function: a cross-sectional study
      2290. Effect of infertility on the sexual function of couples: state of the art
      2291. Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study
      2292. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women
      2293. Effect of intravaginal prasterone on sexual dysfunction in postmenopausal women with vulvovaginal atrophy
      2294. Effect of laparoscopic hysterectomy on sexual function and quality of life: 12-month follow-up results
      2295. Effect of Lepidium meyenii (MACA) on sexual desire and its absent relationship with serum testosterone levels in adult healthy men
      2296. Effect of levitra on sustenance of erection (EROS): an open-label, prospective, multicenter, single-arm study to investigate erection duration measured by …
      2297. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial
      2298. Effect of long‐term testosterone administration on the endometrium of female‐to‐male (FtM) transsexuals
      2299. Effect of Melissa officinalis (lemon balm) on sexual dysfunction in women: A double-blind, randomized, placebo-controlled study
      2300. Effect of metabolic syndrome on fertility of male type 2 diabetic mice
      2301. Effect of midurethral sling surgery on vaginal sensation
      2302. Effect of normative masculinity on males’ dysfunctional sexual beliefs, sexual attitudes, and perceptions of sexual functioning
      2303. Effect of oral hormone therapy on oxidative stress produced by hot flashes in postmenopausal women
      2304. Effect of Pre-marital sexual Counseling on Self-efficacy and sexual Function of Iranian Newlywed Women
      2305. Effect of premature menopause on sexuality
      2306. Effect of radiotherapy for rectal cancer on female sexual function: a prospective cohort study
      2307. Effect of radiotherapy for rectal cancer on ovarian androgen production
      2308. Effect of sex education, based on the theory of planned behavior, on the sexual function of the woman attending Mashhad health centers
      2309. Effect of sex hormones on brain connectivity related to sexual function in perimenopausal women: a resting-state fMRI functional connectivity study
      2310. Effect of sexual diary keeping and self-evaluation on female sexual function and depression: a pilot study
      2311. Effect of sexual Dysfunction and Its Treatment on Quality of Life of Affected Men
      2312. Effect of sexual Educational Package on Knowledge and Female sexual Function for Pregnant Women
      2313. Effect of sexual function on health-related quality of life mediated by depressive symptoms in cardiac rehabilitation. findings of the SPARK project in 493 patients
      2314. Effect of Shift Working on Depression Prevalence and sexual Life of Female Nurses: A Correlational Study in Turkey
      2315. Effect of sildenafil citrate on women affected by sexual dysfunction referred to health clinics
      2316. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder
      2317. Effect of single-session, cryogen-cooled monopolar radiofrequency therapy on sexual function in women with vaginal laxity: the VIVEVE I trial
      2318. Effect of single-treatment, surface-cooled radiofrequency therapy on vaginal laxity and female sexual function: the VIVEVE I randomized controlled trial
      2319. Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction
      2320. Effect of testosterone on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro
      2321. Effect of the 5‐HT2A/2C receptor agonist DOI on female rat sexual behavior
      2322. Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in …
      2323. Effect of thyroid hormone derangements on sexual function in men and women
      2324. Effect of two brain serotonin depletors on the sexual behavior of male rats.
      2325. Effect of vaginal electrical stimulation on female sexual functions: a randomized study
      2326. Effect of Vitex agnus-castus plant on sexual function in women of reproductive age
      2327. Effect size in efficacy trials of women with decreased sexual desire
      2328. Effective factors on sexual dysfunction in women with diabetes: a systematic review
      2329. Effective Factors on sexual Quality of Life in Iranian Women: A Path Model
      2330. Effective Manual Therapy Intervention for
      2331. Effective treatment of erectile dysfunction with vardenafil
      2332. Effectiveness cognitive therapy based on mindfulnesson the sexual and familial function of sexless women
      2333. Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women
      2334. Effectiveness of a Multi-Dimensional Group Counseling Program Based on the GATHER Approach on the Quality of Life in Surgically Menopausal Women
      2335. Effectiveness of a PLISSIT model intervention in patients with type 2 diabetes mellitus in primary care: design of a cluster-randomised controlled trial
      2336. Effectiveness of a sex education program on sexual function in postmenopausal women with sexual dysfunction: A randomized trial
      2337. Effectiveness of Behavioral Activation Treatment in Reduction of Anxiety and Depression of Premenopausal Women
      2338. Effectiveness of Behavioral Activation Treatment in Reduction of Anxiety and Depression of Premenopausal Women
      2339. Effectiveness of behavioral activation treatment on marital intimacy and sexual satisfaction of women during premenopause
      2340. Effectiveness of botulinum neurotoxin on treatment of vaginismus and overall sexual functioning
      2341. Effectiveness of Healthy sexual Behavior in the sexual Dysfunction of Addicted Women
      2342. Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women
      2343. Effectiveness of Korean Medicine Therapy for Parkinson’s Disease Management: National Health Insurance Service-National Sample Cohort (NHIS-NSC)
      2344. Effectiveness of Self Instructional Module on Coping Strategies of Tri-Dimensional Problems of Premenopausal Women–A Community Based Study
      2345. Effectiveness of sexual skills education on sexual attitude and knowledge in married women
      2346. Effectiveness of sexual Skills Training with an Eclectic Approach for Improving sexual Function in Iranian Women
      2347. Effectiveness of structured teaching programme on alternative remedies for menopausal symptoms among women between the age group of 45–55 years in a …
      2348. Effectiveness of treatments of sexual disorders
      2349. Effects and Management of Pelvic Radiation on Female Reproductive System: sexual Dysfunction, Fertility Effects, and Premature Menopause
      2350. Effects of 17 α-methyltestosterone on transcriptome, gonadal histology and sex steroid hormones in rare minnow Gobiocypris rarus
      2351. Effects of 50 and 100 mg desvenlafaxine versus placebo on sexual function in patients with major depressive disorder: A meta-analysis
      2352. Effects of a Combination of Foeniculum vulgare, Melissa officinalis Extract, and Nigella saliva Powder on Healthy Menopausal Women with sexual …
      2353. Effects of a food product (based on Daucus carota) and education based on traditional Persian medicine on female sexual dysfunction: a randomized clinical …
      2354. Effects of a Proprietary Freeze-Dried Water Extract of
      2355. Effects of a proprietary freeze-dried water extract of Eurycoma longifolia (Physta) and Polygonum minus on sexual performance and well-being in men: A …
      2356. Effects of a transdermal testosterone metered-dose nanoemulsion in peri-and postmenopausal women: a novel protocol for treating low libido
      2357. Effects of Adenosine Monophosphate Used in Combination with L‐Arginine on Female Rabbit Corpus Cavernosum Tissue
      2358. Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant …
      2359. Effects of alcohol administered with flibanserin in healthy premenopausal women: a randomized, double-blind, single-dose crossover study
      2360. Effects of androgens on bone in men and women
      2361. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial
      2362. Effects of bacterial vaginosis and its treatment on sexual functions: A cross-sectional questionnaire study
      2363. Effects of cannabinoids on female sexual function
      2364. Effects of CBT and sex thearpy on psychosexual factors among patients with premature ejaculation
      2365. Effects of chronic cigarette and marijuana smoking on reproductive health
      2366. Effects of cognitive-behavioral therapy on sexual function in women with vaginismus disorder
      2367. Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women
      2368. Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well‐Ness (DAWN) Trial
      2369. Effects of depression, anxiety, stress, and partner relationship satisfaction on sexual dysfunction in women in the postpartum period
      2370. Effects of depressive symptoms and experimentally adopted schemas on sexual arousal and affect in sexually healthy women
      2371. Effects of different progestins in oral contraceptives on sexual function and well-being of women
      2372. Effects of Educational Program on Marital Satisfaction in Postmenopausal Women with sexual Dysfunction in Tehran; a Randomized, Controlled Trial
      2373. Effects of experimentally adopted sexual schemas on vaginal response and subjective sexual arousal: A comparison between women with sexual arousal disorder …
      2374. Effects of expressive writing on sexual dysfunction, depression, and PTSD in women with a history of childhood sexual abuse: Results from a randomized clinical trial
      2375. Effects of female genital cutting on the sexual function of Egyptian women. A cross‐sectional study
      2376. Effects of female genital mutilation/cutting on the sexual function of Sudanese women: a cross-sectional study
      2377. Effects of flibanserin on appetitive and consummatory aspects of sexual behavior in ovariectomized female rats primed with estrogen and progesterone
      2378. Effects of flibanserin on the pharmacokinetics of a combined ethinylestradiol/levonorgestrel oral contraceptive in healthy premenopausal women: A …
      2379. Effects of hormone replacement therapy on sexual psychophysiology and behavior in postmenopause
      2380. Effects of hormone therapy on blood pressure
      2381. Effects of hormone treatment on sexual functioning in postmenopausal women
      2382. Effects of hyperthyroidism, hypothyroidism, and thyroid autoimmunity on female sexual function
      2383. Effects of hypoactive sexual desire disorder in women
      2384. Effects of hypothyroidism and subclinical hypothyroidism on sexual function: a meta-analysis of studies using the female sexual function index
      2385. Effects of hysterectomy on sexual function
      2386. Effects of individual differences on the efficacy of different distracters during visual sexual stimulation in women
      2387. Effects of intra-nasally administered testosterone on sexual proceptive behavior in female capuchin monkeys (Cebus apella)
      2388. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals
      2389. Effects of Korean red ginseng on sexual arousal in menopausal women: placebo-controlled, double-blind crossover clinical study
      2390. Effects of long-term high dose testosterone administration on vaginal epithelium structure and estrogen receptor-α and-β expression of young women
      2391. Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships
      2392. Effects of mindfulness-based therapies for female sexual dysfunction: A meta-analytic review
      2393. Effects of neonatal domoic acid treatment and social isolation rearing on measures of attentional processing in rats: An investigation of the “two-hit” hypothesis …
      2394. Effects of oral vs transdermal estrogen therapy on sexual function in early postmenopause: ancillary study of the Kronos Early Estrogen Prevention Study (KEEPS)
      2395. Effects of Oral vs Transdermal Estrogen Therapy on sexual Function in Early Postmenopause: Results from the Kronos Early Estrogen Prevention Study …
      2396. Effects of ovariectomy and dehydroepiandrosterone (DHEA) on vaginal wall thickness and innervation
      2397. Effects of percutaneous tibial nerve stimulation therapy on chronic pelvic pain
      2398. Effects of physical and depressive symptoms on the sexual life of Turkish women in the climacteric period
      2399. Effects of Physiologic Testosterone Replacement on Quality of Life, Self-Esteem, and Mood in Women with Primary Ovarian Insufficiency
      2400. Effects of Pornography Use and Demographic Parameters on sexual Response during Masturbation and Partnered sex in Women
      2401. Effects of predisposing factors on the success and treatment period in vaginismus
      2402. Effects of pregnancy on female sexual function and body image: A prospective study
      2403. Effects of reproductive history on symptoms of menopause: a brief report
      2404. Effects of sacral neuromodulation on female sexual function
      2405. Effects of sex education and Kegel exercises on the sexual function of postmenopausal women: a randomized clinical trial
      2406. Effects of sex hormones in combined oral contraceptives and cyclofem on female sexual dysfunction score: A study on Iranian Females
      2407. Effects of sex hormones in oral contraceptives on the female sexual function score: a study in German female medical students
      2408. EFFECTS OF SMOKING CESSATION ON sexual HEALTH IN MEN
      2409. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight
      2410. Effects of testosterone and estrogen replacement on memory function
      2411. Effects of testosterone on female rat sexual behavior
      2412. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study
      2413. Effects of testosterone therapy for women: a systematic review and meta-analysis protocol
      2414. Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism
      2415. Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals
      2416. Effects of the addition of methyltestosterone to combined hormone therapy with estrogens and progestogens on sexual energy and on orgasm in postmenopausal …
      2417. Effects of Therapeutic-Supportive Interventions on sexual Satisfaction and Function in Women with Breast Cancer: A Systematic Review
      2418. effects of tibolone versus low dose e
      2419. Effects of timing of flibanserin administration relative to alcohol intake in healthy premenopausal women: A randomized, double-blind, crossover study
      2420. Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study
      2421. Effects of transobturator midurethral sling surgery on sexual functions: one-year follow-up
      2422. Effects of urinary incontinence subtypes on women’s sexual function and quality of life
      2423. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy post-menopausal women with vaginal symptoms …
      2424. Effects of yoga on sexual function in women with metabolic syndrome: a randomized controlled trial
      2425. Effects on the quality of life of a new oral contraceptive containing 30 mcg EE and 3 mg drospirenone (Yasmin)
      2426. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled …
      2427. Efficacy and safety of alfuzosin 10 mg once daily in the treatment of symptomatic benign prostatic hyperplasia
      2428. Efficacy and safety of alprostadil cream for the treatment of female sexual arousal disorder: A double‐blind, placebo‐controlled study in Chinese population
      2429. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Improving sexual Function in Women: a double-‐blind, randomized, placebo …
      2430. Efficacy and safety of Ashwagandha (Withania somnifera) root extract in improving sexual function in women: a pilot study
      2431. Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: results from a …
      2432. Efficacy and safety of daily intake of apomorphine SL in men affected by erectile dysfunction and mild hyperprolactinemia: a prospective, open-label, pilot study
      2433. Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra®) in the treatment of erectile dysfunction in Brazilian and Mexican men
      2434. Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis
      2435. Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial
      2436. Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: a systematic review and meta-analysis
      2437. Efficacy and safety of flibanserin” new female Viagra®?”: Literature review
      2438. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally
      2439. Efficacy and safety of MED2005, a topical glyceryl trinitrate formulation, in the treatment of erectile dysfunction: a randomized crossover study
      2440. Efficacy and safety of mirodenafil in men taking antihypertensive medications
      2441. Efficacy and safety of on demand clomipramine for the treatment of premature ejaculation: a multicenter, randomized, double-blind, phase III clinical trial
      2442. Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials
      2443. Efficacy and safety of oral sildenafil citrate (Viagra®) in the treatment of male erectile dysfunction in Colombia, Ecuador, and Venezuela: a double-blind, multicenter …
      2444. Efficacy and safety of oral SK3530 for the treatment of erectile dysfunction in Korean men: a multicenter, randomized, double‐blind, placebo‐controlled, fixed dose …
      2445. Efficacy and safety of red ginseng on women’s health related QOL and sexual function
      2446. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder
      2447. Efficacy and safety of sildenafil in estrogenized women with sexual dysfunction associated with female sexual arousal disorder
      2448. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women
      2449. Efficacy and safety of testosterone patches for the treatment of low sexual desire in surgically menopausal women
      2450. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis
      2451. Efficacy and safety of vardenafil in men with erectile dysfunction caused by spinal cord injury
      2452. Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response …
      2453. Efficacy of acupuncture treatment of sexual dysfunction secondary to antidepressants
      2454. Efficacy of an exercise intervention for sexual side effects of antidepressant medications in women
      2455. Efficacy of Ashwagandha (Withania somnifera Dunal. Linn.) in the management of psychogenic erectile dysfunction
      2456. Efficacy of bibliotherapy as a treatment for low sexual desire in women
      2457. Efficacy of Bremelanotide Across hypoactive sexual desire Disorder Duration Subgroups [15M]
      2458. Efficacy of bremelanotide among women completing the core phase of the RECONNECT studies
      2459. Efficacy of bremelanotide for HSDD in women: RECONNECT open-label extension phase results [8Q]
      2460. Efficacy of Cognitive Behavioral Therapy on Catastrophic thoughts on Women with primary Vaginismus: A Single-Case trial
      2461. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial
      2462. Efficacy of hormone therapy with and without methyltestosterone augmentation of venlafaxine in the treatment of postmenopausal depression: a double-blind …
      2463. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast …
      2464. Efficacy of metacognitive therapy for hypoactive sexual desire disorder among Iranian couples
      2465. Efficacy of oral estrogen plus testosterone gel to improve sexual function in postmenopausal women
      2466. Efficacy of pharmacological and non-pharmacological interventions on low sexual interest/arousal of peri-and post-menopausal women: a meta-analysis
      2467. Efficacy of Physical Therapy in the Management of Reproductive Disorders
      2468. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis
      2469. Efficacy of psychosocial interventions in men and women with sexual dysfunctions—a systematic review of controlled clinical trials
      2470. Efficacy of psychosocial interventions in men and women with sexual dysfunctions—a systematic review of controlled clinical trials
      2471. Efficacy of sildenafil citrate in the treatment of female sexual dysfunction
      2472. Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin 1A receptor agonist in women with SSRI-induced sexual …
      2473. Efficacy of Tribulus terrestris for the treatment of hypoactive sexual desire disorder in postmenopausal women: a randomized, double-blinded, placebo-controlled trial
      2474. Efficacy of Tribulus Terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder: a randomized double-blinded, placebo-controlled …
      2475. Efficacy of type‐5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: A systematic review
      2476. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial
      2477. Efficacy, tolerability and safety of a new medical device, Monurelle Biogel® vaginal gel, in the treatment of vaginal dryness: a randomized clinical trial in women of …
      2478. Eighth International Thyroid Congress Sydney, Australia; February 4-8, 1980
      2479. Ejaculatory abstinence influences intravaginal ejaculatory latency time: results from a prospective randomized trial
      2480. Ejaculatory disorders
      2481. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping
      2482. Ejaculatory dysfunction
      2483. Ejaculatory Dysfunction
      2484. Ejaculatory Dysfunction and Vasodynamics
      2485. Ejaculatory Dysfunction and Vasodynamics
      2486. Ejaculatory dysfunction as a cause of infertility
      2487. Electrical stimulation in sexual dysfunction
      2488. Electroencephalographic activity during sexual behavior: a novel approach to the analysis of drug effects on arousal and motivation relevant for sexual dysfunctions
      2489. Electroencephalographic changes and testosterone levels in a pubertal stress animal model: effects on adult sexual motivation
      2490. Electrophysiological actions of the dopamine agonist apomorphine in the paraventricular nucleus during penile erection
      2491. Elevated serum testosterone, hirsutism, and virilism associated with combined androgen-estrogen hormone replacement therapy.
      2492. Elucidating Unconscious Drivers in Clandestine sexual Practices: Means and Methods for Ego-Syntonic Dynamic sexual Consent
      2493. Elucidating women’s (hetero) sexual desire: Definitional challenges and content expansion
      2494. Email: MFS96@ aol. com
      2495. EMAS position statement: managing the menopause in women with a past history of endometriosis
      2496. EMAS position statement: managing women with premature ovarian failure
      2497. Embracing Our Differences to Help Our Patients
      2498. Emerging concepts in erectile preservation following radical prostatectomy: a guide for clinicians
      2499. Emerging drugs for major depressive disorder
      2500. Emerging drugs for major depressive disorder: an update
      2501. Emerging medication for the treatment of male hypogonadism
      2502. Emerging medication for the treatment of male hypogonadism
      2503. Emerging role of testosterone in menopause
      2504. Emerging therapies for female sexual dysfunction
      2505. Emotion regulation in couples affected by female sexual interest/arousal disorder
      2506. Emotional Aspects of Gynecology
      2507. Emotional attention for erotic stimuli: Cognitive and brain mechanisms
      2508. Emotional Disturbances in Diabetes Mellitus
      2509. Emotional dysregulation: Concurrent relation to sexual problems among trauma-exposed adult cigarette smokers
      2510. Emotional functioning in Huntington’s disease patients and its relation to caregiver experience
      2511. Emotional intimacy, sexual desire, and sexual satisfaction among partnered heterosexual men
      2512. Emotional states of love moderate the association between catecholamines and female sexual responses in the laboratory
      2513. Emotional States of Love Moderate the Association Between Catecholamines and Female sexual Responses in the Laboratoryjsm_2799
      2514. Emotionally Focused Couples Therapy: A Review of the Literature.
      2515. Emotions during sexual activity: Differences between sexually functional and dysfunctional men and women
      2516. Empirically Supported
      2517. Empirically supported couple and family interventions for marital distress and adult mental health problems.
      2518. Empirically supported incentive model of sexual response ignored
      2519. Empirically supported psychological interventions: Controversies and evidence
      2520. Empirically supported treatments or type I errors? Problems with the analysis of data from group-administered treatments.
      2521. EMPOWER (Empowerment and Protection Women Right) Community as Individual Approach Method to Rebuild Women’s Mentality from sexual Violence’s …
      2522. Empowering PAs to ask their female patients about sexual health
      2523. Empowering the woman: a comprehensive model of sexual anti-ageing
      2524. Encompassing sexual medicine within psychiatry: pros and cons
      2525. Endo-Depression; Definition and Suggestion’s Background.
      2526. Endocannabinoid influence on partner preference in female rats
      2527. Endocannabinoids interact with the dopaminergic system to increase sexual motivation: lessons from the sexual satiety phenomenon
      2528. Endocrine and psychological aspects of sexual dysfunction in Klinefelter patients
      2529. Endocrine aspects of female sexual dysfunction
      2530. Endocrine aspects of male sexual dysfunctions
      2531. Endocrine aspects of women’s sexual function
      2532. Endocrine care of transgender adults
      2533. Endocrine causes of erectile dysfunction
      2534. Endocrine control of ejaculation
      2535. Endocrine Disorders
      2536. Endocrine evaluation of erectile dysfunction
      2537. Endocrine Psychiatry in Historical Perspective
      2538. Endocrinologic control of men’s sexual desire and arousal/erection
      2539. Endocrinological investigation of men with erectile dysfunction
      2540. Endocrinology of human female sexuality, mating, and reproductive behavior
      2541. Endocrinology of women sexual health
      2542. ENDOCRINOLOGY: a comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction
      2543. Endocrinology: Androtest©: a structured interview for the screening of hypogonadism in patients with sexual dysfunction
      2544. ENDOCRINOLOGY: NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction
      2545. Endocrinology: Transdermal Testosterone Gel prn application for hypoactive sexual desire disorder in premenopausal women: A controlled pilot study of the effects on …
      2546. ENDOCRINOLOGY: Vaginal Application of Testosterone: A Study on Pharmacokinetics and the sexual Response in Healthy Volunteers
      2547. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women
      2548. Endogenous sex hormone levels and coronary heart disease risk in postmenopausal women: A meta-analysis of prospective studies
      2549. Endogenous testosterone levels and cardiovascular risk: meta-analysis of observational studies
      2550. Endometrial hyperplasia, estrogen therapy, and the prevention of endometrial cancer
      2551. Endometriosis and women’s sexual functioning: a systematic review of the available evidence
      2552. Endometriosis doubles the risk of sexual dysfunction: a cross-sectional study in a large amount of patients
      2553. Endorsement of models describing sexual response of men and women with a sexual partner: An online survey in a population sample of Danish adults ages 20–65 …
      2554. Endothelial function analysis can predict which patients will have arterial insufficiency on penile duplex ultrasound
      2555. Endothelin I activates the NAADP signaling complex on myometrial smooth muscle cell
      2556. Endurance exercise training and male sexual libido
      2557. Enhanced patient activation in cancer care transitions: protocol for a randomized controlled trial of a tailored electronic health intervention for men with …
      2558. Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes
      2559. Enhancing care of the survivor of gynecologic cancer: managing the menopause and radiation toxicity
      2560. Enhancing sexual desire and intimacy via the metaphor of a problem child: Utilizing structural-strategic family therapy
      2561. Enhancing sexuality: A problem-solving approach therapist guide
      2562. Environmental exposure to di-2-ethylhexyl phthalate is associated with low interest in sexual activity in premenopausal women
      2563. Environmental Factors within the Assessment Process. PUB DATE 1996-00-00
      2564. Environmental Mismatches and Mating Effectiveness
      2565. Enzymatic Synthesis of Anabolic Steroid Glycosides by Glucosyltransferase from Terribacillus sp. PAMC 23288
      2566. Enzyme inhibitory activities of plant extracts under the Philippine’s drug discovery program
      2567. Epidemiology
      2568. Epidemiology and neurobiology of female sexual dysfunction
      2569. Epidemiology and pathophysiology of male sexual dysfunction
      2570. Epidemiology of delayed ejaculation
      2571. Epidemiology of female sexual dysfunction
      2572. Epidemiology of male sexual dysfunction
      2573. Epidemiology of Male sexual Dysfunction in Asian and European Regions: A Systematic Review
      2574. Epidemiology of sexual disorders in general medical practice: an Italian survey
      2575. Epidemiology of sexual dysfunction in Iran: A systematic review and meta-analysis
      2576. Epidemiology of sexual dysfunction in the male population
      2577. Epidemiology of sexual dysfunction: the role of psychosocial factors
      2578. Epidemiology of the symptoms of menopause–an intercontinental review
      2579. Epidemiology: Correlates of sexually related personal distress in women with low sexual desire
      2580. EPIDEMIOLOGY: sexual desire in a Nationally Representative Danish Population
      2581. EPIDEMIOLOGY: The HSDD Registry for Women: A Novel Patient Registry for Women with Generalized Acquired hypoactive sexual desire Disorder
      2582. epidemiology: the prevalence of sexual dysfunction and potential risk factors that may impair sexual function in Malaysian women
      2583. Epidemiology: What can prevalence studies tell us about female sexual difficulty and dysfunction?
      2584. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology
      2585. Epilepsy and sexual dysfunction
      2586. Epilogue: Cautiously optimistic for the future of a transdisciplinary sexual medicine
      2587. Epilogue: Challenges in Research Methods and Future Directions on sexual and Gender Minority Mental Health Research
      2588. Epistemic injustice and psychiatric classification
      2589. Erectile Dysfunction
      2590. Erectile dysfunction
      2591. Erectile dysfunction
      2592. Erectile dysfunction
      2593. Erectile Dysfunction
      2594. Erectile dysfunction among HIV patients undergoing highly active antiretroviral therapy: dyslipidemia as a main risk factor
      2595. Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido
      2596. Erectile Dysfunction and Anejaculation in the Neurologic Patient
      2597. Erectile dysfunction and associated risk factors among young Mexican adults: The importance of partner availability
      2598. Erectile dysfunction and cardiovascular risk: a review of current findings
      2599. Erectile dysfunction and central obesity: an Italian perspective
      2600. Erectile dysfunction and comorbid diseases, androgen deficiency, and diminished libido in men
      2601. Erectile dysfunction and premature ejaculation in homosexual and heterosexual men: a systematic review and meta-analysis of comparative studies
      2602. Erectile dysfunction can have a devastating effect on a relationship. Safe and effective treatment is available
      2603. Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment
      2604. Erectile dysfunction in men with chronic medical illness
      2605. Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education
      2606. Erectile dysfunction is common among men with acromegaly and is associated with morbidities related to the disease
      2607. Erectile Dysfunction, An Issue of Urologic Clinics-E-Book
      2608. Erectile dysfunction, depression, and pharmacological treatments: biologic interactions
      2609. Erectile dysfunction: a review and herbs used for its treatment
      2610. ERECTILE DYSFUNCTION: The Associations Among eNOS G894T Gene Polymorphism, Erectile Dysfunction, and Benign Prostate Hyperplasia‐Related Lower …
      2611. Erectile dysfunction: why drug therapy isn’t always enough
      2612. Erectile failure in the aged: evaluation and treatment
      2613. Erectile response with vardenafil in sildenafil nonresponders: A multicentre, double‐blind, 12‐week, flexible‐dose, placebo‐controlled erectile dysfunction …
      2614. Erection
      2615. ERECTION HARDNESS SCORE AND PERCEIVED FAMILY FUNCTIONING OF MEN WITH ERECTILE DYSFUNCTION IN EKU BAPTIST HOSPITAL, DELTA STATE
      2616. Erotica viewing effects on intimate relationships and self/partner evaluations
      2617. ERPs reveal disengagement processes related to condom use embarrassment in intention-behavior inconsistent young adults
      2618. Errata by Fabre et al. in Gepirone‐ER Treatment of hypoactive sexual desire Disorder Associated with Depression in Women
      2619. ERRATAjsm_1535 3225
      2620. ERRATUMjsm_1759 856
      2621. ESHRE Guideline: management of women with premature ovarian insufficiency
      2622. Essential assessment skills for couple and family therapists
      2623. Essential concepts for healthy living update
      2624. Essential Evidence Topics January 2015 North Dakota Academy of Family Physicians Big Sky, Montana
      2625. Essential Oils & Healthy Menopause: History and Research Secrets
      2626. Essentials of female sexual dysfunction from a sex therapy perspective
      2627. Essentials of psychiatric diagnosis: Responding to the challenge of DSM-5
      2628. Essentials of psychiatric nursing
      2629. Establishing a cohort of transgender men and gender nonconforming individuals to understand the molecular impact of testosterone on breast physiology
      2630. Establishing consensus on residency education in women’s health
      2631. Estetrol review: profile and potential clinical applications
      2632. Estimating the Prevalence of sexual Dysfunction Using the New ICD-11 Guidelines.
      2633. Estimating the prevalence of sexual function problems: The impact of morbidity criteria
      2634. Estradiol modulates Kiss1 neuronal response to ghrelin
      2635. Estradiol Regulation of Kiss1 Neurons
      2636. Estradiol Sensitization of sexual Behaviors in the Ovariectomized Rat: Mechanisms and Applications
      2637. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.
      2638. Estrogen and transdiagnostics: a systematic review
      2639. Estrogen implants: embodiments of deeper problems in the marketing of drugs
      2640. Estrogen replacement therapy for the treatment of postmenopausal genitourinary tract dysfunction
      2641. Estrogen-androgen for hormone replacement. A review.
      2642. Estrogens, androgens, and the hormonal modulation of female primate sexual motivation in rhesus monkeys
      2643. Ethical aspects of sexual medicine. Internet, vibrators, and other sex aids: toys or therapeutic instruments?
      2644. Ethical Decision Making in Geriatric Medicine
      2645. Ethical dilemmas: Abstracts of papers from 15th anniversary meeting of society for sex therapy and research, New York, March 18–20, 1988
      2646. Ethics and sex therapy: A neglected dimension.
      2647. Ethno-survey of traditional use of plants as aphrodisiacs in Kashmir Himalaya, India
      2648. Ethnobotanical study of medicinal plants used in the treatment of sexual dysfunctions in traditional medicine in Kampemba-Lubumbashi, DR Congo
      2649. Ethnobotanical Survey of Medicinal Plants Used For the Management of Male sexual Dysfunction and Infertility in Tana River County, Kenya
      2650. Etiological factors in female hypoactive sexual desire disorder
      2651. Etiological Perspectives of ABDL Behavior from Members of an Online ABDL Community
      2652. Etiology and management of sexual dysfunction
      2653. Etiology and Management of sexual Dysfunction
      2654. Etiology and Risk Factors of Erectile Dysfunction
      2655. Etiology of female sexual dysfunction
      2656. Etonogestrel contraceptive implant-associated secondary anorgasmia
      2657. European association of urology guidelines for sexual and reproductive health 2020: what is new?
      2658. European Society for sexual Medicine position statement “Assessment and hormonal management in adolescent and adult trans people, with attention for sexual …
      2659. Evaluate models of high-frequency sexual behaviors already
      2660. Evaluating a couple-based intervention addressing sexual concerns for breast cancer survivors: study protocol for a randomized controlled trial
      2661. Evaluating benefits and harms of screening
      2662. Evaluating benefits and harms of screening-the streetlight effect?
      2663. Evaluating changes in sexual functioning in depressed patients: sensitivity to change of the CSFQ
      2664. Evaluating Consumer Health Information: What Fails to Harm Us Makes Us Smarter
      2665. Evaluating erectile dysfunction: Don’t forget hypofunctional thyroid
      2666. Evaluating medications for women
      2667. Evaluating sexual dysfunction in women
      2668. Evaluating the quality of websites offering information on female hypoactive sexual desire disorder
      2669. Evaluating the relationship between women’s sexual desire and satisfaction from a biopsychosocial perspective
      2670. Evaluating the sexual experience in men: validation of the sexual experience questionnaire
      2671. Evaluation and management of female sexual dysfunction
      2672. Evaluation and management of hypoactive sexual desire disorder
      2673. Evaluation and treatment of female sexual disorders
      2674. Evaluation and treatment of orgasmic dysfunction
      2675. Evaluation and Treatment of sexual Disorders Due to Medical Conditions
      2676. Evaluation and treatment of substance/medication-induced sexual dysfunction
      2677. Evaluation of a cognitive behavior therapy program for people with sexual dysfunction
      2678. Evaluation of a sexual health approach to prevent HIV among low income, urban, primarily African American women: results of a randomized controlled trial
      2679. Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability
      2680. Evaluation of changes in sexual response and factors influencing sexuality during pregnancy among Nigerian women in Jos, Nigeria
      2681. Evaluation of clinical effects of microsurgical subinguinal varicocelectomy with and without testicular delivery
      2682. Evaluation of different electrophysiological studies in the detection of urinary and sexual dysfunction in diabetic women
      2683. Evaluation of Erectile Disorder
      2684. Evaluation of female orgasmic disorder
      2685. evaluation of female sexual function after vaginal surgery with the FSFi (Female sexual Function index): our experience
      2686. Evaluation of female sexual function in persons with type 2 diabetes mellitus seen in a tertiary hospital in Southeast Nigeria with emphasis on its frequency and …
      2687. Evaluation of female sexual interest/arousal disorder
      2688. Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications
      2689. Evaluation of flibanserin: science and advocacy at the FDA
      2690. Evaluation of male fertility-enhancing activities of water seed extract of hunteria umbellata in wistar rats
      2691. Evaluation of Male hypoactive sexual desire Disorder
      2692. Evaluation of Male sexual Dysfunction
      2693. Evaluation of Obesity Influence in the sexual Function of Postmenopausal Women: A Cross-Sectional Study
      2694. Evaluation of Phosphodiesterase-5 Inhibitory Potential of Biofield Energy Treated DMEM by Determining cGMP Level in Human Endothelial Cell Line
      2695. Evaluation of premature ejaculation
      2696. Evaluation of prevalence of sexual dysfunctions and its related factors in women
      2697. Evaluation of prevalence of sexual dysfunctions and its related factors in women.
      2698. Evaluation of quality of life and sexual satisfaction in women suffering from chronic pelvic pain with or without endometriosis
      2699. Evaluation of results from a single session psychotherapeutic intervention in population affected by the Colombian internal armed conflict, 2009
      2700. Evaluation of safety for flibanserin
      2701. Evaluation of sexual dysfunction and its associated risk factors in the male partners of the infertile couples using International Index of Erectile Function
      2702. Evaluation of sexual dysfunction in LUTS/BPH patients.
      2703. Evaluation of sexual dysfunction in men with spinal cord injury using the male sexual quotient
      2704. Evaluation of sexual function and quality of life in Iranian women with tubal ligation: a historical cohort study
      2705. Evaluation of sexual Function in Breast Cancer Survivors Using Female sexual Function Index: A Systematic
      2706. Evaluation of sexual function in postmenopause women with metabolic syndrome
      2707. Evaluation of sexual function in women with deep infiltrating endometriosis
      2708. Evaluation of sexual function in women with labia minora hypertrophy: a preliminary study
      2709. Evaluation of spermatogenic, aphrodisiac and anti-oxidant activity of classical siddha drug Thathu Viruthi Chooranam in rodents
      2710. Evaluation of student pharmacists’ ability and confidence using drug information resources to analyze drug–drug interactions
      2711. Evaluation of Testosterone Hormone Level in Healthy Obese Subjects in Khartoum State
      2712. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder
      2713. Evaluation of the effect of carrot seed (Daucus Carota) in women of fertile age with hypoactive sexual desire disorder: A randomized double-blind clinical trial
      2714. Evaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction—a prospective, randomized, double-blind, placebo-controlled clinical trial
      2715. Evaluation of the female sexual dysfunction in a sample of iranian infertile women
      2716. Evaluation of the female sexual function after vaginal surgery using the FSFI (Female sexual Function Index)
      2717. Evaluation of the female sexual function index in a population based sample from Finland
      2718. Evaluation of the female with sexual dysfunction
      2719. Evaluation of the Hamburg model of couple therapy in the treatment of low sexual desire and vaginismus. A prospective group comparison
      2720. Evaluation of the mistakes in self-diagnosis of sexual dysfunctions in 11,000 male outpatients: a real-life study in an andrology clinic
      2721. Evaluation of the patient with erectile dysfunction
      2722. Evaluation of the quality of life and sexual functioning of women using a 30-μg ethinyloestradiol and 3-mg drospirenone combined oral contraceptive
      2723. Evaluation of the Safety and Efficacy of Hybrid Fractional 2940 nm and 1470 nm Lasers for Treatment of Vaginal Tissue: Pilot Study
      2724. Evaluation of the sexual desire Relationship Distress Scale (SDRDS) in women with hypoactive sexual desire disorder
      2725. Evaluation of the sildenafil effect on female sexual dysfunction
      2726. Evaluation of young men with organic erectile dysfunction
      2727. Evaluation Systems of Female sexual Function
      2728. Evening the score on sex drugs: feminist movement or marketing masquerade?
      2729. Event monitoring in the UK
      2730. Everything you always wanted to know about sex and Neurology: neurological disability and sexuality
      2731. Evidence & ethics: Once more into the fray
      2732. Evidence and health policy: using and regulating systematic reviews
      2733. Evidence and opinion: finding the proper balance
      2734. Evidence Based Review of Hysterectomy and sexuality
      2735. Evidence based review of medicines for sexual dysfunction in females: A report commissioned by the New Zealand
      2736. Evidence for centrally initiated genital vasocongestive engorgement in the female rat: Findings from a new model of female sexual arousal response
      2737. Evidence for the efficacy and effectiveness of systemic family therapy
      2738. Evidence for the possible occurrence of Grave’s disease in a blue-eyed black lemur (Eulemur flavifrons)
      2739. Evidence that relationship quality, social support, and SSRI use do not account for the shared underlying relationships among symptoms of depression, anxiety, and …
      2740. Evidence-based practice for nurse practitioner students: a competency-based teaching framework
      2741. Evidence-Based Practice Summary Benefits and Harms of Flibanserin and Testosterone for the Treatment of Low Libido in Menopausal Women
      2742. Evidence-Based Practice Summary Hormone therapy for menopausal women with low libido
      2743. Evidence-Based Practice Summary Prevalence of low libido in US menopausal women and women who have been treated for cancer
      2744. Evidence-based reproductive toxicity of propylthiouracil-induced hypothyroidism in sexually experienced male rats.
      2745. Evidence-based treatments for low sexual desire in women
      2746. Evolution of flow-oriented design strategies in the continuous preparation of pharmaceuticals
      2747. EVOLUTION OF sexual HEALTH IN PARKINSON
      2748. Evolutionary Perspectives on hypoactive sexual desire Disorder in Women
      2749. Evolving techniques to evaluate ejaculatory function
      2750. Evşen NAZİK1
      2751. Ex‐centric textualities and rehearsed narratives at a gender identity clinic in Brazil: Challenging discursive colonization
      2752. Examination of the effect of COVID‐19 on sexual dysfunction in women
      2753. EXAMINATION OF THE SIMILARITIES AND DISSIMILARITIES BETWEEN HYPERsexualITY AND PROBLEMATIC PORNOGRAPHY USE
      2754. Examining Clinician Attitudes on sexual Health Assessment After an Educational Intervention
      2755. Examining relationship quality across three types of relationship agreements
      2756. Examining the Relationship Between Antecedents of sexuality and Women’s Reported Level of sexual Satisfaction During the First Five Years of Marriage
      2757. Examining the Relationships between Men’s and Women’s Motives for Pretending Orgasm and Levels of sexual desire, and Relationship and sexual Satisfaction
      2758. Examining the sexual function and related attitudes among aged women: A cross-sectional study
      2759. Executive summary of the consensus statement on assistance to women with HIV infection in the health care sector
      2760. Exercise improves sexual function in women taking antidepressants: results from a randomized crossover trial
      2761. Exercise Predictors of Self-Reported sexual Performance among Healthy Adults
      2762. Existential Group Therapy: Therapy Illustrations
      2763. Existing and future educational needs in graduate and postgraduate education
      2764. Exit Survey of Women with HSDD Treated With Bremelanotide Demonstrated Meaningful Treatment Benefits [28G]
      2765. Exo-clinical trials of nutritional supplements for sexual dysfunction: Precedents, Principles, and protocols
      2766. Exotic dance: An exploratory study of disordered eating, substance abuse, and disembodiment
      2767. Expanding Access to sexual and Reproductive Health Care in Alternative Primary Care Settings
      2768. Expanding the analysis of psychosocial factors of sexual desire in men
      2769. Expansion of the concept of mental disorder in the DSM-5
      2770. Experience, meaning, and identity in sexuality: A psychosocial theory of sexual stability and change
      2771. Experiences of Menopause on sexual Intimacy and Coping Strategies Used among Karen Married Women
      2772. Experimental models for the study of female and male sexual function
      2773. Experimental models in sexual medicine: eight best practices
      2774. Expert commentary B: Asexuality: Dysfunction or variation?
      2775. Expert opinion on existing and developing drugs to treat female sexual dysfunction
      2776. Expert Reviews Ovarian conservation vs removal at the time of benign hysterectomy
      2777. Experts debate—should DSM-V raise the bar for female sexual dysfunction diagnosis?
      2778. Experts Publish sexual Dysfunction Guidelines
      2779. Explorations of a sex Therapy Question in Feminism: Feminist Interventions in sex Therapy
      2780. EXPLORATORY RESEARCH PROJECT-PN-II-ID-PCE-2011-3-0784
      2781. Exploring a biopsychosocial model of women’s sexual problems
      2782. Exploring erotic plasticity as an individual difference variable: Theory and measurement
      2783. Exploring factors in the relationship balance assessment
      2784. Exploring Female sexuality
      2785. Exploring hypersexual behavior in men with Parkinson’s disease: is it compulsive sexual behavior?
      2786. Exploring men’s perceptions of a community-based men’s shed programme in England
      2787. Exploring psychotherapists’ perceptions of the impact of childhood sexual abuse on adult intimate relationships.
      2788. Exploring reasons why men and women refrain from sex despite desire
      2789. Exploring sexual behaviors and health communication among older women
      2790. Exploring sexual dysfunction in the menopausal woman
      2791. Exploring sexuality attitudes and knowledge in nursing: An education program
      2792. Exploring the continuum: medical information to effective clinical practice*. Paper II. Towards aetiology‐centred clinical practice
      2793. Exploring the functions of chemical substances in individuals’ sexual behaviour
      2794. Exploring the relationship between sexual function, sense of coherence, and well-being in a sample of Iranian breast cancer survivors
      2795. Exploring the role of sexual avoidance in male sexual dysfunction
      2796. Exposing orgasm in the brain: a critical eye
      2797. Exposure to an anabolic steroid changes female mice’s sexual responses according to sex partner
      2798. Exposure to methylphenidate during peri-adolescence affects endocrine functioning and sexual behavior in female Long–Evans rats
      2799. Exposure to sexualized media content and selective attention for sexual cues: An experimental study
      2800. Expression and distribution of phosphodiesterase isoenzymes in the human seminal vesicles
      2801. Expressions of female sexuality
      2802. Extended duration of efficacy of vardenafil when taken 8 hours before intercourse: a randomized, double-blind, placebo-controlled study
      2803. Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?
      2804. Extending the prediction of infidelity using a five-factor model
      2805. Extending therapeutic use of psychostimulants: focus on serotonin-1A receptor
      2806. EXTENT OF FEMALE PARTNER sexual FUNCTION IMPROVEMENT IN FEMALE PARTNERS OF MEN WITH PEYRONIE’S DISEASE WHO RECEIVED …
      2807. Extinction of aversive classically conditioned human sexual response
      2808. Extra-Thyroidal Factors Impacting Thyroid Hormone Homeostasis
      2809. Extraction and microencapsulation of khat: effects on sexual motivation and estradiol level in female rats
      2810. Extradyadic behaviors and gender: How do they relate with sexual desire, relationship quality, and attractiveness
      2811. Extragenital Adolescent Endometriosis
      2812. Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women
      2813. EYE DYNAMICS IN PATIENTS WITH FEMALE
      2814. EYE DYNAMICS IN PATIENTS WITH FEMALE
      2815. EYE DYNAMICS IN PATIENTS WITH FEMALE
      2816. Eye of the beholder? Sociocultural factors in the body image and sexual well-being of heterosexual women
      2817. Eyes Wide Shut: Erasing Women’s Experiences from the Clinic to the Courtroom
      2818. F52. 0 sexual dysfunction.
      2819. Facilitated early cortical processing of nude human bodies
      2820. Facilitating sexual health: Intimacy enhancement techniques for sexual dysfunction
      2821. Facilitation of proceptivity/sexual motivation in female rats by a serotonin 2A/2C (5-HT2A/2C) receptors agonist
      2822. Facilitation of sexual behavior in ovariectomized rats by estradiol and testosterone: a preclinical model of androgen effects on female sexual desire
      2823. Facilitators and barriers in sexual history taking
      2824. Facing the complexities of women’s sexual desire
      2825. Factor structure and normative data of the Greene Climacteric Scale among postmenopausal Portuguese women
      2826. Factor Structure, Reliability, and Validity of the Malay version of the sexual desire Inventory-2 (SDI-2-BM) in a Sample of Lower Urinary Tract Symptoms (LUTS) and …
      2827. Factors affecting sexual function and body image of early-stage breast cancer survivors in Poland: a short-term observation
      2828. Factors affecting sexuality in older Australian women: sexual interest, sexual arousal, relationships and sexual
      2829. Factors affecting sexuality in older Australian women: sexual interest, sexual arousal, relationships and sexual distress in older Australian women
      2830. Factors associated with common sexual concerns in women: New findings from the Canadian Contraception Study
      2831. Factors associated with low sexual desire in 45-year-old men: Findings from the German Male sex-Study
      2832. Factors associated with marital satisfaction and stability of married men and women
      2833. Factors associated with mortality after widowhood.
      2834. Factors associated with sexual arousal, sexual sensation seeking and sexual satisfaction among female African American adolescents
      2835. Factors associated with sexual dysfunction in men with HIV infection
      2836. Factors associated with sexual dysfunction in Taiwanese females with rheumatoid arthritis
      2837. Factors associated with sexual function in Iranian women with type 2 diabetes mellitus: partner relationship as the most important predictor
      2838. Factors associated with sexual health and well being in older adulthood
      2839. Factors associated with specific diagnostic and statistical manual of mental disorders, sexual dysfunctions in breast cancer survivors: a study of patients and their …
      2840. Factors associated with specific DSM-IV sexual dysfunctions among breast cancer survivors: A study of patients and their partners
      2841. Factors associated with the age of natural menopause and menopausal symptoms in Chinese women
      2842. Factors impacting women’s sexual desire: Examining long-term relationships in emerging adulthood.
      2843. Factors influencing stress, anxiety, and depression among Iranian pregnant women: the role of sexual distress and genital self-image
      2844. Factors Influencing Transition to Shisheh (Methamphetamine) among Young People Who Use Drugs in Tehran: A Qualitative Study
      2845. Factors related to coital frequency of women in their thirties
      2846. Factors shaping women’s sexual satisfaction: a comparison of medical and social models
      2847. Factors that affect libido
      2848. Factors that Influence Individual Differences in Female sexual Response in a College-Aged Population
      2849. Factors that influence sexual arousal in men: A focus group study
      2850. Faculty of Health Sciences & Technology
      2851. FACULTY OF HEALTH SCIENCES SCHOOL OF MEDICINE
      2852. Fallowfield’s sexual Activity Questionnaire in women with without and at risk of cancer
      2853. False bodies, true selves: Moving beyond appearance-focused identity struggles and returning to the true self
      2854. Familiarizing Students with the Empirically Supported Treatment Approaches for Psychophysiological Disorders and Chronic Pain.
      2855. Families, mental illness, and suicide
      2856. Family Counseling and Psychotherapy
      2857. Family History for Cardio-Metabolic Diseases: A Predictor of Major Adverse Cardiovascular Events in Men With Erectile Dysfunction
      2858. Family Involved Psychosocial Treatments for Adult Mental Health Conditions: A Review of the Evidence
      2859. Family sex communication and the sexual desire, attitudes, and behavior of late adolescents
      2860. Fast and slow sexual strategies are not opposites: Implications for personality and psychopathology
      2861. Fatigue and cognition-hormonal perspectives
      2862. Fatigue is associated with high prevalence and severity of physical and emotional symptoms in patients on chronic hemodialysis
      2863. FDA advisers to assess drug for low sexual desire in women
      2864. FDA approval of flibanserin—treating hypoactive sexual desire disorder
      2865. FDA Approvals of Brand-Name Prescription Drugs in 2015
      2866. FDA approves female sexual dysfunction drug
      2867. FDA Approves Flibanserin to Treat Female hypoactive sexual desire Disorder: A Billion Dollar Market?
      2868. FDA approves ultra-orphan drug on a 4-patient trial
      2869. FDA committee recommends approval for” female Viagra”
      2870. FDA Decisions on Measures of hypoactive sexual desire Disorder in Women: A History, With Grounds to Consider Clinical Judgment
      2871. FDA lacks desire for flibanserin–but does hypoactive sexual desire disorder even exist?
      2872. FDA new drug approvals in Q2 2019.
      2873. FDA Panel Backs New Emergency Contraceptive
      2874. FDA panel rejects testosterone patch for women on safety grounds
      2875. Fear avoidance and self-efficacy in relation to pain and sexual impairment in women with provoked vestibulodynia
      2876. Fear-based reasons for not engaging in sexual activity during pregnancy: associations with sexual and relationship well-being
      2877. Feasibility and preliminary effectiveness of a novel cognitive–behavioral couple therapy for provoked vestibulodynia: a pilot study
      2878. Feasibility of a brief online psychoeducational intervention for women with sexual interest/arousal disorder
      2879. Feasibility of interactive voice response methods in health behavior research with immigrant Latinos
      2880. Feasibility of transvaginal natural orifice transluminal endoscopic surgery–assisted living donor nephrectomy: is kidney vaginal delivery the approach of the future?
      2881. feasible?
      2882. Features of psychological status in women with functional ovarian cysts
      2883. Fecal incontinence, sexual complaints, and anorectal function after third-degree obstetric anal sphincter injury (OASI): 5-year follow-up
      2884. Feed Group
      2885. Feelings under dynamic description: The asexual spectrum and new ways of being.
      2886. Female adolescents, sexual empowerment and desire: A missing discourse of gender inequity
      2887. Female androgen deficiency
      2888. Female androgen deficiency syndrome—an unproven hypothesis
      2889. Female coital orgasm and male attractiveness
      2890. Female copulatory orgasm and male partner’s attractiveness to his partner and other women
      2891. Female cosmetic genital reconstruction: a review of current trends, treatments, and techniques
      2892. Female hypoactive sexual desire disorder
      2893. Female hypoactive sexual desire disorder
      2894. Female hypoactive sexual desire Disorder
      2895. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues
      2896. Female hypoactive sexual desire disorder psychological treatment
      2897. Female hypoactive sexual desire Disorder: A Practical Guide to Causes, Clinical Diagnosis, and Treatment
      2898. Female hypoactive sexual desire disorder: History and current status
      2899. Female hypoactive sexual disorder: Case studies of physiologic androgen replacement
      2900. Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management
      2901. Female low sexual desire and sexually transmitted infections
      2902. Female orgasm and overall sexual function and habits: a descriptive study of a cohort of US women
      2903. Female orgasmic disorder
      2904. Female Orgasmic Disorder
      2905. Female orgasmic disorder
      2906. Female Orgasmic Disorder
      2907. Female rat sexual behavior is unaffected by perinatal fluoxetine exposure
      2908. Female reproductive behavior
      2909. Female sexual
      2910. Female sexual arousal disorder (FSAD)
      2911. Female sexual Arousal Disorder: A holistic approach
      2912. Female sexual arousal disorders
      2913. Female sexual arousal disorders
      2914. Female sexual behavior in mice is controlled by kisspeptin neurons
      2915. Female sexual desire disorders–prevalence, classification and treatment possibilities
      2916. Female sexual desire disorders: subtypes, classification, personality factors and new directions for treatment
      2917. Female sexual desire Questionnaire
      2918. Female sexual desire—beyond testosterone
      2919. Female sexual desire, response, and behavior
      2920. Female sexual desire, subjectivity, and the problem of negative sexual objectification
      2921. Female sexual desire: what helps, what hinders, and what women want
      2922. Female sexual disorders
      2923. Female sexual disorders nowadays
      2924. Female sexual disorders: assessment, diagnosis, and treatment
      2925. Female sexual disorders: assessment, diagnosis, and treatment
      2926. Female sexual disorders: Psychiatric aspects
      2927. Female sexual disorders: Treatment options in the pipeline
      2928. Female sexual distress in infertile Turkish women
      2929. Female sexual distress in infertile Turkish women İnfertil türk kadınlarda cinsel sıkıntı
      2930. Female sexual Distress Scale—Revised
      2931. Female sexual dysfunction
      2932. Female sexual dysfunction
      2933. Female sexual dysfunction
      2934. Female sexual dysfunction
      2935. Female sexual dysfunction
      2936. Female sexual dysfunction
      2937. Female sexual dysfunction
      2938. Female sexual dysfunction
      2939. Female sexual dysfunction
      2940. Female sexual Dysfunction
      2941. Female sexual dysfunction
      2942. Female sexual dysfunction
      2943. Female sexual dysfunction
      2944. Female sexual dysfunction
      2945. Female sexual dysfunction
      2946. Female sexual dysfunction
      2947. Female sexual dysfunction
      2948. Female sexual dysfunction
      2949. Female sexual dysfunction
      2950. FEMALE sexual DYSFUNCTION
      2951. Female sexual dysfunction
      2952. Female sexual Dysfunction
      2953. Female sexual dysfunction
      2954. Female sexual Dysfunction
      2955. Female sexual Dysfunction
      2956. Female sexual Dysfunction (FSD)
      2957. Female sexual dysfunction (FSD): Prevalence and impact on quality of life (QoL)
      2958. Female sexual dysfunction a theoretical consideration of the nature of the sexual response and etiological factors
      2959. Female sexual dysfunction after ileal pouch–anal anastomosis
      2960. Female sexual dysfunction among married women in the Gaza Strip: an internet-based survey
      2961. Female sexual dysfunction among menopausal women
      2962. Female sexual dysfunction among Muslim women: increasing awareness to improve overall evaluation and treatment
      2963. Female sexual dysfunction among the wives of opioid-dependent males in Iran
      2964. Female sexual dysfunction among women attending the family planning clinic at Aminu Kano Teaching Hospital: A cross-sectional survey
      2965. Female sexual dysfunction amongst rural postmenopausal women
      2966. Female sexual dysfunction and adolescents
      2967. Female sexual Dysfunction and Cancer
      2968. Female sexual dysfunction and hormonal status in multiple sclerosis patients
      2969. FEMALE sexual DYSFUNCTION AND HORMONAL STATUS IN SPINAL CORD INJURED (SCI) PATIENTS
      2970. Female sexual dysfunction and infertility
      2971. Female sexual dysfunction and its associated risk factors: an epidemiological study in the north-east of Iran
      2972. Female sexual dysfunction and its relationship with marital satisfaction in Indian women
      2973. Female sexual dysfunction and postmenopausal androgen therapy
      2974. Female sexual dysfunction and premature menopause with focus on women’s wording
      2975. Female sexual Dysfunction and Schizophrenia: A Clinical Review
      2976. Female sexual dysfunction and the placebo effect: a meta-analysis
      2977. Female sexual Dysfunction and the Placebo Effect: A Meta-analysis
      2978. Female sexual dysfunction and use of hormone therapy in postmenopausal women
      2979. Female sexual Dysfunction as a Warning Sign of Chronic Disease Development
      2980. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention
      2981. Female sexual Dysfunction during Reproductive Age: Types and Associated Risk Factors
      2982. Female sexual dysfunction following vaginal surgery: a review
      2983. Female sexual dysfunction following vaginal surgery: myth or reality?
      2984. Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors
      2985. Female sexual Dysfunction in Alcohol and Drug Abuse
      2986. Female sexual dysfunction in essential hypertension: a common problem being uncovered
      2987. Female sexual dysfunction in female genital mutilation
      2988. Female sexual dysfunction in Iran: study of prevalence and risk factors
      2989. Female sexual dysfunction in Lower Egypt
      2990. Female sexual dysfunction in married medical students
      2991. Female sexual dysfunction in obstetrics and gynecology
      2992. Female sexual dysfunction in patients with endometriosis: Indian scenario
      2993. Female sexual dysfunction in patients with psoriasis and vitiligo: an Egyptian pilot study
      2994. Female sexual dysfunction in postmenopausal women
      2995. Female sexual dysfunction in type 2 diabetes: a case control study
      2996. Female sexual Dysfunction in women with Multiple Sclerosis
      2997. Female sexual Dysfunction in Women with Pelvic Pain
      2998. Female sexual dysfunction in women with thyroid disorders
      2999. Female sexual dysfunction management after pubovaginal/midurethral sling surgery
      3000. Female sexual dysfunction—from diagnosis to treatment
      3001. Female sexual dysfunction—medical and psychological treatments, committee 14
      3002. Female sexual dysfunction, feminist sexology, and the psychiatry of the normal
      3003. Female sexual dysfunction, voiding symptoms and depression: common findings in partners of men with erectile dysfunction
      3004. Female sexual dysfunction: a call to arms for collaboration to understand the sexological elephant
      3005. Female sexual dysfunction: A case study of disease mongering and activist resistance
      3006. Female sexual dysfunction: A comparative study in drug naive 1st episode of depression in a general hospital of South Asia
      3007. Female sexual dysfunction: a focus on flibanserin
      3008. Female sexual dysfunction: a primary care perspective
      3009. Female sexual dysfunction: A review
      3010. Female sexual dysfunction: a systematic overview of classification, pathophysiology, diagnosis and treatment
      3011. Female sexual dysfunction: a systematic review of outcomes across various treatment modalities
      3012. Female sexual dysfunction: anatomy, physiology, evaluation and treatment options
      3013. Female sexual Dysfunction: Assessment and Treatment.
      3014. Female sexual dysfunction: barriers to treatment
      3015. Female sexual Dysfunction: Classification and Definitions
      3016. Female sexual dysfunction: classification, pathophysiology, and management
      3017. Female sexual Dysfunction: clinical approach
      3018. Female sexual dysfunction: Definition, classification, and debates
      3019. Female sexual dysfunction: definitions, causes, and treatment
      3020. Female sexual dysfunction: Diagnosis and treatment in 2002; When sexual dysfunction occurs in women, several diagnostic and therapeutic strategies can help …
      3021. Female sexual dysfunction: Don’t assume it’sa side effect
      3022. Female sexual dysfunction: Drug treatment options
      3023. Female sexual Dysfunction: Epidemiology, Physiology, Evaluation, and Treatment
      3024. Female sexual dysfunction: focus on low desire
      3025. Female sexual dysfunction: Focus on low desire
      3026. Female sexual Dysfunction: Identifying the Problem
      3027. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options
      3028. Female sexual Dysfunction: Indian Scenario
      3029. Female sexual dysfunction: is it a treatable disease?
      3030. Female sexual dysfunction: Knowledge development and practice implications
      3031. Female sexual Dysfunction: Natural and Complementary Treatments
      3032. Female sexual dysfunction: new developments
      3033. Female sexual dysfunction: new perspectives on anatomy, physiology, evaluation and treatment
      3034. Female sexual dysfunction: pharmacologic and therapeutic interventions
      3035. Female sexual dysfunction: physiology, epidemiology, classification, evaluation and treatment
      3036. Female sexual dysfunction: principles of diagnosis and therapy
      3037. Female sexual dysfunction: reality or disease-mongering?
      3038. Female sexual dysfunction: review of the disorder and evidence for available treatment alternatives
      3039. Female sexual Dysfunction: Screening, Diagnosis and Treatment
      3040. Female sexual dysfunction: State of the art
      3041. Female sexual Dysfunction: The Effectiveness of Psychological and Medical Treatments
      3042. Female sexual dysfunction: the important points to remember
      3043. Female sexual dysfunction: therapeutic options and experimental challenges
      3044. Female sexual dysfunction: what Arab gynecologists think and know
      3045. Female sexual dysfunction: what we know, what we suspect, and enduring enigmas
      3046. Female sexual dysfunction: what’s new?
      3047. FEMALE sexual DYSFUNCTION…
      3048. Female sexual dysfunctionand digital era: To listen to voice of a female
      3049. Female sexual Dysfunctions
      3050. Female sexual Dysfunctions
      3051. Female sexual Dysfunctions and Urogynecological Disorders
      3052. Female sexual dysfunctions: definitions and classification
      3053. Female sexual dysfunctions: prevalence and related factors in a sample of young university women–a cross-sectional study
      3054. Female sexual dysfuntion and gynaecological practice: Report of six cases
      3055. Female sexual Dysfuntion: Effective Treatment Strategies for All Ages
      3056. Female sexual Function after Vaginal Delivery with Episiotomy and Cesarean Section
      3057. Female sexual function and dysfunction
      3058. Female sexual Function and Dysfunction
      3059. Female sexual Function and Dysfunction
      3060. Female sexual function and dysfunction in the reproductive years: the influence of endogenous and exogenous sex hormones
      3061. Female sexual function and dysfunction: a cross-national prevalence study in Slovenia
      3062. Female sexual function and dysfunction: can the Cinderella of medicine turn into a princess?
      3063. Female sexual function and fertility after ileal pouch-anal anastomosis
      3064. Female sexual function and its associations with number of children, pregnancy, and relationship satisfaction
      3065. Female sexual function and the pelvic floor
      3066. Female sexual function and urinary incontinence in nulliparous athletes: An exploratory study
      3067. Female sexual function at midlife and beyond
      3068. Female sexual function during pregnancy and after childbirth
      3069. Female sexual function evaluation of the tension-free vaginal tape (TVT) and transobturator suburethral tape (TOT) incontinence surgery: results of a prospective study
      3070. Female sexual function following mid-urethral slings for the treatment of stress urinary incontinence
      3071. Female sexual Function in Childhood, Adolescent, and Young Adult Cancer Survivors
      3072. Female sexual function in users of combined oral and traditional contraceptive methods
      3073. Female sexual Function Index short version: a MsFLASH item response analysis
      3074. Female sexual Function Index-FSFI
      3075. Female sexual function, dysfunction, and pregnancy: implications for practice
      3076. Female sexual Function: The Role of Animal Models in Assessing Female sexual Dysfunction
      3077. Female sexual functioning and pregnancy
      3078. Female sexual healing and longevity
      3079. Female sexual Health
      3080. Female sexual health consensus clinical guidelines
      3081. Female sexual health predicts male and female partner satisfaction following IPP placement
      3082. Female sexual health: Barriers to optimal outcomes and a roadmap for improved patient–clinician communications
      3083. Female sexual Interest and Arousal Disorder: How We Can Help When Our Patient’s Libido Hits the Brakes
      3084. Female sexual interest/arousal disorder: a diagnosis out of thin air
      3085. Female sexual Issues in Clinical Practice
      3086. Female sexual Orgasmic Dysfunction and Genital Sensation Deficiency
      3087. Female sexual pain disorders and cognitive behavioral therapy
      3088. Female sexual Problems and the Gynecologist
      3089. Female sexual problems I: Loss of desirewhat about the fun?
      3090. Female sexual response: the role of drugs in the management of sexual dysfunction
      3091. Female sexual satisfaction and pharmaceutical intervention: A critical review of the drug intervention studies in female sexual dysfunction
      3092. Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients
      3093. Female sexual wellness, relationship mutuality, and femininity ideology
      3094. Female sexuality
      3095. Female sexuality and Androgens
      3096. Female sexuality and common sexual dysfunctions: evaluation and management in a primary care setting
      3097. Female sexuality and sexual dysfunction: Are we stuck on the learning curve?
      3098. Female sexuality at reproductive age as an indicator of satisfaction with life–descriptive cross-sectional survey
      3099. Female sexuality during pregnancy and postpartum: a study of 80 Tunisian women
      3100. FEMALE sexualITY IN AYURVEDA
      3101. Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention
      3102. Female sexuality: A State of Mind
      3103. Female sexuality.
      3104. Female Viagra’and the intersection of medicine, gender, and desire: reinforcing misconceptions of female sexuality in the sexopharmaceutical era
      3105. Feminism, psychology, and the gendering of neoliberal subjectivity: From critique to disruption
      3106. Feminist Psychology and the “Body Problem” sexuality, Physical Appearance, and Women’s Physical and Mental Health
      3107. Feminist sex Therapy in the Age of Viagramm
      3108. Ferri’s clinical advisor 2018 E-Book: 5 Books in 1
      3109. Fertility and sexuality in the spinal cord injury patient
      3110. Fertility, Belief, and sexuality
      3111. Fezf1 is a novel regulator of female sex behavior in mice
      3112. Field Testing of ICD-11 Proposals for Female sexual Dysfunctions in India: Cognitive Interviews with Patients
      3113. Finasteride and erectile dysfunction in patients with benign prostatic hyperplasia or male androgenetic alopecia
      3114. Finding her voice: First class female sexuality
      3115. Finding strength in diversity with The Journal of sexual Medicine as the common bond
      3116. Finnish women and men who self-report no sexual attraction in the past 12 months: Prevalence, relationship status, and sexual behavior history
      3117. Fireworks exploded in my mouth: affective responses before, during, and after the very first kiss
      3118. First pharmacological therapy for hypoactive sexual desire disorder in premenopausal women: Flibanserin
      3119. First published in The Journal of Clinical Endocrinology & Metabolism, Vol. 91, issue 10, pages
      3120. Fish Oils and Bleeding—Where Is the Evidence?
      3121. Fisiopatologia del trastorno del deseo sexual en el climaterio
      3122. Five Questions About the Relational and Bodily Experiences Theory: A Consideration of the Theoretical Framework, the Major Constructs, and Intended Application of …
      3123. Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors
      3124. Flash count diary: Menopause and the vindication of natural life
      3125. Fleeing the Apollonian Marriage Bed: Daphne and the Discourse of desire
      3126. Flibanserin
      3127. Flibanserin
      3128. Flibanserin (Addyi): the first FDA-approved treatment for female sexual interest/arousal disorder in premenopausal women
      3129. FLIBANSERIN (continued)
      3130. Flibanserin and 8‐OH‐DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair‐bond quality
      3131. Flibanserin and female sexual desire
      3132. Flibanserin and its discontents
      3133. Flibanserin approval: facts or feelings?
      3134. Flibanserin as pharmacological therapy of inhibited sexual desire in women
      3135. Flibanserin efficacy and safety in premenopausal women with generalized acquired hypoactive sexual desire disorder
      3136. Flibanserin for female sexual dysfunction.
      3137. Flibanserin for hypoactive sexual desire disorder in premenopausal women
      3138. Flibanserin for hypoactive sexual desire disorder in premenopausal women
      3139. Flibanserin for hypoactive sexual desire disorder: an open-label safety study
      3140. Flibanserin for hypoactive sexual desire disorder: place in therapy
      3141. Flibanserin for low sexual desire in women: A molecule from bench to bed?
      3142. Flibanserin for postmenopausal women—are they really that different?
      3143. Flibanserin for premenopausal hypoactive sexual desire disorder: pooled analysis of clinical trials
      3144. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women
      3145. Flibanserin for treating hypoactive sexual desire disorder
      3146. Flibanserin for treating low sexual desire in women
      3147. Flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the PLUMERIA study
      3148. Flibanserin ineffective for hypoactive sexual desire disorder in women
      3149. Flibanserin Tablets (Addyi)
      3150. Flibanserin Therapy and CYP2C19 Genotype
      3151. Flibanserin toxicity in a toddler following ingestion
      3152. Flibanserin treatment increases appetitive sexual motivation in the female rat
      3153. Flibanserin Versus Vardenafil in the Treatment of Female sexual Dysfunction, Randomized Controlled Clinical Trial
      3154. Flibanserin‐Stimulated Partner Grooming Reflects Brain Metabolism Changes in Female Marmosets
      3155. Flibanserin–the female Viagra?
      3156. Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain …
      3157. Flibanserin: A controversial drug for female hypoactive sexual desire disorder
      3158. FLIBANSERIN: A Happy Ending Solution to hypoactive sexual desire Disorder
      3159. Flibanserin: A Miracle Drug in Management of hypoactive sexual desire Disorder in Female.
      3160. Flibanserin: a novel, nonhormonal agent for the treatment of hypoactive sexual desire disorder in premenopausal women
      3161. Flibanserin: a potential treatment for hypoactive sexual desire Disorder in premenopausal women
      3162. Flibanserin: Approval of a controversial drug for a controversial disorder
      3163. Flibanserin: first global approval
      3164. Flibanserin: from bench to bedside
      3165. Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder
      3166. Flibanserin: more than just a” Pink Viagra”
      3167. Flibanserin: The first drug approved for the treatment of hypoactive sexual desire disorder in pre-menopausal women
      3168. Flibanserin: The First Pharmacologic Therapy for Women with hypoactive sexual desire Disorder
      3169. Flow-oriented synthetic design in the continuous preparation of the aryl piperazine drug flibanserin
      3170. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial
      3171. Fluoxetine-induced changes in tactile sensation and sexual functioning among clinically depressed women
      3172. Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients
      3173. Fluparoxan in male erectile disorder: a case report
      3174. Focus on early years to create fairer society and reduce health inequality, Marmot review says
      3175. Focus on sexual health
      3176. Focus on the Impact of Gynecological Surgery on Female sexual Function
      3177. Focus on Women’s Mental Health
      3178. Focusing “hot” or focusing “cool”: Attentional mechanisms in sexual arousal in men and women
      3179. Folk Medicines
      3180. Follicle-stimulating hormone promotes the transformation of cholesterol to estrogen in mouse adipose tissue
      3181. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes?
      3182. Food with influence in the sexual and reproductive health
      3183. Forbidden fruit in the golden years: Elderly sexuality
      3184. FORBIDDEN FRUIT IN THE GOLDEN YEARS: GERIATRIC sexualITY
      3185. Forecasting the critical role of intermittent therapies for the control of bone resorption
      3186. Forensic and medico-legal aspects of sexual crimes and unusual sexual practices
      3187. Forensic psychology of spousal violence
      3188. Formulations and use of androgens in women
      3189. Foundations of professional psychology: The end of theoretical orientations and the emergence of the biopsychosocial approach
      3190. Four solid forms of flibanserin: Insight into the crystal structures, properties, stability, and solid-state transition
      3191. Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial
      3192. Framing disease: The example of female hypoactive sexual desire disorder
      3193. Freedom to’and ‘freedom from’: A new vision for sex-positive politics
      3194. freedoM to” and “freedoM FroM
      3195. Freedom, invisibility, and community: A qualitative study of self-identification with asexuality
      3196. Frequency and predictors of sexual dysfunctions among male Nigerians with diabetes mellitus (A Preliminary report)
      3197. Frequency and timing of coital orgasm in women desirous of becoming pregnant
      3198. Frequency Distribution of Female sexual Dysfunction in Patients with Lower Urinary Tract Symptoms Referred to University Hospitals and a Private Urology …
      3199. Frequency of sexual activity and cardiovascular risk in subjects with erectile dysfunction: Cross‐sectional and longitudinal analyses
      3200. FREQUENCY OF sexual DYSFUNCTION IN FEMALES SUFFERING FROM MAJOR DEPRESSIVE DISORDER.
      3201. Frequency of sexual Dysfunctions and Behaviors Among Women Attending Health Care Centers in West of Tehran
      3202. Frequency of sexual dysfunctions in type 2 diabetic males
      3203. Fresh from the biotech pipeline—2015
      3204. Freud’s handicap
      3205. FRI-09 THE CREATION OF THE NEOVAGINA: A HISTORY OF VAGINAL RECONSTRUCTION
      3206. FRI-10 PIONEERING ANATOMICAL RESEARCH ON FEMALE PELVIS AND VESICO-VAGINAL FISTULAS AT THE UNIVERSITY OF PADUA (15TH-18TH CENTURY)
      3207. FRI-11 TO STIMULATE OR NOT TO STIMULATE: MEDICAL MASTURBATION, FEMALE FRIGIDITY AND CONTEMPORARY UNDERSTANDINGS OF FEMALE …
      3208. Frigid transgressions: Unveiling the queer potentialities of asexuality
      3209. Frigidity: An intellectual history
      3210. From diagnosis to treatment: The office management of premature ejaculation
      3211. From effects of psychotropic medication to mechanisms of sexual functioning: a clinically oriented review
      3212. From Female sexuality and Hysteria to Feminine Psychology: the Gender of Insanity in Literature
      3213. From Impotence to Erectile Dysfunction: Reflections on 50 Years in Male sexual Medicine
      3214. From morality to mental health: Virtue and vice in a therapeutic culture
      3215. From Primary Hypergonadotropic Amenorrhea to “POI”: Aetiology and Therapy
      3216. From sexual desire discrepancies to desirable sex: Creating the optimal connection
      3217. From sexual desire Discrepancies to Desirable sex: Creating the Optimal Connection From sexual desire Discrepancies to Desirable sex: Creating the …
      3218. From talk to action: mapping the diagnostic process in psychiatry
      3219. From the Editor on Women’s Health: Potential detrimental health effects during pregnancy and menopause
      3220. From the journals, July—August 2005
      3221. FROM THE MARGINS TO THE BASEMENT
      3222. From whence comes HSDD?
      3223. Frontier View on Drug Discoveries for Different Diseases-Part II
      3224. Frontier View on Drug Discoveries for Different Diseases-Volume 3
      3225. Frontiers in Aging Science Volume 1 Challenging Aging The Anti-senescence Effects of Hormesis, Environmental
      3226. Frontiers in Gynecological
      3227. Frontiers in gynecological endocrinology: Volume 1: from symptoms to therapies
      3228. FSD PHARMACOTHERAPY: Tibolone and Transdermal E2/NETA for the Treatment of Female sexual Dysfunction in Naturally Menopausal Women: Results of a …
      3229. Functional and dysfunctional sexual behavior: a synthesis of neuroscience and comparative psychology
      3230. Functional brain correlates of heterosexual paedophilia
      3231. Functional Foods and Women’s High Cholesterol
      3232. Functional neuroanatomy of human cortex cerebri in relation to wanting sex and having it
      3233. Functional neuroanatomy of sexual arousal
      3234. Functional neuroimaging studies of sexual arousal and orgasm in healthy men and women: a review and meta-analysis
      3235. Functional sexuality, sexual difficulties, and sexual dysfunctions
      3236. Functional significance of the rapid regulation of brain estrogen action: where do the estrogens come from?
      3237. Functional specialization within rostral prefrontal cortex (area 10): a meta-analysis
      3238. Functioning During a Pandemic
      3239. Fundamentals of Theory and Practice Revisited: sex Therapy: Historical Evolution, Current Practice. Part I
      3240. FUNDING AND CONFLICTS OF INTEREST: None
      3241. Further examination of measurement properties of Spanish version of the sexual desire Inventory with undergraduates and adolescent students
      3242. Further validation of the Female sexual Function Index: Specificity and associations with clinical interview data
      3243. Furthering our understanding of asexuality: an investigation into biological markers of asexuality, and the development of the asexuality identification scale
      3244. Future Developments and Research
      3245. Future Directions in sexual Medicine
      3246. Future of male infertility research and treatment
      3247. Future predictions on the fate of PAS children: What hath alienators wrought
      3248. Future sexual medicine physiological treatment targets
      3249. Future targets for female sexual dysfunction
      3250. Gaining political will for actions to achieve health equity: lessons from Australia for advocates
      3251. Gay Men, Drinking, and Alcoholism
      3252. Gender and Asexuality in Academic Sources
      3253. Gender and Mental Health
      3254. Gender and mental health: a review of two textbooks of psychiatry
      3255. Gender and sexuality
      3256. Gender and sexuality
      3257. Gender and sexuality diversity (GSD): Respecting difference
      3258. Gender bias and sex distribution of mental disorders in the DSM-IV-TR
      3259. Gender commonalities and differences in the neural processing of visual sexual stimuli
      3260. Gender difference of androgen actions on skeletal muscle transcriptome
      3261. Gender differences and similarities in sexual desire
      3262. Gender differences and the medicalization of sexuality in the creation of sexual dysfunctions diagnosis
      3263. Gender differences in beliefs about the causes of male and female sexual desire
      3264. Gender differences in desire discrepancy as a predictor of sexual and relationship satisfaction in a college sample of heterosexual romantic relationships
      3265. GENDER DIFFERENCES IN EXPLANATIONS FOR INFIDELITY OF LATVIAN RESIDENTS
      3266. Gender differences in factors associated with hypoactive sexual desire
      3267. Gender differences in HIV-related psychological distress in heterosexual couples
      3268. Gender Differences in HIV-Related Psychological Distress in Heterosexual Couples
      3269. Gender differences in implicit processing of sexual stimuli
      3270. Gender differences in psychiatric disorders with a focus on estrogen
      3271. Gender differences in sexual attitudes and behaviors: A review of meta-analytic results and large datasets
      3272. Gender differences in sexual desire: The effects of anger and anxiety
      3273. Gender differences in sexual dysfunctions among individuals with obesity
      3274. Gender Differences in sexual Health Impairment in Hidradenitis Suppurativa: A Systematic Review
      3275. Gender differences in sexual motivation
      3276. Gender Differences in Social Relationships and Social Support of School Children
      3277. Gender differences in the cardiovascular effect of sex hormones
      3278. Gender differences in the cardiovascular effects of sex hormones
      3279. Gender differences in the diagnosis of mental disorders: Conclusions and controversies of the DSM–IV.
      3280. Gender differences in the relationship of sexual functioning with implicit and explicit sex liking and sex wanting: A community sample study
      3281. Gender discrepancy in asexual identity: The effect of hegemonic gender norms on asexual identification
      3282. GENDER IDENTITY DISORDER
      3283. Gender in Contemporary US Culture. Asexuality in Representation and Reception.
      3284. Gender Incongruence
      3285. Gender Incongruence 28
      3286. Gender issues and sexual desire: the role of emotional and relationship variables
      3287. Gender role and women’s health: Effects of feminine gender role stress and femininity on somatic symptoms and sexual functioning
      3288. Gender-based violence and mental disorders in female college students
      3289. Gender-specific medicine and ageing: the endocrine impact: second world congress, Rome, Italy, March 8-11, 2007
      3290. Gender‐specificity of solitary and dyadic sexual desire among gynephilic and androphilic women and men
      3291. Gender, sexuality, and intimate relationships
      3292. Gendered populations and trauma beyond Oedipus: reply to Angel’s commentary
      3293. Genders and sexualities in History
      3294. Gene polymorphism at serotonin 5-HT1A receptors: moving towards personalized medicine for psychosis and mood deficits
      3295. General and sex profile of women with partner affected by premature ejaculation: results of a large observational, non‐interventional, cross‐sectional, epidemiological …
      3296. General management of female sexual dysfunction for urologists
      3297. General practitioners’ knowledge, attitudes, beliefs, and practices in the management of sexual dysfunction—results of the Portuguese sexOS study
      3298. General practitioners’ procedures for sexual history taking and treating sexual dysfunction in primary care
      3299. Generalized Restriction: Understanding Anorexia Nervosa in an Interpersonal Context
      3300. Genetic and environmental risk factors for sexual distress and its association with female sexual dysfunction
      3301. Genetic polymorphisms of monoamine oxidase (MAO) B and serotonin transporter receptor (5-HTTR) influence variability in neurobehavioral symptoms by n-hexane …
      3302. Genetics and erectile dysfunction: leveraging early foundations for new discoveries
      3303. Genital and subjective measurement of the time course effects of an acute dose of testosterone vs. placebo in postmenopausal women
      3304. Genital and subjective sexual arousal in women: effects of menopause, sympathetic nervous system activation, and arousal disorder
      3305. Genital responsiveness in healthy women with and without sexual arousal disorder
      3306. Genital sensory detection thresholds and patient satisfaction with vaginoplasty in male-to-female transgender women
      3307. Genital vascular responsiveness and sexual feelings in midlife women: Psychophysiologic, brain, and genital imaging studies
      3308. Genito pelvic vaginal laxity: classification, etiology, symptomatology, and treatment considerations
      3309. Genito Urinary Syndrome of Menopause (GSM) or Vulvo-vaginal Atrophy (VVA) an Unspoken Sorrow
      3310. Genito-pelvic pain through a dyadic lens: Moving toward an interpersonal emotion regulation model of women’s sexual dysfunction
      3311. Genito-sensory analysis in women with arousal and orgasmic dysfunction
      3312. Genitourinary and sexual adverse effects of psychotropic medication
      3313. Genitourinary changes with aging
      3314. Genitourinary Syndrome of Menopause and Female sexual Dysfunction
      3315. Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: a double-blind, randomized, placebo-controlled cross-over trial
      3316. Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women
      3317. Gepirone‐ER treatment of low sexual desire associated with depression in women as measured by the Derogatis Inventory of sexual Function (DISF) fantasy …
      3318. Gerald R. Weeks and Nancy Gambescia
      3319. Geriatric Gynecology
      3320. Geriatric gynecology
      3321. Geriatric psychiatry
      3322. Geriatric Psychiatry: A Companion to the American Pyschiatric Publishing Textbook of Geriatric Psychiatry
      3323. Geriatric sexuality
      3324. Geriatric sexuality
      3325. Geriatric sexuality
      3326. Germaine Greer’s On Rape Revisited: Clarifying the Long-standing Relationship Between Rape and Heterosexual Pleasure in Greer’s Work.
      3327. Gery C. Karantzas and Patricia Noller
      3328. Gettin’It On Vs. Givin’It Up: The Association Between sexual Goals, Interdependence and sexual desire in Long-Term Relationships
      3329. Getting it on versus getting it over with: sexual motivation, desire, and satisfaction in intimate bonds
      3330. Getting the Word Out: Sharing the Benefits of Vaginally Applied Testosterone Cream in the Perimenopausal Years
      3331. Giacomo Tirabassi, Angelo Gioia, Lara Giovannini, Marco Boscaro, Giovanni Corona, Angelo Carpi, Mario Maggi &
      3332. Giuseppe Scimeca, Antonio Bruno, Gianluca Pandolfo, Umberto Micò, Vincenzo M. Romeo, Elisabetta Abenavoli, Adriano Schimmenti, et al.
      3333. Giving in to arousal or staying stuck in disgust? Disgust-based mechanisms in sex and sexual dysfunction
      3334. Global and specific attachment patterns in romantic relationships: distinct and interactional functions.
      3335. Global consensus position statement on the use of testosterone therapy for women
      3336. Global consensus statement on testosterone therapy for women: an Australian perspective
      3337. Global consensus statement on testosterone therapy in women
      3338. Glücksmedizin
      3339. Glutamate afferents from the medial prefrontal cortex mediate nucleus accumbens activation by female sexual behavior
      3340. Glutamate in Male and Female sexual Behavior: Receptors, Transporters, and Steroid Independence
      3341. Going Wild: Law and Literature and sex
      3342. Goldilocks and menopause
      3343. Gonadal dysfunction in chronic kidney disease
      3344. Gonadal hormones and cognitive aging: a midlife perspective
      3345. Gonadal Steroid-Independent sexual Behavior in Female and Male B6D2F1 Gonadectomized Mice
      3346. Gonadal Suppressive and Cross‐sex Hormone Therapy for Gender Dysphoria in Adolescents and Adults
      3347. Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech
      3348. GORDON CONWELL THEOLOGICAL SEMINARY-CHARLOTTE MASTERS OF ARTS IN COUNSELING PROGRAM CO 719 HUMAN sexualITY SPRING …
      3349. Green fingers or pink viagra? female sexual dysfunction and medicalisation in contemporary medical discourse
      3350. Group counseling curriculum for women with female interest/arousal disorder
      3351. Group Counseling: The Efficacy of Group Work.
      3352. Group mindfulness-based therapy significantly improves sexual desire in women
      3353. Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
      3354. Guidelines: Making the Diagnosis and Managing the Partner
      3355. Guilt about first intercourse: An antecedent of sexual dissatisfaction among college women
      3356. Guilt and lack of orgasm during sexual intercourse: Myth versus reality among college women
      3357. Gut Microbes are Linked to sexual desire, Differences in Gut Microbes and Fecal Metabolomes of Women with vs Without HSDD
      3358. Gynaecological aspects of the treatment and follow-up of transsexual men and women
      3359. GYNAECOLOGICAL PROBLEMS IN THE AGEING WOMAN: A REVIEW
      3360. Gynecologic problems in women with autoimmune diseases
      3361. Gynecologic radiation oncology patients report unmet needs regarding sexual health communication with providers
      3362. Gynecologic Surgical Outcomes Through the Patient’s Eyes: Are Physicians Looking in the Same Direction?
      3363. Gynecological associated disorders and management
      3364. Gynecological Cancers
      3365. Gynecological Issues for Cancer Survivors
      3366. Gynecomastia in subjects with sexual dysfunction
      3367. Handbook of forensic psychology: Resource for mental health and legal professionals
      3368. Handbook of Male Infertility & Andrology
      3369. Handbook of sexual and gender identity disorders
      3370. Handbook of sexual Dysfunction
      3371. Hard science’: Gendered constructions of sexual dysfunction in theViagra Age’
      3372. Has flibanserin revolutionized the treatment of hypoactive sexual desire disorder or is there still room for more effective therapeutics?
      3373. Has testosterone passed the test in premenopausal women with low libido? A systematic review
      3374. Has training in human sexuality changed over the past twenty years? A survey of clinical psychology, counseling psychology, and doctor of social work …
      3375. Having ‘The Talk’
      3376. Having an Orgasm with the Power of the Mind
      3377. Having your cake and eating it, too: Factors impacting perception of life satisfaction during outside partnerships
      3378. Healing and functional outcomes after obstetric anal sphincter injury in HIV positive vs HIV negative patients
      3379. Healing the Wounded Heart: The Heartache of sexual Abuse and the Hope of Transformation
      3380. Healing the wounded self: Combining hypnotherapy with ego state therapy
      3381. Health and Ageing in Older Adults: A gender-specific and life-course perspective
      3382. Health and behavior: A multidisciplinary perspective
      3383. Health care clinicians in sexual health medicine: focus on erectile dysfunction
      3384. HEALTH CARE OF THE OLDER ADULT: AN AUSTRALIAN AND NEW ZEALAND PERSPECTIVE
      3385. Health care providers have used the Diagnostic and Statistical Manual of Mental Disorders (DSM) to support communication of essential characteristics of mental …
      3386. Health needs assessment
      3387. Health seeking practices of infertile women
      3388. Health-Related Quality of Life and Adjustment in Patients with Hepatocellular Carcinoma
      3389. Health-related quality of life in patients with hepatocellular carcinoma: a systematic review
      3390. Health-related quality of life, definitions and determinants.
      3391. Health‐Related Characteristics and Unmet Needs of Men with Erectile Dysfunction: A Survey in Five E uropean Countries
      3392. Health‐related quality of life by human immunodeficiency virus status in a cross‐sectional survey of gay and bisexual prostate cancer survivors
      3393. Health, body image, gender, and migration status: their relationship to sexuality in old age
      3394. Health, Disease, and the Basic Aims
      3395. Health, disease, and the basic aims of medicine
      3396. Healthcare costs and quality of life outcomes following gender affirming surgery in trans men: a review
      3397. Healthcare resource utilization and expenditures of women diagnosed with hypoactive sexual desire disorder
      3398. Healthcare utilization in women diagnosed with hypoactive sexual desire disorder: Interim baseline results from the HSDD Registry for Women
      3399. Healthy Aging & Functional Capacity
      3400. Heart Disease and Erectile Dysfunction
      3401. Heart rate variability biofeedback increases sexual arousal among women with female sexual arousal disorder: Results from a randomized-controlled trial
      3402. Heatwave-related Mortality in Australia: Who’s impacted the most?
      3403. Help-seeking behavior of women with self-reported distressing sexual problems
      3404. Help-seeking behaviors for female sexual dysfunction: a cross sectional study from Iran
      3405. Help-seeking for sexual difficulties and the potential role of interactive digital interventions: Findings from the third British National Survey of sexual Attitudes and …
      3406. Helping people with sexual problems: a practical approach for clinicians
      3407. Herbal dietary supplements for erectile dysfunction: a systematic review and meta-analysis
      3408. Herbal medicine for low sexual desire in menopausal women: A clinical review
      3409. Herbal medicine for sports: a review
      3410. Herbal Medicine in Andrology
      3411. Herbal prescription for managing menopausal disorders: A practice survey in Korean medicine doctors
      3412. Herbal remedies for hypoactive sexual desire based on Persian medicine
      3413. Herbal slimming products and natural sexual enhancers
      3414. Het mannelijk seksueel functioneren na een besnijdenis
      3415. Heterosexual men’s sexual desire: Supported by, or deviating from, traditional masculinity norms and sexual scripts?
      3416. Heterosexual women’s causal attributions regarding impairment in sexual function: Factor structure and associations with well-being
      3417. Heterosexuality
      3418. HEY, DOC CAN I TALK TO YOU ABOUT sex?
      3419. Hidden disorder/hidden desire
      3420. High levels of testicular interleukin-1 could be involved in the impairment of male fertility of IL-1 receptor antagonist knock-out mice or mice with systemic infection …
      3421. High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury
      3422. High prevalence of sexual dysfunction in women with rheumatic diseases: a not recognized health domain
      3423. High rates of sexual behavior in the general population: Correlates and predictors
      3424. High triglycerides predicts arteriogenic erectile dysfunction and major adverse cardiovascular events in subjects with sexual dysfunction
      3425. High-density lipoprotein cholesterol-raising strategies
      3426. High-dose ascorbic acid increases intercourse frequency and improves mood: a randomized controlled clinical trial
      3427. High-yield brain and behavior
      3428. Higher testosterone levels are associated with unfaithful behavior in men
      3429. highlightS froM thE Edition
      3430. HiGHliGHtS fRom tHE Edition> interview with dr. Jackson by Editor-in-Chief> inflatable penile prosthesis implantation
      3431. HISTO-ANATOMICAL AND PRELIMINARY TLC INVESTIGATIONS ON TRIBULUS TERRESTRIS L.(ZYGOPHYLLACEAE) SPECIES
      3432. Historical and international context of nosology of female sexual disorders
      3433. Historical Links Between Psychiatry and sexual Medicine
      3434. Historical revolutions in sex therapy: A critical examination of men’s sexual dysfunctions and their treatment
      3435. Historical, scientific, clinical and feminist criticisms of “the human sexual response cycle” model
      3436. History and Discovery
      3437. History of the International Society for the Study of Women’s sexual Health (ISSWSH)
      3438. History of the treatment of female sexual dysfunction (s)
      3439. History Taking and Physical Examination
      3440. HIV and Testosterone in Men
      3441. HIV infection and women’s sexual functioning
      3442. HIV-1 status is independently associated with decreased erectile function among middle-aged MSM in the era of combination antiretroviral therapy
      3443. HIV-associated female sexual dysfunction–clinical experience and literature review
      3444. Holding onto womanhood: A qualitative study of heterosexual women with sexual desire loss
      3445. Hormonal and surgical treatment options for transgender women and transfeminine spectrum persons
      3446. Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women
      3447. Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study
      3448. Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA)
      3449. Hormonal changes and sexual dysfunction
      3450. Hormonal changes associated with physical activity and exercise training
      3451. Hormonal changes in menopause and implications on sexual health
      3452. Hormonal consequences, replacement therapy, and lost workdays after cervical cancer treatment
      3453. Hormonal contraception and female sexuality: position statements from the European Society of sexual Medicine (ESSM)
      3454. Hormonal contraception and sexual desire: a critical review
      3455. Hormonal contraceptives, female sexual dysfunction, and managing strategies: a review
      3456. Hormonal correlates and causes of sexual desire: A review
      3457. Hormonal determinants of the severity of andropausal and depressive symptoms in middle-aged and elderly men with prediabetes
      3458. Hormonal Evaluation and Therapy of Erectile Dysfunction
      3459. Hormonal predictors of sexual motivation in natural menstrual cycles
      3460. Hormonal profile of menopausal women receiving androgen replacement therapy: a meta-analysis
      3461. Hormonal therapy after menopause
      3462. Hormonal Therapy for Male sexual Dysfunction
      3463. HORMONAL THERAPY IN THE POSTMENOPAUSAL WOMAN WITH sexual DYSFUNCTION Claudia Panzer MD
      3464. Hormonal therapy is associated with better self-esteem, mood, and quality of life in transsexuals
      3465. Hormonal treatment effect on sexual distress in transgender persons: 2-year follow-up data
      3466. Hormonal, metabolic, and endometrial safety of testosterone vaginal cream versus estrogens for the treatment of vulvovaginal atrophy in postmenopausal women: a …
      3467. Hormone Levels and sexual Functioning After Risk-Reducing Salpingo-Oophorectomy
      3468. Hormone management of trans women
      3469. Hormone receptors and sexuality in the human female
      3470. Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study
      3471. Hormone replacement therapy and sexuality
      3472. Hormone Replacement Therapy in Female sexual Dysfunction.
      3473. Hormone Replacement Therapy in Premature Ovarian Insufficiency
      3474. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause
      3475. Hormone replacement therapy in young women with surgical primary ovarian insufficiency
      3476. Hormone replacement therapy: update and practical prescribing
      3477. Hormone Therapies and Menopause: Where Do We Stand in the Post-WHI Era?
      3478. Hormone Therapy
      3479. Hormone Therapy (I): Estrogens, Progestogens, and Androgens
      3480. Hormone Therapy in Menopause
      3481. Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals
      3482. Hormone Therapy Use After Premature Surgical Menopause Based on Prescription Records: A Population-Based Study
      3483. Hormone Therapy, Mental Health, and Quality of Life Among Transgender People: A Systematic Review
      3484. Hormones and human partnering
      3485. Hormones and human sexuality
      3486. Hormones and sex Behavior
      3487. Hormones and sex Behavior
      3488. Hormones and sexual function.
      3489. Hormones and sexual functioning in menopausal transition
      3490. Hormones and sexuality during transition to menopause
      3491. Hormones and sexuality: current complexities and future directions
      3492. Hormones and sexuality: effect of estrogen and progestogen.
      3493. Hormones are the Masterkey in Chemical co-ordination system of body.
      3494. Hormones, metabolism, aging and men’s health
      3495. Hormones, the brain, and me.
      3496. How and why thoughts change: Foundations of cognitive psychotherapy
      3497. How Can Experiential Psychotherapy Help Transform
      3498. How can the objectified know their objectification?
      3499. How changes in depression and anxiety symptoms correspond to variations in female sexual response in a nonclinical sample of young women: a daily diary study
      3500. How did erectile dysfunction become “natural”? A review of the critical social scientific literature on medical treatment for male sexual dysfunction
      3501. How do men and women define sexual desire and sexual arousal?
      3502. How do SSRIs cause sexual dysfunction
      3503. How do women survivors of childhood sexual abuse experience’good sex‘later in life? A mixed-methods investigation
      3504. How does childhood trauma impact women’s sexual desire? Role of depression, stress, and cortisol
      3505. How does lower urinary tract dysfunction affect sexual function in men and women? ICI‐RS 2015—Part 1
      3506. How does paying attention improve sexual functioning in women? A review of mechanisms
      3507. How drug companies manipulate prescribing behavior
      3508. How hot are they? Neural correlates of genital arousal: an infrared thermographic and functional magnetic resonance imaging study of sexual arousal in men and …
      3509. How hot is he? A psychophysiological and psychosocial examination of the arousal patterns of sexually functional and dysfunctional men
      3510. How is asexuality different from hypoactive sexual desire disorder?
      3511. How Japanese culture affects the sexual functions of normal females
      3512. How Lesbian Relationships Are Similar to and Different from Heterosexual Relationships: Lived Experience of Lesbian Women Who Were Previously Married to …
      3513. How predictable is the erectile function of patients with epilepsy?
      3514. How sexual is sexual desire? desire and Testosterone in Women
      3515. How Similar is “Similar”? A Deeper Dive into Bucher Versus Bayesian Network Meta-Analysis
      3516. How the emotional motor system controls the pelvic organs
      3517. How the Female Orgasm Was Turned into a Trademark
      3518. How the prevalence rates of male sexual dysfunction vary using different criteria
      3519. How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer
      3520. How to improve complex drug development? A critical review of FDA advisory meetings
      3521. How to purchase viagra, Generic viagra when
      3522. How to Take a sexual History
      3523. How: Genotyping techniques and study designs
      3524. HP-07-003 First sexual intercourse among high school students in Slovenia
      3525. HRT for women with premature ovarian insufficiency: a comprehensive review
      3526. HSDD and asexuality: A question of instruments
      3527. HSDD, Flibanserin, and Eye Dynamics: A Double-Blind Randomized Placebo-Controlled Clinical Trial [24I]
      3528. HSDD: Circuits of sexual desire/Inhibition| Psychiatrist. com
      3529. http://heanoti. com/index. php/hn
      3530. Human asexuality: What do we know about a lack of sexual attraction?
      3531. Human Reproductive Health in Relation to Thyroid Alterations
      3532. Human sex differences in sexual psychology and behavior
      3533. Human sex-response cycles
      3534. Human sexual Anatomy and Physiology
      3535. Human sexual desire Disorder: Do We Have a Problem?.
      3536. Human sexual development is subject to critical period learning: Implications for sexual addiction, sexual therapy, and for child rearing
      3537. Human sexual development is subject to critical-period learning: Paradigm-shifting implications for sexual therapy and for child-rearing
      3538. Human sexual response
      3539. Human sexual response
      3540. Human sexuality
      3541. Human sexuality and ageing
      3542. Human sexuality of children and adolescents: A comprehensive training guide for social work professionals
      3543. Human sexuality today
      3544. Humor preferences among angered males and females: Associations with humor content and sexual desire
      3545. Huntington’s Disease
      3546. Huntington’s disease and ALS-the ethical challenges for families and professionals facing genetic disease
      3547. Hurlbert Index of sexual Assertiveness: A study of psychometric properties in a Spanish sample
      3548. Hurlbert index of sexual compatibility
      3549. Husbands who use sexual dissatisfaction to balance the scales of power in their dual-career marriages
      3550. Hyperactive sexual desire in Klinefelter Syndrome: Treatment with sertraline
      3551. Hyperprolactin as cause of hypoactive sexual desire in men
      3552. Hyperprolactinemia and sexual disorders in men.
      3553. Hypersexual desire in males: An operational definition and clinical implications for males with paraphilias and paraphilia-related disorders
      3554. Hypersexual desire in males: are males with paraphilias different from males with paraphilia-related disorders?
      3555. Hypersexual disorder: A proposed diagnosis for DSM-V
      3556. Hypersexual disorder: Just more muddled thinking
      3557. Hypersexual disorder: Searching for clarity
      3558. Hypersexuality and high sexual desire: Exploring the structure of problematic sexuality
      3559. Hypersexuality during use of levodopa
      3560. Hypersexuality following anterior communicating artery aneurysm rupture
      3561. Hypersexuality: clinical aspects
      3562. Hypersexuality: the controversial mismatch of the psychiatric diagnosis
      3563. Hypertension and sexual dysfunction: time to act
      3564. Hypertension and stroke
      3565. Hyperthyroidism and erectile dysfunction: a population-based case—control study
      3566. Hyperthyroidism: a risk factor for female sexual dysfunction
      3567. Hypnosis in the treatment of an adjustment disorder
      3568. Hypnosis in the treatment of sexual desire disorders
      3569. Hypnotic Interventions in the treatment of sexual dysfunctions
      3570. Hypnotic Relaxation Therapy and sexual Function in PostmenopausalWomen: Results of a Randomized Clinical Trial
      3571. Hypo Active sexual desire
      3572. hypoactive market desire disorder
      3573. hypoactive sexual desire
      3574. hypoactive sexual desire
      3575. hypoactive sexual desire
      3576. hypoactive sexual desire
      3577. hypoactive sexual desire (HSD) disorder: a psychiatric condition with a biological “dark side”
      3578. hypoactive sexual desire among depressed female patients treated with selective serotonin reuptake inhibitors: a comparison between escitalopram and fluoxetine
      3579. hypoactive sexual desire and testosterone deficiency in men
      3580. hypoactive sexual desire disorder
      3581. hypoactive sexual desire disorder
      3582. hypoactive sexual desire disorder
      3583. hypoactive sexual desire disorder
      3584. hypoactive sexual desire Disorder
      3585. hypoactive sexual desire Disorder
      3586. hypoactive sexual desire disorder (HSDD) is not “female erectile dysfunction (ED)”: challenges with the characterization of HSDD in women based on a systematic …
      3587. hypoactive sexual desire Disorder (HSDD) is not “The Female Erectile Dysfunction (ED)”: Challenges with the Characterization of HSDD in Women
      3588. hypoactive sexual desire Disorder and current pharmacotherapeutic options in women
      3589. hypoactive sexual desire disorder and depression: A treatment outcome study.
      3590. hypoactive sexual desire disorder caused by antiepileptic drugs
      3591. hypoactive sexual desire disorder in a population-based study of Brazilian women: associated factors classified according to their importance
      3592. hypoactive sexual desire disorder in men: clinical approach in sexual medicine
      3593. hypoactive sexual desire disorder in menopausal women: a survey of Western European women
      3594. hypoactive sexual desire disorder in postmenopausal women
      3595. hypoactive sexual desire disorder in postmenopausal women: quality of life and health burden
      3596. hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and sexuality (WISHeS)
      3597. hypoactive sexual desire disorder in premenopausal women: case studies
      3598. hypoactive sexual desire disorder in surgical menopause
      3599. hypoactive sexual desire disorder in women from the perspective of Persian medicine
      3600. hypoactive sexual desire Disorder in women: An Evolving Understanding
      3601. hypoactive sexual desire disorder in women: treatment options beyond testosterone and approaches to communicating with patients on sexual health
      3602. hypoactive sexual desire disorder, HSDD
      3603. hypoactive sexual desire disorder, sexual distress and quality of life between women with surgical menopause and women with natural menopause
      3604. hypoactive sexual desire disorder: A biopsychosocial perspective
      3605. hypoactive sexual desire disorder: a review of epidemiology, biopsychology, diagnosis, and treatment
      3606. hypoactive sexual desire disorder: An overview.
      3607. hypoactive sexual desire disorder: an underestimated condition in men
      3608. hypoactive sexual desire disorder: can it be treated by drugs?
      3609. hypoactive sexual desire disorder: can we treat it with drugs?
      3610. hypoactive sexual desire disorder: How do you identify it and treat it?
      3611. hypoactive sexual desire disorder: International Society for the Study of Women’s sexual Health (ISSWSH) expert consensus panel review
      3612. hypoactive sexual desire Disorder: Inventing a Disease to
      3613. hypoactive sexual desire disorder: inventing a disease to sell low libido
      3614. hypoactive sexual desire disorder: Prevalence and comorbidity in 906 subjects
      3615. hypoactive sexual desire disorder: separating fact from fiction
      3616. hypoactive sexual desire Disorder: Understanding the Impact on Midlife Women
      3617. hypoactive sexual desire DISORDERS IN FEMALE PATIENTS AFTER KIDNEY TRANSPLANTATION
      3618. hypoactive sexual desire dysfunction in community-dwelling older women
      3619. hypoactive sexual desire in a couple with unresolved loyalty conflicts
      3620. hypoactive sexual desire in a Couple With Unresolved Loyalty Conflicts: Discussion
      3621. hypoactive sexual desire in heterosexual women: A feminist analysis
      3622. hypoactive sexual desire in men
      3623. hypoactive sexual desire in Men
      3624. hypoactive sexual desire IN MENOPAUSAL WOMEN IN EUROPE
      3625. hypoactive sexual desire in transsexual women: prevalence and association with testosterone levels
      3626. hypoactive sexual desire in women
      3627. hypoactive sexual desire: A cognitive model
      3628. hypoactive sexual dysfunction in a young woman
      3629. Hypogonadism and erectile dysfunction: the role for testosterone therapy
      3630. Hypogonadism and metabolic syndrome
      3631. Hypogonadism associated with long-term opioid therapy: A systematic review
      3632. Hypogonadism in human immunodeficiency virus-positive men
      3633. Hypogonadism in Male sexual Dysfunction
      3634. Hypopituitarism
      3635. Hypothalamic Melanocortin 4 Receptors Regulate sexual Behavior in Mice
      3636. Hysterectomy and concurrent oophorectomy for endometrial cancer: which women benefit?
      3637. Hysterectomy and sexual function
      3638. Hysterectomy outcomes: Evaluating the quality of life factors in sexual functioning, physical and emotional health, and partner-satisfaction levels
      3639. Hysterical traits are not from the uterus but from the testis: A study in men with sexual dysfunction
      3640. I Have a Partner
      3641. I–THEORETICAL-METHODOLOGICAL PREPARATION STUDY OF sexual DYSFUNCTIONS
      3642. Iatrogenic and post-traumatic female sexual disorders
      3643. IBA, 260 PCMH screening opportunities for, 254box18. 2 during pregnancy, 358
      3644. Ideal female sexual function
      3645. Ideal partner preferences among adolescents
      3646. Identification of sexual disorders in clinical settings using a brief assessment tool and training program
      3647. Identification of the Gender-Specific Health Needs of Women Following Lung Transplantation
      3648. Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen
      3649. Identifying HSDD in the family medicine setting
      3650. Identifying objective markers of sexual arousal: Using eye-tracking, pupillometry, and heart rate variability
      3651. Identifying the disruptions in the sexual response cycles of women with sexual Interest/Arousal Disorder
      3652. Identifying what matters to hysterectomy patients: Postsurgery perceptions, beliefs, and experiences
      3653. Ignorance is not bliss: if we don’t understand hypoactive sexual desire disorder, how can flibanserin treat it? Commentary
      3654. II. Antidepressants and sexual behavior: Acute fluoxetine, but not ketamine, disrupts paced mating behavior in sexually experienced female rats
      3655. II. Slow oscillations in vaginal blood flow: Regulation of vaginal blood flow patterns in rat by central and autonomic mechanisms
      3656. III–sexual PROBLEMS EXPERIENCE IN EVERYDAY LIFE
      3657. IJHG review
      3658. Illustrating the circuits of sexual desire
      3659. Imagery, fantasy, and female sexual arousal
      3660. Imaging Data From Phase III Study Support Parathyroid as Bone Builder
      3661. Imbalance in the blood concentrations of selected steroids in pre-pubertal gilts depending on the time of exposure to low doses of zearalenone
      3662. Immature defense mechanisms are associated with lesser vaginal orgasm consistency and greater alcohol consumption before sex
      3663. Immediate processing of erotic stimuli in paedophilia and controls: a case control study
      3664. Immunomodulators and immunosuppressants for patients with relapsing-remitting multiple sclerosis: a network meta-analysis
      3665. Impact of an integrated mindfulness and cognitive behavioural treatment for provoked vestibulodynia (IMPROVED): A qualitative study
      3666. Impact of androgen deprivation therapy on sexual function
      3667. Impact of androgen deprivation therapy on sexual function: a response
      3668. Impact of antidepressant drugs on sexual function and satisfaction
      3669. Impact of apical prolapse surgical correction on the quality of life of women
      3670. Impact of breast hypertrophy on musculoskeletal pain, sexual function and physical activity
      3671. Impact of breast hypertrophy on musculoskeletal pain, sexual function and physical activity.
      3672. Impact of chemotherapy and hormone therapy on female sexual health
      3673. Impact of contraceptive type on sexual desire of women and of men partnered to contraceptive users
      3674. Impact of diabetes mellitus on the sexuality of Peruvian postmenopausal
      3675. Impact of estrogens in males and androgens in females
      3676. Impact of gender on sexual problems and perceptions among urban Malay elderly in Malaysia
      3677. Impact of gynecological surgery on female sexual function
      3678. Impact of health education on preventive therapy with integrated monitoring of Tuberculosis cases
      3679. Impact of hormones on female sexual function and dysfunction
      3680. Impact of hysterectomy or levonorgestrel-releasing intrauterine system on ovarian function, bone, and sexual functioning in menorrhagic patients
      3681. Impact of Incontinence on Female sexual Function
      3682. Impact of Infertility on the sexuality of Couples: an Overview
      3683. Impact of iron supplementation on sexual dysfunction of women with iron deficiency anemia in short term: a preliminary study
      3684. Impact of male partner responses on sexual function in women with vulvodynia and their partners: A dyadic daily experience study.
      3685. IMPACT OF MEDICAL STUDENT WELL-BEING WORKSHOP ON THE MEDICAL STUDENTS’STRESS LEVEL: A PRELIMINARY STUDY
      3686. Impact of Nursing Intervention on Female sexual Problems and Its effect on Husband Satisfaction
      3687. Impact of Obesity on Female sexual Dysfunction: A Remiss
      3688. Impact of opioid therapy on gonadal hormones: focus on buprenorphine
      3689. Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction.
      3690. Impact of Overactive Bladder Syndrome on Female sexual Function
      3691. Impact of physical resistance training on the sexual function of women with polycystic ovary syndrome
      3692. Impact of retirement on depression, a systematic review
      3693. IMPACT OF SELF-CARE GUIDELINES ON FUNCTIONING AND WELL-BEING OF POSTMENOPAUSAL WOMEN WITH AGING VAGINAL SYMPTOMS
      3694. Impact of sexual dysfunction on quality of life among anxiety disorder patients
      3695. Impact of the changing hormonal milieu on psychological functioning
      3696. Impact of the metabolic syndrome on erectile dysfunction
      3697. Impact of the mode of delivery on female sexual function after childbirth
      3698. Impact of thyroid disease on testicular function
      3699. Impact of Trauma on Marital Life
      3700. Impact of treatment induced premature menopause on quality of life following hematopoietic cell transplantation
      3701. Impact of urinary incontinence on female sexual health in women during midlife
      3702. Impact of varicocelectomy on gonadal and erectile functions in men with hypogonadism and infertility
      3703. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy
      3704. Impacts of medical treatments for lower urinary tract symptoms suggestive to benign prostatic hyperplasia on male sexual functions
      3705. Impaired lipid profile is a risk factor for the development of sexual dysfunction in women
      3706. Impaired masturbation‐induced erections: A new cardiovascular risk factor for male subjects with sexual dysfunction
      3707. Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia
      3708. Impaired sexual function
      3709. Impairment of couple relationship in male patients with sexual dysfunction is associated with overt hypogonadism
      3710. Implementation of a Bibliotherapy in the treatment of sexual dysfunction. Research review
      3711. Implementing a successful clinical development program for female sexual dysfunctions (aka how to navigate a regulatory minefield)
      3712. Implication of Cigarette Smoking and Cessation on sexual Function in Men and Women
      3713. Implications of diminished ovarian reserve (DOR) extend well beyond reproductive concerns
      3714. Implications of off-label use: An example from the final results of an observational cohort study on Intrinsa®(testosterone patch)
      3715. Implicit and explicit associations with erotic stimuli in sexually functional and dysfunctional men
      3716. Implicit and explicit associations with erotic stimuli in women with and without sexual problems
      3717. Implicit and explicit attitudes toward sex and romance in asexuals
      3718. Implicit and explicit cognitive sexual processes in survivors of childhood sexual abuse
      3719. Implicit and explicit sexual attitudes: How are they related to sexual desire and sexual satisfaction in men and women?
      3720. Implicit Measures in Clinical sex Research: A Critical Evaluation
      3721. Imploding the Diagnostic Statistical Manual
      3722. Importance of gynecological assessment for the treatment of vaginismus as a predictive value
      3723. Impotence and aging: clinical and hormonal factors
      3724. Improved bleeding profile and tolerability of tibolone versus transdermal E2/NETA treatment in postmenopausal women with female sexual dysfunction
      3725. Improved spontaneous erectile function in men with mild‐to‐moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: A …
      3726. Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study
      3727. Improvement in sexual functioning in patients with type 2 diabetes and depression treated with bupropion
      3728. Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: A randomized, double‐blind, placebo …
      3729. Improvement of the quality of the DSM‐IV diagnostic definitions through computerized algorithms using macros in SPSS and SAS language
      3730. Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily
      3731. Improving female sexual health: A quantitative evaluation of an educational intervention for medical and mental health professionals. Helping clinicians take …
      3732. Improving Marital Satisfaction: An Enrichment Program for Couples in the Huntington, New York Seventh-day Adventist Church
      3733. Improving Mind-Body Connection and sexual Response while Strengthening the Pelvic Floor Muscles
      3734. Improving quality of life after breast cancer: dealing with symptoms
      3735. Improving sexual Function in People With Chronic Kidney Disease: A Narrative Review of an Unmet Need in Nephrology Research
      3736. Improving sexual satisfaction in persons with spinal cord injuries: collective wisdom
      3737. Improving the gender-affirmation process for transgender and gender-nonconforming individuals: associations among time since transition began, body satisfaction …
      3738. Improving the management of testosterone deficiency
      3739. Improving the quality of sexuality education programs: emerging evidence from research, relevant challenges for sexology
      3740. Improving the sexual quality of life of couples affected by erectile dysfunction: A double‐blind, randomized, placebo‐controlled trial of vardenafil
      3741. Impulse Control Disorders and Criminal Responsibility: A Neuroscientific Insanity Defense
      3742. Impulsivity and the Experience of desire in the Choice of Erotic Stimuli
      3743. IMS updated recommendations on postmenopausal hormone therapy
      3744. in Aging Adults
      3745. In Focus
      3746. In grateful appreciation of Dr. Margery Gass for her dedication and service to NAMS on her retirement
      3747. In Memoriam: Harold I. Lief, MD
      3748. In premenopausal women with low sexual desire, is flibanserin (Addyi®) an effective and safe treatment?
      3749. In pursuit of ‘good’sex: Self-determination and the sexual experience
      3750. In pursuit of “good” sex: Self-determination and the intimate experience
      3751. In recent years, there has been a veritable explosion in therapeutic approaches, self-help books, and groups aimed at the treatment of “sexual addiction.” In this chap …
      3752. in Relationships
      3753. In search for animal models of female sexual dysfunction
      3754. In search of desire: The role of intimacy, celebrated otherness, and object-of-desire affirmation in sexual desire in women
      3755. In sickness and in health: The effects of hysterectomy on women’s partners and intimate relationships
      3756. In the article appearing in volume 13, pages 770-779, of Menopause, entitled BTestosterone patch for the treatment of hypoactive sexual desire disorder in naturally …
      3757. In the mind and bed of the beholder?: individual and situational differences in the experience of sexual interactions
      3758. IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NORTH DAKOTA SOUTHWESTERN DIVISION
      3759. In their own words: a qualitative content analysis of women’s and men’s preferences for women’s genitals
      3760. In vitro effects of intravenous propofol infusion on cytokine gene expression in rats
      3761. In vitro wound healing potential of the triterpene lupeol isolated from the steam bark of bowdichia virgilioides Kunth
      3762. Inappropriate sexual Behaviors in Dementia
      3763. Incidence and Knowledge of hypoactive sexual desire Disorder and Its Treatment: A Survey [6Q]
      3764. Incidence and prevalence of sexual dysfunction in women and men: a consensus statement from the Fourth International Consultation on sexual Medicine 2015
      3765. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature
      3766. Incidence and Risk Factors for sexual Dysfunction in Male Patients with Psychotic Disorders
      3767. Incidence of arousal and orgasmic disorders in women with female genital mutilation/cutting
      3768. Incidence of postpartum mood disorders depending on selected risk factors–a logistic regression model
      3769. Incidence of sexual dysfunction: a prospective survey in Ghanaian females
      3770. Including sexual Function in Patient Evaluation in the Rehabilitation Setting
      3771. Incognito libido: Introducing the sexual false self scale
      3772. Incompetence schemas and sexual functioning in heterosexual and lesbian women: the mediator role of automatic thoughts and affective states during sexual activity
      3773. Incorporating mindfulness and chat groups into an online cognitive behavioral therapy for mixed female sexual problems
      3774. Incorporating mindfulness into an internet-based intervention for female sexual dysfunctions
      3775. Incorporating pelvic floor exercises in complete decongestive therapy for females with lower extremity lymphedema, with and without genital involvement, to improve …
      3776. Incorporating sexual medicine into clinical practice
      3777. Incorporating women: A theory of female sexuality informed by psychoanalysis and biological science
      3778. Increasing orgasm and decreasing dyspareunia by a manual physical therapy technique
      3779. Increasing women’s sexual desire: the comparative effectiveness of estrogens and androgens
      3780. Index of sexual Satisfaction (ISS): a study on the reliability and validity
      3781. Individual and dyadic barriers to a pharmacotherapeutic treatment of hypoactive sexual desire disorders: results and implications from a small-scale study with …
      3782. Individual and relationship factors associated with the self-identified inability to experience orgasm in a community sample of heterosexual men from three European …
      3783. Individual differences in women’s salivary testosterone and estradiol following sexual activity in a nonlaboratory setting
      3784. Individual prolactin reactivity modulates response of nucleus accumbens to erotic stimuli during acute cannabis intoxication: an fMRI pilot study
      3785. Indo-American
      3786. Infectious Disease
      3787. Infertility and sexual Dysfunction (SD) in the Couple
      3788. Infertility and sexual dysfunctions: a systematic literature review
      3789. Infertility-related distress and female sexual function during assisted reproduction
      3790. Infidelity and its associated factors: A systematic review
      3791. Infidelity: A practitioner’s guide to working with couples in crisis
      3792. Inflammatory Bowel Diseases and sexual Health: More Studies Are Needed
      3793. Inflatable Penile Prosthesis Washout
      3794. Influence of dyslipidemia on the quality of sexual life in women in the menacme using a combined oral contraceptive
      3795. Influence of genotype and hyperandrogenism on sexual function in women with congenital adrenal hyperplasia
      3796. Influence of methyltestosterone postmenopausal therapy on plasma lipids, inflammatory factors, glucose metabolism and visceral fat: a randomized study
      3797. Influence of self perceived vulvar appearance on female sexual function
      3798. Influence of self‐perceived incontinence severity on quality of life and sexual function in women with urinary incontinence
      3799. Influence of sildenafil on genital engorgement in women with female sexual arousal disorder
      3800. Influence of Unilateral Cryptorchidism on Libido, Haematology and Serum Reproductive Hormones, Total Protein, Lipid Profile and Oxidative Stress in West …
      3801. Influence of weight reduction by sibutramine on female sexual function
      3802. Influence of X-chromosome dosage on masculine behaviors
      3803. Influences of different hysterectomy techniques on patients’ postoperative sexual function and quality of life
      3804. Influences of economic, social and cultural marginalization on the association between alcohol use and sexual risk among formerly incarcerated Latino men
      3805. Influences of situational factors and alcohol expectancies on sexual desire and arousal among heavy-episodic drinking women: Acute alcohol intoxication and …
      3806. Influencias de las cogniciones en el placer sexual femenino.
      3807. INFOPOEMS
      3808. Infusional therapies, continuous dopaminergic stimulation, and nonmotor symptoms
      3809. Inhaled Fluticasone-Salmeterol Better Than Fluticasone Alone for Moderate to Severe Asthma
      3810. Inhibited arousal in women
      3811. Inhibited sexual desire
      3812. Inhibited sexual desire and sexual avoidance
      3813. Inhibited sexual desire in women
      3814. Inhibition of serotonin synthesis: A novel therapeutic paradigm
      3815. Inhibitors of 5 [alpha]-reductase-related side effects in patients seeking medical care for sexual dysfunction
      3816. Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction
      3817. Initiating new sexual behaviours in heterosexual relationships
      3818. Injectable Botulinum Toxin for Pelvic Pain: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
      3819. Innovations, reviews and proposals on the DSM-5: The case of sexual dysfunctions, gender dysphoria and paraphilic disorders
      3820. Insight of Women’s sexual Function and Intimate Relationships AfterTermination of Pregnancy: A Review on Recent Findings and FuturePerspectives
      3821. Insights into flibanserin oxidative stress degradation pathway: in silico–in vitro toxicity assessment of its degradates
      3822. Insomnia and sexual dysfunction associated with severe worsening of the quality of life in sexually active hysterectomized women
      3823. Instruments for Screening, Diagnosis, and Management of Patients with Generalized Acquired hypoactive sexual desire Disorder
      3824. Instruments to measure sexual dysfunction in community and psychiatric populations
      3825. Insulin resistance and hypogonadism
      3826. Integrated and gender-affirming transgender clinical care and research
      3827. Integrating couple therapy into work with sexual dysfunctions
      3828. Integrating psychotherapy and pharmacotherapy in the treatment of premature ejaculation
      3829. Integrating Psychotherapy and Psychopharmacology
      3830. Integrating Psychotherapy and Psychopharmacology in sexual Disorders
      3831. Integrating sex therapy and couple therapy in the treatment of hypoactive sexual desire disorder: An attachment-based approach
      3832. Integrating sex Therapy and Couple Therapy.
      3833. Integrating sex therapy interventions with couple therapy
      3834. Integrating sexual partners into pharmacological sex therapy
      3835. Integration of medical and psychologic diagnosis and treatment
      3836. Integration of sex and sexuality into counseling programs
      3837. Integrative Therapy in a Woman with Secondary Low sex desire
      3838. Integrative therapy in a woman with secondary low sex desire.
      3839. Integrative Treatment of Female sexual Dysfunction
      3840. Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM‐V revisions: 1. For women with …
      3841. Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM‐V revisions: 2. For women with …
      3842. Intensified antituberculosis therapy in adults with tuberculous meningitis
      3843. Inter-relationships between sexual abuse, female sexual function and childbirth
      3844. Interacting Factors Between Physical Health, Mental Health, and a Long Quality Life
      3845. Interactions between human sexual arousal and sexual desire: A challenge for social neuroscience
      3846. Interactions between inflammation and female sexual desire and arousal function
      3847. Interactions of catecholamines and progesterone receptors in the medial amygdala enhance female sexual motivation
      3848. Interactions of Sleep and Female sexual Function: a Review
      3849. Intercourse frequency among men presenting to a sexual health clinic: does age matter?
      3850. Interest, arousal, and shifting diagnoses of female sexual dysfunction, or: How women learn about desire
      3851. Intermittent Treatment with the Psychodynamic Psychiatrist: A Patient-Centered Approach
      3852. INTERNAL MEDICINE. Comparison of Prevalence and Female sexual Dysfunction between Diabetic and Non-Diabetic in Kelantan.
      3853. International handbook of psychiatry: a concise guide for medical students, residents, and medical practitioners
      3854. International Journal of Africa Nursing Sciences
      3855. International Journal of Clinical and Health Psychology
      3856. International Journal of Gynaecology Research
      3857. INTERNATIONAL JOURNAL OF PAIN MANAGEMENT
      3858. International Society for sexual Medicine’s guidelines for the diagnosis and treatment of premature ejaculation
      3859. International Society for the Study of Women’s sexual Health (ISSWSH) Review of Epidemiology and Pathophysiology, and a Consensus Nomenclature and Process …
      3860. Internet and sexuality in Morocco, from cyber habits to psychopathology
      3861. Internet Based Cognitive Behavioral Therapy for sexual Dysfunctions After Breast Cancer
      3862. Internet-based brief sex therapy for heterosexual men with sexual dysfunctions: a randomized controlled pilot trial
      3863. Internet-based cognitive behavioral therapy for DSM-IV sexual dysfunctions in breast cancer survivors: Predictors of treatment response
      3864. Internet-based cognitive behavioral therapy for sexual dysfunctions in women treated for breast cancer: design of a multicenter, randomized controlled trial
      3865. Internet-based cognitive behavioral therapy realizes long-term improvement in the sexual functioning and body image of breast cancer survivors
      3866. Internet‐Based sex Therapy
      3867. Interoception and awareness of physiological sexual arousal in women with sexual arousal concerns
      3868. Interoceptive awareness moderates the relationship between perceived and physiological genital arousal in women
      3869. Interoceptive awareness, alexithymia, and sexual function
      3870. Interpersonal dependency in child abuse perpetrators and victims: A meta-analytic review
      3871. Interpretation of the sexual Functioning Questionnaire in the presence of vulvar pain
      3872. Interprofessional health education and its impact on integral healthcare
      3873. Interrelationship between Androgen Levels, Ageing, and Cognitive Functions
      3874. Intervention: androgens
      3875. Interventions for couples
      3876. Interventions for psychosexual dysfunction in women treated for gynaecological malignancy
      3877. Interventions for sexual dysfunction following treatments for cancer
      3878. Interventions for sexual dysfunction following treatments for cancer in women
      3879. Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology clinical practice guideline adaptation of Cancer Care …
      3880. Interventions to treat erectile dysfunction and premature ejaculation: an overview of systematic reviews
      3881. Interview with Brian S. Alper of DynaMed
      3882. Intestinal Stoma: sexual Dysfunction and Intimacy for Ostomates
      3883. Intimacy and sex therapy
      3884. Intimacy disorders and sexual panic states
      3885. Intimacy in the midst of caregiving: Examining relationship and sexual satisfaction of parents raising children with special needs
      3886. Intimacy, libido, depressive symptoms and marital satisfaction in postpartum couples
      3887. Intimacy, sexual desire and differentiation in couplehood: A theoretical and methodological review
      3888. Intimacy, sexuality, and Fertility Issues Associated With Cancer Treatment
      3889. Intimate partner abuse among women diagnosed with depression
      3890. Intimate partner relationship distress in the DSM‐5
      3891. Intimate stimuli result in fronto-parietal activation changes in anorexia nervosa
      3892. Intimate tablets: digital advocacy and post-feminist pharmaceuticals
      3893. Intimately connected: The importance of partner responsiveness for experiencing sexual desire.
      3894. Intracrinology: The New Science of sex Steroid Physiology in Women
      3895. Intranasal apomorphine. Nastech Pharmaceutical
      3896. Intranasal niosomal in situ gel as a promising approach for enhancing flibanserin bioavailability and brain delivery: In vitro optimization and ex vivo/in vivo evaluation
      3897. Intrapsychic and interpersonal factors related to hypoactive sexual desire
      3898. Intravaginal DHEA for the treatment of vulvovaginal atrophy, intracrinology at work
      3899. Intravaginal energy-based devices and sexual health of female cancer survivors: a systematic review and meta-analysis
      3900. Intravaginal testosterone improves sexual satisfaction and vaginal symptoms associated with aromatase inhibitors
      3901. Intrinsa fails to impress FDA advisory panel
      3902. Intrinsa: An Inquiry into Female sexual Dysfunction and Testosterone
      3903. Intrinsa: testosterone patch for low sexual desire in women
      3904. Intrinsic and extrinsic religiosity and sexual compulsivity with Christian males: understanding concepts and correlations based on race, age and socioeconomic status …
      3905. Intrinsic links among sex, emotion, and reproduction
      3906. Introducing asexuality, unthinking sex
      3907. Introducing sexual dysfunction in mental care
      3908. Introduction and overview: Clinical perspectives on and treatment for sexual desire disorders.
      3909. Introduction and Pharmacodynamics
      3910. Introduction to sexual medicine
      3911. Introduction to special issue on surgical menopause
      3912. Introduction to the special section on contemporary issues in human sexuality: Research and practice.
      3913. Introduction: 2013 Symonds Prize Essay
      3914. Introduction: A Long History of a Pseudoscientific Object
      3915. Introduction: Clinician’s handbook of evidence-based practice guidelines: The role of practice guidelines in systematic quality improvement
      3916. Introduction: New developments in the area of sexual dysfunction (s)
      3917. Introduction: sexual health matters!
      3918. Introduction: the need of sexual medicine in contemporary psychiatry and the need of psychiatry in the growing field of sexual medicine
      3919. Intrusive partners-elusive mates: The pursuer-distancer dynamic in couples
      3920. Inventories for male and female sexual dysfunctions
      3921. Investigating Neuromodulation as a Treatment for Female sexual Dysfunction
      3922. Investigation of ejaculatory disorder by silodosin in the treatment of prostatic hyperplasia
      3923. Investigation of factors affecting sexual disorders in women with breast cancer
      3924. Investigation of Host Factors Required for Lymphocytic Choriomeningitis Virus Entry
      3925. Investigation of the effect of Elaeagnus angustifolia flower capsule on sexual satisfaction and levels of androgenic hormones in 18-40 year old married women …
      3926. Investigation of three Tanacetum L. taxa from Turkey on the proliferation of human prostate cancer cells and expression of detoxification enzyme activities
      3927. Investigation on psychological symptoms improves ANDROTEST accuracy in predicting hypogonadism in subjects with sexual dysfunction
      3928. Investigational noncardiovascular uses of phosphodiesterase-5 inhibitors
      3929. Investigational therapies in the treatment of obesity
      3930. Investigations in sexual Medicine for Women and Men with sexual Health Problems
      3931. Involvement of 5-HT1A and 5-HT2A receptors but not α2-adrenoceptors in the acute electrophysiological effects of cariprazine in the rat brain in vivo
      3932. Iranian Couples Conceptualization of the Role of sexual Socialization in Their sexual desire: A Qualitative Study
      3933. Irreducible volar subluxation of the metacarpophalangeal joint of the thumb
      3934. Is “Dilator Use” More Effective Than “Finger Use” in Exposure Therapy in Vaginismus Treatment?
      3935. Is 100mg Flibanserin Effective in Increasing the Number of sexually Satisfying Events (SSE) in Women with hypoactive sexual desire Disorder (HSDD)?
      3936. Is beautiful always good? Implicit benefits of facial attractiveness
      3937. Is cognitive processing affected in adults with hypospadias?: P300 study
      3938. Is committed desire intentional? A qualitative exploration of sexual desire and differentiation of self in couples
      3939. Is dehydroepiandrosterone a hormone?
      3940. Is dialysis adequacy a useful predictor for sexual function in males and females with end-stage renal disease?
      3941. Is dyspareunia unrelated to early sexual abuse?
      3942. Is early exposure to pornography a risk factor for sexual compulsivity? Findings from an online survey among young heterosexual adults
      3943. Is female sexual dysfunction related to personality and coping? An exploratory study
      3944. Is female sexual function related to the male partners’ erectile function?
      3945. Is Flibanserin a Safe and Effective Treatment to Increase sexual desire in Premenopausal Women with hypoactive sexual desire Disorder?
      3946. Is flibanserin meaningfully superior to placebo?
      3947. Is Healthcare Hazardous to Life? An American Transcendentalist Perspective
      3948. Is hypersexuality dimensional? Evidence for the DSM-5 from general population and clinical samples
      3949. Is it good to be giving in the bedroom? A prosocial perspective on sexual health and well-being in romantic relationships
      3950. Is it sufficent to be a sex therapist to deal efficiently with couples who have sexual problems?
      3951. Is it time to move on from” hypoactive sexual desire disorder?”
      3952. Is menopause a disorder?
      3953. Is mild erectile dysfunction associated with severe psychological symptoms in Chinese patients with moderate-to-severe chronic prostatitis/chronic pelvic pain …
      3954. Is multiple sclerosis only a neurological problem? Evaluation of sexual dysfunctions in a group of multiple sclerosis patients
      3955. Is obesity a further cardiovascular risk factor in patients with erectile dysfunction?
      3956. Is one question enough to detect female sexual dysfunctions? A diagnostic accuracy study in 6,194 women
      3957. Is polycystic ovary syndrome associated with risk of female sexual dysfunction? A systematic review and meta-analysis
      3958. Is pornography use associated with sexual difficulties and dysfunctions among younger heterosexual men?
      3959. Is psychosexual therapy a reliable alternative to bupropion extended-release to promote the sexual function in infertile women? An RCT
      3960. Is responsive sexual desire for partnered sex problematic among men? Insights from a two-country study
      3961. Is Shifting to a Progestin Worthwhile When Estrogen—Progestins Are Inefficacious for Endometriosis-Associated Pain?
      3962. is still important in the elderly
      3963. Is successful lithium augmentation limited to serotonergic antidepressants?(letter). Bschor, Apr, 240 Lack of pharmacologic interaction
      3964. Is testosterone a food for the brain?
      3965. Is Testosterone an Effective Hormonal Therapy for Women With Antidepressant-Resistant Major Depression?
      3966. Is testosterone involved in low female sexual desire?
      3967. Is testosterone or estradiol the hormone of desire? A novel study of the effects of testosterone treatment and aromatase inhibition in postmenopausal women
      3968. Is Testosterone the Hormone of desire? For Some Women, Some of the Time
      3969. Is the coital imperative really imperative? An exploratory study of the experience of individuals in heterosexual relationships who have been unable to have …
      3970. Is the Female sexual Function Affected by the Vaginal Wall Prolapse?
      3971. Is the functional ‘normal’? Aging, sexuality and the bio-marking of successful living
      3972. Is the hype around the reproductive health claims of maca (Lepidium meyenii Walp.) justified?
      3973. Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women?
      3974. Is the sexual satisfaction of postmenopausal women enhanced by physical exercise and pelvic floor muscle training?
      3975. Is there a correlation between androgens and sexual desire in women?
      3976. Is there a gender difference in strength of sex drive? Theoretical views, conceptual distinctions, and a review of relevant evidence
      3977. Is there a link between social phobia and sexual problems?